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ABSTRACT 
The interaction of biomaterials with biological systems is a complex process, that 
is triggered in response to implants and wounds. It is essential to understand the phases of 
wound healing response, particularly the interactions of immune cells such as macrophages 
and fibroblasts, with the local extracellular matrix which can influence implant acceptance 
or the restoration of the damaged wound site. Materials properties such as compressive 
modulus, surface geometry, functionalization, and topology can be tuned to modulate the 
inflammatory and fibrotic responses to wounds and implants.  
Naturally derived materials, such as alginate, are widely used biomaterials owing 
to their biocompatibility and the diverse crosslinking strategies that can be used for 
fabrication. Soft alginate gels can be synthesized after methacrylation to be relatively stable 
under physiological conditions, while retaining pH sensitivity, which can be useful in the 
treatment of chronic wounds. Studying the collagen response to NIH/3T3 fibroblasts 
encapsulated in these soft hydrogels can develop wound healing strategies to promote 
faster wound healing. The transition of collagen organization from aligned to isotropic 
states in the dually crosslinked stiffer methacrylated alginate (ALGMA) hydrogels shows 
promise towards the development of topical gels for wound care.  
Modifying the surface properties using arginine-like derivatives is effective in 
modulating the fibroblast response to implanted glass beads in SKH1-E mice. Collagen 
response to modified glass beads using SHG microscopy was evaluated using several 
factors such as collagen amount, secretion of collagen III, and organization of collagen. 
The albizziin modification showed both isotropic collagen organization as well similar 
collagen type III as unwounded skin. Furthermore, statistical analysis uncovered 
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correlations between SHG derived parameters and the materials properties of the chemical 
modifiers. Collagen type III was correlated with the surface tension of the modifier, and an 
empirical equation was derived relating materials parameters with the observed collagen 
measurements. 
The effectiveness of diverse wound care strategies on shallow and deep wounds on 
porcine subjects was conducted using SHG microscopy. Treatment duration, as well as 
scaffold preparation were instrumental in reducing a scarring response and accelerating 
wound closure rates.  By combining the understanding of wound healing in diverse tissue 
environments, with environmentally responsive wound dressings, it is possible to improve 
the quality of life for millions of patients across the world.  
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CHAPTER 1 
GENERAL INTRODUCTION 
There is an urgent need to understand the challenges of designing biocompatible materials. 
All materials used in tissue engineering trigger some level of biological responses upon 
implantation. Common challenges associated with the host response are failures due to chronic 
inflammatory responses as well as the formation of the avascular, fibrotic sheath around the 
implant. The avascular, chronic inflammatory host response can thus contribute to incomplete 
healing of percutaneous wounds for dermal implants and higher rates of infection from 
opportunistic pathogens.1,2 In the United States alone, over 25% of the GDP will be expended on 
research and development of novel biomaterials by 2040.3 Our main motivation for these research 
projects was to conceptualize a rational design for tissue engineering scaffolds that could 
incorporate influences of material properties, biochemical responses and biological activity.  
The Advanced Healthcare Materials paper submitted in this thesis as Chapter 2 addresses 
the challenges associated with understanding the key role played by material characteristics that 
can influence implant compliance within natural tissue environments. By considering diverse types 
of material scaffolds as well as cellular responses from macrophages and fibroblasts, detailed 
insight was obtained on the need to elucidate cell-matrix interactions from a biomedical 
engineering perspective.  
Second Harmonic Generation microscopy has enabled sensitive label-free detection and 
analysis of collagen response from cells proliferating in diverse biological environments. Chapters 
3 focuses on the current state of the art techniques that have been studied using similar high content 
imaging platforms for analyzing biomedical scaffolds and their applications. With the combined 
insight from multimodal imaging techniques and the need for rational design of scaffolds, research 
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was conducted on soft, tunable hydrogel materials that can be fabricated for diverse applications. 
As implant failures are commonly observed as a result of inflammatory responses or unfavorable 
fibrotic encapsulation. The host responses to implanted materials are similar to those following 
injury.4,5 Cells recruited to the wound play a key role in the series of inflammatory response based 
process. The normal wound-process is restored after the foreign objects such as pathogens, 
unrecognized proteins etc. are either dissolved, degraded or phagocytosed.5 Fibrous encapsulation 
of implants isolates the implant from the host tissue. Over the Chapters 4 and 5, we focus on the 
effect of modifying the surface topology of implants through diverse strategies as well as identify 
key parameters that can guide rational design of biomaterials. 
The collaborative research carried out in conjunction with the Corporate Research 
Materials Lab at 3M, facilitated a detailed study into the effect of different scaffolds to avoid 
scarring responses in porcine subjects. By carefully analyzing the samples for collagen-related 
biomarkers, it was possible for this blind study to provide unbiased insight into wound healing. 
We have included some of the most interesting results from this collaboration as Chapter 6. The 
perspective obtained from this collaboration was critical us to understand the challenges for 
designing scaffolds for lungs, heart, liver, skin, and bone systems. For successfully tuning the in 
vivo fibrotic response and the non-specific adsorption of proteins that can foul the implant surface 
and trigger undesirable responses, it was essential to work with stiffer alginate hydrogels to have 
the NIH/3T3 fibroblasts interact with physiologically relevant stiffnesses. Stiffer substrates, such 
as musculoskeletal regions, often trigger inflammatory responses  while those for softer tissues, 
like liver and lungs, incite an anti-inflammatory response from the native macrophages and 
fibroblasts.6,7 By evaluating the tunability of collagen organization to the different crosslinking 
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strategies for methacrylated alginate hydrogels, it was possible for us initiate decoupling of cell-
matrix interaction cues in Chapter 7.  
 The combination of most of the research on tunable, soft hydrogels for tissue 
engineering applications is explained in greater detail in Chapter 8 through the study of 
photomask-tuned alginate hydrogels that can mimic natural tissue environments. Through 
decoupling the influence of crosslinking mechanism on the collagen and overall cell-matrix 
interaction, it was possible to selectively observe the influence of mechanical stiffness on how 
cells secrete and organize collagen. This study thus becomes a fitting culmination of our analysis 
techniques for visualizing how cells sense the local microenvironment which can inform design of 
effective tissue engineering scaffolds. 
References 
1. Bryers, J. D., Giachelli, C. M. & Ratner, B. D. Engineering biomaterials to integrate and 
heal: The biocompatibility paradigm shifts. Biotechnology and Bioengineering 109, 1898–
1911 (2012). 
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3. Place, E. S., Evans, N. D. & Stevens, M. M. Complexity in biomaterials for tissue 
engineering. Nat. Mater. 8, 457–470 (2009). 
4. Mutsaers, S. E., Bishop, J. E., McGrouther, G. & Laurent, G. J. Mechanisms of tissue 
repair: From wound healing to fibrosis. Int. J. Biochem. Cell Biol. 29, 5–17 (1997). 
5. Avula, M. N., Rao, A. N., McGill, L. D., Grainger, D. W. & Solzbacher, F. Foreign body 
response to subcutaneous biomaterial implants in a mast cell-deficient Kitw-Sh murine 
model. Acta Biomater. 10, 1856–1863 (2014). 
6. Quinlan, A. M. T. & Billiar, K. L. Investigating the role of substrate stiffness in the 
persistence of valvular interstitial cell activation. J. Biomed. Mater. Res. - Part A 100 A, 
2474–2482 (2012). 
7. Ali, M. Y., Chuang, C.-Y. & Saif, M. T. a. Reprogramming cellular phenotype by soft 
collagen gels. Soft Matter 10, 8829–37 (2014). 
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CHAPTER 2 
METHODS FOR IMPLANT ACCEPTANCE AND WOUND HEALING: 
MATERIAL SELECTION AND IMPLANT LOCATION MODULATE 
MACROPHAGE AND FIBROBLAST PHENOTYPES 
Modified from a manuscript published in Advanced Healthcare Materials, 5(20) 2575-2594 
(2016) 
This review is focused on materials and methods used to induce phenotypic changes in 
macrophages and fibroblasts. Herein, we give a brief overview on how changes in the phenotypes 
of macrophages and fibroblasts are critical biomarkers for identification of implant acceptance, 
wound healing effectiveness and also essential for evaluating the regeneration capabilities of some 
hybrid strategies. The different types of cells present during FBR have been extensively studied 
for evaluating the response to different materials, and there are varied material approaches towards 
fabrication of biocompatible, and non-cytotoxic substrates. We discuss how natural and synthetic 
materials have been used to engineer desirable outcomes in lung, heart, liver, skin, and 
musculoskeletal implants, and it has been observed that certain properties such as rigidity, surface 
shapes and porosity play a key role in the progression of the immune response. Several fabrication 
strategies are discussed to control the phenotype of infiltrating macrophages and fibroblasts: 
decellularization of scaffolds, surface coatings, implant shape, and pore size apart from 
biochemical signaling pathways that can inhibit or accelerate unfavorable immune response. It is 
essential hence to factor all the different design principles, material fabrication criteria for 
evaluating the choice of implant materials or regenerative therapeutic strategies. 
2.1. Introduction 
The field of biomaterials is an evolving interface between different synergistic topics of science 
and engineering. The growth of the field of tissue engineering has a huge impact on the cost of 
healthcare all over the world, to the effect that by 2040 over 25% of the total US GDP shall be 
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invested in biomaterials research and development1.  There is hence clearly. a growing need for 
technologies that can provide treatment, while promoting regeneration of healthy parenchymal and 
stromal tissue2. This niche is met by applying transdisciplinary principles from fields such as 
biological engineering, biochemistry, materials science, and chemical engineering to fabricate 
implants or scaffolds. However, the innate and complex intricacies in biological responses to 
material properties are challenging to predict a priori, meaning that implant failure often occurs 
as a result of inflammation3 and fibrous encapsulation4. Abating or eliminating such host responses 
is of central importance in current bio-implant design. There are several key characteristics 
involved in the host response to biomaterials, two of which are activation of macrophages and 
fibroblasts.5 These cells are essential to tissue regeneration, with the former mediating 
inflammation and the latter can instigate fibrous encapsulation. 
Macrophages are thought to exist on a spectrum of phenotypes bookended by classical 
activated M1 macrophages and alternatively activated M2 macrophage. Another description of 
macrophage activation uses an analogy of a color wheel, in which classically activated, wound-
healing, and regulatory macrophages occupy the ‘primary colors’ that blend into ‘shades’ of 
macrophage activation. M1 macrophages can be activated by lipopolysaccharides (LPS) or 
interferon-γ (IFN-γ) and produce cytokines and chemokines such as tumor necrosis factors-α 
(TNF-α), interleukin-1 (IL-1), interleukin-6 (IL-6), and nitric oxide; while M2 macrophages can 
be induced by IL-4 and release cytokines including tumor growth factor-β (TGF-β) and IL-106–9. 
M1 macrophages are also known as inflammatory macrophages, which aid in ‘sterilizing’ the 
wound environment after injury, such as implantation of a biomaterial; in contrast, M2 
macrophages are often termed anti-inflammatory and relieve inflammation and aid in tissue 
formation. These two contrary function allow macrophages to play critical roles in host responses9. 
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Despite in depth studies examining macrophage function in the implant milieu, their response and 
activation pathways are not completely understood. Macrophages function differently depending 
on their location10 and can be further polarized into several sub-phenotype base on their 
microenviroment6. 
The substrate and chemically sensitive differentiation of fibroblasts into myofibroblasts has 
been confirmed to have dramatic influence on the reorganization of the extracellular matrix 
(ECM)11. Myofibroblasts have been studied for their role in tumor stroma remodeling and their 
influence on modifications of the ECM. Their presence is mediated by two main factors: de novo 
stress due to contractile actin bundles being activated and through mechanical stress12. Both these 
factors are also inherently linked to macrophage polarization towards acute or chronic responses. 
The contractile actin bundles mediated change in ECM activity has been observed to be 
responsible for the secretion of TGF-β or its latent form, which also results in classical activation 
of M1 macrophage response13. Similarly, the mechanical stress has been known to play a role in 
the activation of the matrix metalloproteinases (MMPs), which are themselves responsible for 
activating TGF-β, from its latent form. Both fibroblasts and myofibroblasts secrete collagen and 
exert mechanical influence to alter ECM organization as a function of the material properties of 
implants or wounds.    
It is known that shortly after implantation, protein adsorption at the implant surface will take 
place in seconds, followed by neutrophils adhesion which last 1 or 2 days14. Generally, monocytes 
will be recruited to the site of injury and will differentiate into macrophage within one week after 
implantation. If the material is not able to be phagocytosed, macrophage presence will persist, and 
eventually culminates in macrophage fusion into multinucleate giant cells followed by fibrous 
encapsulation of the foreign body15. Initially, host responses to different implants were classified 
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primarily on the basis of the fibrotic capsule that was formed. Further studies have displayed a 
diversity of cytokines and growth factors that intricately influence the acceptance of the implant, 
and its long-term stability in vivo.  
 
Figure 2.1. Time line of macrophage and fibroblast & myofibroblast population at the implant 
site. 
 
Different growth factors and cytokines at the implant site are able to initiate complex 
pathways that differentiate monocytes into the various macrophage phenotypes. Based on the 
initial acceptance of the implants, these interactions can lead to the presence of fibroblasts, which 
are primarily responsible for the initiation of angiogenesis and the formation of ECM in the 
vicinity. Together, the changes in the phenotypes of the fibroblasts and macrophages responding 
to the wound or implant greatly influence the severity of the response.  
Inflammation and formation of the fibrotic capsule16,17 were two of the first markers of the 
host response observed. Eventually it became essential to define the fibrotic response as beneficial 
or inflammatory. Depending on the location of the implants, surface properties, materials types, 
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and time-scales over which the studies were conducted, the extent of the host response was found 
to vary greatly.  
Herein, we describe the macrophages and fibroblast response to bio implants with various 
materials, structures, and implant locations as a result of FBR. The purpose of this review is to 
organize current effort in modulating macrophage and fibroblast response to reduce FBR caused 
by bio implant and analysis how material selection and implant geometry structure can reduce 
FBR. This review provided the design principle of biocompatible implant with different implant 
locations.  
2.2. Influence of Material Selection on the Host Response 
Material selection is one of the primary factors for consideration in designing biomedical 
implants. Here, we have classified biomaterials into three main types: natural, synthetic, and hybrid 
materials. Natural materials derive from living sources and are generally bio-friendly. Synthetic 
materials have potentially infinite diversity and are generally more amenable to sterilization and 
fabrication processes16. Hybrid materials aim to combine the advantages of both natural materials 
and synthetic materials through physical and/or chemical linkages of the two types of materials. 
This section will discuss… 
2.2.1 Natural Materials 
Natural materials can be either bioactive or bioinert. Dermatan sulfate injection could 
significantly reduce myofibroblast and macrophage concentration and collagen content in 
inflammation environment17. Conversely, silk is relatively inert to cell: silicone implant coated 
with spider silk protein was able to reduce cytokine release and inhibit monocytes differentiation 
into macrophages18. In other cases, less cell population was found on silk fibroin and human 
tropoelastin hybrid protein coated scaffolds19.   
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However, natural materials often have several functions with micro-environment 
dependence20. Improper usage of natural materials can also lead to enhanced FBR. Material such 
as chondroitin sulfate proteoglycans were known to cause inflammation and delay healing process 
after spinal cord injury. On the contrast, chondroitinase ABC injection could cause large-scale 
digestion and restore healing process21,22.  
Because of the variability and uncertainty during natural synthesis, the same categories of 
natural material can also differ in size and functional groups. Correct understanding and 
appropriate application of natural materials are essential for reducing FBR. The following sections 
will analysis different cell response principles for alginate, chitosan, and hyaluronic acid.  
2.2.1.1. Alginate 
Alginate is a polysaccharide derived from algae. Alginate has been widely used for drug 
encapsulation or tissue engineering owing to its low toxicity, good biocompatibility, and gelation 
under mild conditions with divalent cations. In addition, the structure of alginate is similar to the 
ECM of living tissues and it provides a moist, inert microenvironment for encapsulated cells.  
Alginate is generally considered to elicit an anti-inflammatory response and high molecular 
weight alginate (500 kDa) has been shown to reduce pro-inflammatory cytokines IL-1β and IL-
623. However, a recent study showed that cell responses can be modified through changing the 
ratio of guluronic acid (G block) to mannuronic acid (M block). Previous research has shown that 
alginate containing 94% M block leads to higher TNF-α secretion than LPS stimulation in 
RAW264.7 macrophages while polymannuronate (100% M block) of a similar molecular weight 
produces significantly less TNF-α24. Further research demonstrated that this effect was more 
pronounced when comparing alginate degradation products from the G block and M block25,26. 
Alginate oligosaccharides, particularly unsaturated guluronate oligosaccharide prepared by 
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enzymatic degradation (GOS-ED), induce strong inflammatory responses, measured by nitrite 
production, in RAW264.7 cells with a concentration and molecular weight dependence26. 
However, alginate oligosaccharides degraded either by acid hydrolysis or oxidation showed no 
significant effect on naïve RAW264.7 cells, and oxidative degraded G block (GOS-OD) can even 
reduce inflammatory response in LPS induced RAW264.7 macrophages in a concentration 
dependent manner25. Pathway study found that GOS-OD can efficiently inhibit LPS binding to 
cell surface and reduce cell activation25. 
The material properties of alginate are highly affected by the G/M ratio. One obvious 
difference that arises from altering the G/M ratio is the mechanical properties of the resulting gel. 
The G block forms an ‘egg box’ structure in the presence of di- and tri-valent cations, resulting in 
improved crosslinking and higher stiffness compared to M block rich alginate hydrogels27. There 
are a limited number of studies interrogating the relationship between the FBR and the G/M ratio 
of alginate. Many of the studies that have been performed have inconsistent results28–31. One of 
the previous studies claimed alginate with MG blocks or M block only, but not G block only, could 
stimulate human monocytes derived macrophage to produce inflammation cytokines such as TNF-
α, IL-1, and IL-6. The alginate with lower G/M ratio resulted in higher cytokines release.30 
However, other recent study showed alginate with 60% M block can induce higher amount of 
TNF-α than 75% M block alginate, and alginate with M block only didn’t show significant 
difference in TNF-α production compare with control group.24 There is a clear need to better 
understand the how the G/M ratio influences host responses.  
2.2.1.2. Chitosan 
Another natural material whose material properties and host responses are impacted by the 
ratio of its monomers and molecular weight is chitosan. Chitosan is partially deacetylated chitin 
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(poly-N-acetylglucosamine), which is the main component of crustacean shells. Chitosan can be 
biodegradable with a degree of deacetylation (DD) ranging from 15% to 85%32. It is also insoluble 
in human body fluid at high molecular weight s(MW>20kDa)33. Cellular responses to chitosan 
change with differing DD32–35. 
The effect of DD is known to provoke a stronger antimicrobial response in chitosan with a 
higher DD36,37.  Further studies have shown that high molecular weight chitosan scaffolds 
(MW=890-830 KDa) with 95% DD significantly reduce cellular adhesion and had a lower M1/M2 
ratio, measured by surface receptors CD206 for M2 macrophages and CCR7 for M1 macrophages, 
compared to chitosan scaffolds with 85% DD35. Further reducing the DD of high molecular weight 
chitosan (76% DD) resulted in high secretion of inflammatory cytokine IL-1β in bone marrow 
derived mouse macrophages in vitro, while chitin (7% DD) was a less potent stimulator of the M1 
response34. Taken together, these responses suggest a non-linear relationship between 
inflammation response and DD.  
Mechanistic studies have also been performed to ascertain the effect of the acylation on the 
inflammasome, with multiple pathways implicated. IL-1β release in the presence of 76% DD 
chitosan inhibited in both peritoneal and bone marrow derived macrophages harvested from 
NLRP3-/- mice compared to wild type (WT). Pathways including K+ efflux, reactive oxygen 
species generation, and lysosomal destabilization were also involved. All of these pathways are 
necessary for peak IL-1β release in response to chitosan34. Pathways were also varied by 
macrophage initial phenotype: in M0 and M2a macrophage,  IL-1ra could be induced by 80% DD 
chitosan but not 98% DD chitosan without active IL-4/STAT-6 axis, while there was no significant 
difference in M1 macrophage32. Moreover, 80% DD chitosan at both medium and low molecular 
weight was reported to cause delayed STAT-1 activation, but 98% DD chitosan cannot.32 
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Although the mechanisms of macrophage activation as a result of chitosan acylation have 
been widely studied, the results are not directly comparable owing to the use of different 
macrophage cell lines, different molecular weights, and sources of chitosan. Other difficulties in 
comparing chitosan activation of macrophages stem from limited studies comparing a variety of 
DD. Some studies have even compared the acylation effect on macrophages using chitosan with 
molecular weights that differ by orders of magnitude36, which may lead to a less reliable conclusion 
since molecular weight of chitosan might also impact cellular responses and modulate the FBR. 
Since the inflammatory response is not linearly related to DD34,35,  there is a need for systematic 
studies over a range of DD for consistent molecular weight. The effect of chitosan on different 
macrophage polarization is also necessary to provide a better picture on how implanted chitosan 
would modulate the innate immune response. 
Molecular weight of chitosan over the range of 50 to 300 kDa does not have a significant 
effect on macrophage response.38 Similar to alginate, very low molecular weight chitosan, , 
specifically degradation products termed chitosan oligosaccharide (COS), have been reported to 
induce a strong inflammatory response39,40. Chitosan enzymatic hydrolyzed with a degree of 
polymerization of 3-6 was found to greatly enhance inflammatory responses by increasing TNF-α 
and NO production in RAW 264.7 macrophages. COS induced inflammation is caused mainly by 
activating toll like receptor-4.39 Interestingly, 20 kDa chitosan has little to no effect on macrophage 
morphology and CD40 expression while COS with an average molecular weight 750 Da causes 
M1 activation.40 Even though high molecular weight chitosan does not induce a strong 
inflammatory response, degradation of the implant may result in an undesirable M1 macrophages 
response at these later time points. Chitosan (80%DD) with molecular weights ranging from 150 
to 10,000 Da were implanted into skeletally aged rabbits’ knee trochlea. These low molecular 
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weight materials have a faster degrade rate.41 High degradation rates can lead to massive release 
of COS and further cause serious implant inflammation; conversely, low degradation rates may 
effect tissue regeneration.  
Chitosan is generally known to induce a higher inflammatory response than glass slides 
and tissue culture plastic in vitro.42–44 Higher cell mobility was observed for human primary 
monocytes derived macrophages cultured on chitosan film compare to tissue culture polystyrene 
plates.43 Other studies have shown increased M1 markers such as IL-6, TNF-α, and IL-1β42. Anti-
inflammatory cytokines increased significantly after 10 days. Mechanistic studies have shown that 
macrophages recognize chitosan via CD206.42  
Loading chitosan with drug or chemokines can also modulate cellular responses. Chitosan 
nanoparticles loaded with the non-steroidal anti-inflammatory drug (NSAID) diclofenac reduces 
IL-6 and prostoglandin E2 (PGE2) secretion from LPS activated human macrophages while 
increasing TNF-α release45. In contrast, chitosan encapsulating the anticancer agent methylglyoxal 
leads to high inflammatory mRNA expression including IL-6, IL-1β, TLR-4, and TNF-α in 
Sarcoma-180 tumor bearing mice46. It has been reported that maleimide-streptavidin modified 
methacrylamide chitosan hydrogel can loaded with growth factors such as IFN-γ and remain at 
high concentration in chitosan scaffold with less than 20% release after one month in vitro. 
However, when these materials were implanted into ???, they did not show observable differences 
compared to chitosan implants without the growth factor47.  
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2.2.1.3. Hyaluronic Acid 
Native hyaluronic acid (HA) is a non-sulfated glycosaminoglycan (GAG) with molecular 
weights up to 10 million Da.48 HA can be naturally degraded and re-synthesized in vivo.49 HA is 
known to interact with several cell surface markers, such as CD44. and can influence the FBR in 
a molecular weight dependent manner.50 
HA has distinct biological functions at different molecular weights. High molecular weight 
HA often lead to anti-inflammation51 and low molecular weight HA can cause inflammation52. 
Recently, HA molecular weight effects on macrophage reprogramming and cytokine release have 
been demonstrated.53 HA molecular weight spanning 10-1 to 103 kDa were tested in macrophages 
polarized with LPS/IFN-γ or IL-4 along with naïve cells. Very high (103 kDa) and very low 
molecular weight (10-1 kDa) HA has direct influence on macrophage polarization regardless of the 
initial phenotype53. In different phenotypes, most anti-inflammatory cytokines increase 
logarithmically with molecular weight; in contrast, most pro-inflammatory decrease 
logarithmically53. Similar studies were performed on LPS/IFN-γ activated human peripheral blood 
monocytes obtained from donors. IL-1β production after incubation with 5 to 1,700 kDa HA 
showed a decrease with molecular weight without a clearly identifiable trend. Large variety was 
found between each donor, and was used to explain the lack of a trend48.  
Although numerous studies on cellular responses to HA have been conducted in vitro, there 
is large uncertainty in the effect of  HA molecular weight in vivo. One interesting phenomenon 
found both in vivo and in vitro showed that LPS activated macrophage could increase HA synthase 
(HAS) 1 and HAS 2 mRNA expression and decrease hyaluronidases54. However, despite the 
reduction in hyaluronidases, rapid degradation of HA was still observed in macrophages even 
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though the HA concentration increased in other tissues54, which suggested LPS activated 
macrophage may be able to degrade HA without hyaluronidases. HA synthase is able to synthesize 
high molecular weight HA50, thus upregulation of synthase will lead to high molecular weight HA 
and reduce the inflammatory response caused by HA. The rapid degradation of HA in macrophages 
may abrogate this effect since low molecular weight HA is pro-inflammatory. The mechanism 
behind this response is still unknown. 
The main surface marker that recognizes HA is CD44, which is upregulated in 
inflammatory environments.53 Although IL-4 and LPS/INF-γ activated macrophage have similar 
levels of CD44 expression, IL-4 induced M2 macrophage can cause CD44 sulfation by post-
translational modifications such as increasing chondroitin sulfate, while TNF-α can significantly 
reduce the sulfation and HA binding to macrophages55.  Since inhibition of chondroitin sulfate 
adhesion on CD44 could increase HA binding, chondroitin sulfate also regulates HA binding55. 
Considering these factors, HA with pre-sulfating treatment may also reduce macrophage adhesion 
and induce an anti-inflammatory response. In fact, collagen films coated with 16% sulfated 
hyaluronic acid cultured with macrophages in vitro lead to increased M2 cytokines such as IL-10 
and lower M1 cytokines such as TNF-α and IL-12 compared to 6% sulfated HA followed by native 
HA56,57. 
2.2.2. Synthetic Materials 
Compared to natural materials, synthetic materials are generally less biocompatibility. 
However, due to their high plasticity, synthetic materials can easily be fabricated to have tunable 
mechanical properties, controlled degradation, and various structures 60,61. Unlike natural 
materials, many synthetic materials are more resistant to increased temperature and can be 
processed or sterilized easily. Synthetic materials are generally divided into bio-degradable and 
non-biodegradable categories. 
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2.2.2.1. Biodegradable Synthetic Materials 
Polymers such as poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) are 
commonly used biodegradable materials. An ideal biodegradable implant can maintain their 
function and degrade without releasing cytotoxic substances. One of the major advantages of using 
biodegradable implant is that a second surgical intervention is not required16. With controlled 
degradation kinetics, tissue regeneration rates ideally match the degradation process.  
PLA has been used for clinical application and has a low in vivo degradation rate ranging 
from months to years62. Because PLA alone often induces relatively high inflammatory response 
in the early stage of implantation63–65, PLA copolymer or surface coated PLA have been 
synthesized to improve host responses. Cardiovascular stent implants composed of high molecular 
weight PLA blended with phospholipid polymer bearing phosphorylcholine groups was able to 
reduce thrombus formation and significantly decrease inflammatory cytokines, IL-6, IL-1β, and 
TNF-α, released compared with PLA alone when implanted subcutaneously in rats and in arteries 
of rats or rabbits64. Unlike most natural materials, which cannot be processed under harsh reaction 
conditions, PLA implants can be fabricated through various processes including hot-melt 
extrusion62 due to its thermal and chemical stability.  
The degradation behavior of synthetic material implant is mainly determined by polymer 
structure, molecular weight, morphology, and implant environment. Shape memory material 
composed of polyhedral oligomeric silsesquioxane (POSS) and PLA star-shaped copolymers 
exhibited a relationship between delay in degradation and PLA chain length63. Both in vitro and 
in vivo degradation studies on POSS-PLA found that there was a lag phase period preceding a 
rapid degradation phase, in which the lag phase showed less than 10% degradation in 2-6 months 
with a dependence on PLA chain length while 90% of the mass was lost in 2 months during the 
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degradation phase regardless of PLA chain length63. Interestingly, longer PLA chain length 
extended the lag phase but showed no observable effect in changing the degradation rate in the 
later phase63. This could be a result of the dense PLA chain in outermost layer that delayed body 
fluid interfusion. Relatively mild inflammatory responses were observed when implanted 
subcutaneously in rats comparing to PLA alone. Through controlling PLA chain length, POSS-
PLA implants could be applied to mid or long-term therapy such as bone bridging.     
One disadvantage of biodegradable synthetic materials is that, in many cases, degradation 
products are not biocompatible and will lead to inflammatory response. A secondary acute 
inflammation was often observed in the site of implant during the rapid degradation period63. Thus, 
how to design a bio-implant that can stay functional as long as the therapy requires and then 
degrade at a controlled rate that will not lead to a strong acute inflammation becomes an issue. 
One common used method to reduce implant host response is combining implant with anti-
inflammatory drug such as dexamethasone62,66. Biodegradable materials can achieve diffusion and 
degradation mediated control release. Both PLA and PLGA based polymers can perform sustained 
drug release kinetics and have a reduction in the late stage of implantation62,66.   
One effective solution recently developed is, rather than avoiding release of harmful 
degradation products, combining a secondary material to degradable implant that can neutralize 
degradation product. Materials with buffer capabilities such as apatitic nanoparticles can 
significantly reduce the acidic environment in the implant site caused by PLA or PLGA 
degradation products67. Reduced degradation rate and host responses, including macrophage 
infiltration and fibrous encapsulation have been reported67.  
Degradation product can also be active pharmaceutical ingredients68–71. Calcium phosphate 
cement (CPC) implants containing PLGA microparticles have been developed recently as bone 
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implants68. The research hypothesized that the acidic degradation product of PLGA could be 
neutralized by calcium phosphate, which would eliminate the inflammatory response caused by 
PLGA degradation while further releasing calcium and phosphate ions that favor bone 
regeneration68. Although the degree of neutralization and amount of ion released was not tested, 
the implantation outcome in femoral condyle of rabbits showed enhanced bone formation without 
inflammation in CPC with PLGA comparing to CPC alone or CPC with other non-degradable 
microparticles68. CPC has also been coupled to PLGA through end group modified PLGA. 69 Here, 
acid terminated PLGA showed a higher degradation and bone formation rate compared to end-
capped PLGA69.  In addition, the degradation rate of CPC-PLGA was only slightly affected by 
PLGA molecular weight and microparticle size but was highly dependent on PLGA end group and 
particle morphology70,71. With appropriate end group modification to control degradation rate, this 
CPC-PLGA implant could be applied to various situations. By combining different materials that 
can neutralize opponents’ degradation products, these studies provided a novel strategy to reduce 
degradation induced inflammation.  
2.2.2.2. Non-Biodegradable Synthetic Materials 
Non-biodegradable materials are often used as permanent implants and can avoid 
cytotoxicity and inflammatory responses caused by degradation products. Titanium is the most 
commonly used permanent bone implant. Applications include dental implants and total joint 
arthroplasty implants. Although it has been reported that titanium alloy, compared to zirconium 
alloy, leads to a higher inflammatory response through increased IL-6 and TNF-α release in 
osteoblasts and fibroblasts72,  titanium is still the first choice for bone implant due to its mechanical 
properties and chemical resistance. Several methods have been developed to reduce the 
inflammation caused by titanium implant such as modifying surface chemistry73,74 or surface 
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pattern modification75. Hydrophilic surface modified titanium can significantly decrease 
inflammatory cytokines TNF-α, IL-1, and IL-1β gene expression in THP-1 and RAW264.7 
macrophages73,74. Surface modifications with calcium or strontium ions also induces more anti-
inflammatory M2 J774.A1 macrophages76. 
Non-biodegradable polymers are often used for surface modification of biodegradable or 
natural materials to change their chemical and physical properties. Poly(ethylene glycol) (PEG), a 
highly hydrophilic polymer widely used in hydrogel and drug implants, is often conjugated to 
implants or particle surfaces to increase their wettability or water solubility77. PEG also has a 
‘stealth’ capability78 as it can avoid cell recognition and reduce protein and cell adhesion79. 
Poly(propylene) (PP) is more generally used as a mesh implant. It was reported to activate both 
inflammatory IL-6 and anti-inflammatory cytokine IL-1RA7 and cause chronic inflammation80. 
Such inflammation could be largely decreased by coating with a polyurethane based hydrogel81.  
Despite the improved mechanical properties of non-degradable biopolymers, biodegradable 
materials are often favored since they do not require secondary surgery and favor tissue 
regeneration. In addition, for permanent implant applications, it is important to note that non-
biodegradable implant are susceptible to wear. Implant abrasion is one of the reasons for 
permanent implant failure, which was often found in joint implants. Wear mediated particles can 
lead to inflammation82, which can further cause perennial overexpression of TNF-α and IL-1β83. 
Coating these materials with one that is lubricating could possibly reduce the abrasion.  
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2.2.3. Hybrid Materials 
On the basis of the above studies, a compelling case can be made for the inclusion of hybrid 
materials for implants. Since most natural materials do not have the range of mechanical properties 
that synthetic materials86 and many synthetic materials lead to inflammatory responses, there are 
increasing interests in developing hybrid materials that incorporate the advantages of both natural 
and synthetic materials to form biocompatible and mechanically tunable implant.  
One of the most common hybrid implants are the type where synthetic scaffolds are coated 
with natural materials to reduce the host response. From its wide range of properties, silk fibroin 
protein, which is extracted from silkworm or spider-silk, is considered a potential candidate due 
to its mechanical resilience87. Hybrid scaffolds can be created by combining electrospun silk fibers 
with tunable gelatin hydrogels to synthesize musculoskeletal implants87. By dosing these scaffolds 
with nano-doses of hydroxyapatite, biomineralization was observed which can be further improved 
to combat bone degradation and resorption due to ailments such as arthritis87. Naïve silicone 
implants with thin spider silk proteins show a minimal inflammatory response, reduced fibrosis, 
and inhibited differentiation of monocytes to macrophages20. The hybrid surfaces abated the 
transition of fibroblasts to myofibroblasts88. Those positive responses, which were also concurred 
by experiments conducted by other groups, such as Kundu et al. who used silk fibroin composite 
hydrogels derived from silkworm, and Mooney et al. who used fibroin extracted from spider silk89–
91, indicated that silk coated hybrid scaffolds had a better performance for reducing inflammatory 
responses as compared to purely natural implants. Through the studies conducted on silk proteins 
and their tunable or biocompatible nature91 these hybrid substrates can be used as rigorous models 
for understanding the immune response in different locations within the body. 
Other than coating natural materials on synthetic scaffold surfaces for improved 
biocompatibility, the combination of natural and synthetic material was also developed for the 
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purpose of morphological modification. As some natural materials are pH sensitive, chitosan at 
pH lower than 6 is positive charged. This allows negative charged material, poly(γ-glutamic acid),  
to form self-assembled multi-layer structures with chitosan through electrostatic interactions90. 
Such structures offer chitosan with drug delivery capability, and successfully reprogramed 
macrophage response with drug loaded. Chitosan-PGA loaded with diclofenac was reported to 
decrease PGE2 released from LPS activated human monocytes derived macrophages45. 
 The combination of synthetic and natural materials certainly increases the materials space 
for biomedical implants, but also results in high lab-to-lab differences. One example is alginate-
polylysine (PLL) microcapsules. Alginate-PLL microcapsules have been developed since 1980 93. 
However, alginate-PLL microcapsules with different G/M ratios and molecular weights were 
fabricated, leading to results that are difficult to compare94. Even with similar physiochemical 
properties, Alginate-PLL microcapsules could lead to various inflammatory responses due to 
differences in the G/M ratio94. This effect was magnified in vivo as the zeta potential increases 
significantly for alginate-PLL particles with 53% G-block but remains unchanged for 43% G-
block after 1 day implantation94. Silk fibroins coated titanium particles were also reported to 
function differently dependent on the biological source of silk95. 
2.2.4. Summary of Material Selection 
Both natural and synthetic materials exhibit distinct properties, in which natural materials 
generally are biocompatible while synthetic materials have higher plasticity and are more easily 
modified. Current efforts in material selection mostly lies in reducing the inflammatory response 
caused by the bioimplant. One overarching theme is that most materials can be modified through 
molecular weight, and both natural and synthetic materials with small molecular weight, 
particularly degradation products, can lead to inflammation. Moreover, host responses to natural 
materials are further influenced by factors such as surface modification and monomer ratio. 
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Currently, most cellular responses mechanisms have not been completely developed. Detailed host 
responses to different natural, synthetic, and hybrid materials are listed in Table 2.1. 
 
2.3. Effect of Surface Topology and Functionalization on the FBR and Biocompatibility 
The local geometry of nanoparticles and scaffolds show very interesting effects on the host 
response. Through subtle changes in the exposed surface area, the shape of the surface available 
for interaction, and the overall geometry of the material, it has been observed that the host response 
can be triggered towards biocompatibility or extended fibrosis. For different cell types such as 
macrophages, changes in the geometry greatly influence their ability to phagocytose and thereby 
limit their interactions with the material, which in turn influences the signaling pathways for 
polarization. On the other hand, the geometry and material characteristics as a whole have been 
shown to influence fibroblast activation and differentiation, based on the local stress observed. 
This section will focus on three main geometrical considerations for designing biomaterials 
implants. The first aspect is the effect of decellularized scaffolds, wherein the aim is to observe 
cell interactions in a noise-free microenvironment. The second is the shape of the implant, 
including the impact of the radius of curvature on macrophage and fibroblast phenotype. Finally, 
the impact of pore size will be discussed, including its impact on cell differentiation. 
2.3.1. Effect of Decellularized Scaffolds 
Macrophage presence and phenotype at the site of implantation is essential for 
vascularization. In this section, we aim to elucidate the influence of decellularized scaffolds on the 
FBR. Decellularized scaffolds are ones obtained from different sources such as the trachea, 
esophagus, lungs, etc. as well as through murine versions of the same. The intense degradation of 
the ECM allows for removal of most of the triggers for the inflammatory response apart from 
GAGs, proteoglycans, and smaller blood proteins. GAGs are highly polar polysaccharide 
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compounds that perform a wide range of functions such as tissue hydration, coagulation, and 
enzyme activation.9 By ensuring that there are no residual cytokines such as TGF-β present in the 
decellularized scaffolds,10–12 macrophage responses can be studied in a tunable, noise-free 
microenvironment.  
Another important facet of decellularized scaffolds is their ability to provide viable models 
to study invasive diseases, which show increased FBR type symptoms. Idiopathic pulmonary 
fibrosis (IPF) has been studied in depth for over 15 years.13,14 By treating healthy decellularized 
lung scaffolds with bleomycin, it is possible to model how IPF biopsies showed local regions of 
high rigidity. These regions when cultured with fibroblasts showed increased differentiation to 
myofibroblasts, and higher presence of CD68+ macrophages. The progression of fibrosis, and 
subsequent macrophage and fibroblast phenotypic changes, can be readily observed in the de novo 
environment with reduced interference from inherently present cellular receptors and cytokines.15  
Surface coatings of these de novo scaffolds can be used for manipulating the host response 
for increased biocompatibility. Myofibroblast differentiation from fibroblasts are readily observed 
in vitro under these conditions, and further research has been detailed under specific case studies 
for the work done on improving the biocompatibility of lung implants.16,17   
  Coating implant surfaces with NSAIDs can reduce the FBR and also the infiltration of 
macrophages into the drug-releasing implant.18 Different modes of inoculation, primarily oral or 
through implants, were compared, which showed that sustained oral doses of salicylic acid led to 
renal failure, as compared to an improved non-inflammatory response and acceptance of the 
implant itself. Furthermore, they compared the degraded by-products of scaffold hydrogels such 
as PLGA over longer periods of time compared to simpler poly-L-lactic acid (PLLA) hydrogels 
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coated with salicylic acid, which showed that there were no inflammatory response by-products 
produced by the NSAIDs coated implants. 
2.3.2. Surface Shapes and Coatings 
Hydrogel based treatments have gained traction over the past several decades as novel 
systems for drug delivery, regenerative therapeutics, and sustainable in vitro models.19,20 Their 
jelly like natural structure provides a moist and relatively inert microenvironment, which is 
necessary for tissue engineering and 3D cell culture applications. Hydrogels have proven 
biocompatibility especially when comprised of components such as collagen, hyaluronic acid, or 
alginate. These hydrogels can be easily functionalized to produce a tunable microenvironments for 
changing macrophage and fibroblast phenotypes in a controlled fashion.21,22 Anseth and co-
workers23 have demonstrated 3D cell culture as a necessary tool for understanding cellular 
behavior especially for the progression of the host response. Their work indicated that different 
types of cells had a preference for specific underlying shapes and symmetries which are 
intrinsically related to mechanotransduction signals.23  
As discussed previously, alginates are a popular material for biomedical implants due to 
low toxicity, easy tunability, and good biocompatibility in both liquid and hydrogel form. Coated 
alginates and hydrogels provide a similarly tunable environment. Kolhar et al.24 demonstrated that 
the shape and coatings of different alginate microcapsules directly influences the adhesion and 
migration of RBE4 rat brain endothelial cells and the efficiency of drug delivery. Surface and 
shape effects of different biomaterial interactions have been found to vary greatly for different 
locations.25 As macrophages are phagocytes, modifications in shapes and coatings have been 
observed to be valid parameters to study this aspect of the host response. Wolf et al.26 described 
in detail the effect that different scaffold geometries have on the host response, and observed how 
the 2D sheets and powder scaffolds work best for a rapid wound healing response based on their 
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ease of phagocytosis, whereas multi-sheet or tubular implants show the most compatible response 
for bone tissue implants.  
Based on the observation that most hydrophilic, non-coated synthetic materials, elicited a 
highly inflammatory response in vivo, it became essential to explore combinations of natural and 
synthetic substrates for FBR studies. Hashizume et al.27 focused on polyester urethane urea 
(PEUU) combined with decellularized ECM scaffolds, the former contribute to the elastomeric 
properties while the latter contributed to its biocompatibility. The PEUU/ECM hybrid showed 
cellular infiltration by macrophages and better incorporation into the abdominal wall. However, 
both the naïve PEUU and the composite material showed myofibroblast differentiation. This study 
mentioned that longer time periods would be necessary for eventual scaffold degradation and 
further characterization of macrophage polarization, as compared to generally visualizing CD68+ 
macrophage infiltration, would be essential to determine the end result initiated by the scaffold. 
The FBR is influenced by the topology of the underlying substrates on the innate host 
response. Many research groups studied this response mechanism, such as Mooney and co-
workers,28 who demonstrated the importance of material shape and surface chemistry for an 
improved adaptive immune system boost strategy using mesoporous, cylindrical silicon rods 
(MSRs) as a host for immune cells. This technique can be modified by tuning the size of pores and 
the length of these MSRs. Subcutaneous implants of the MSRs loaded with specific factors such 
as granulocyte macrophage colony-stimulating factor, were analyzed to see how effectively they 
resulted in proliferation of bone marrow-derived dendritic cells. The efficacy of this new system 
was tested against conventional methods and the results showed that MSR based adjuvant therapy 
was 2.5 times more effective with more scope for improvement based on optimization of the aspect 
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ratio of scaffolds. Further work is being conducted on controlling the degradation kinetics of the 
MSRs for clinical studies, which will allow for even better positive host responses. 
     Device geometry plays an important role in macrophage and fibroblast activation. Different 
sized and shaped materials have resulted in unabated inflammation, formation of FGBCs, fibrosis, 
and uncontrolled damage to neighboring tissues. 29 All of these events are significant in the FBR 
to different implants and dictate the phenotypes of macrophage and fibroblast in the surrounding 
ECM and tissue. The studies showed how 1.5 mm circular particles elicit the most optimal 
biocompatibility, irrespective of material composition. They also suggested potential strategies for 
improving the FBR to biomaterials by focusing on porosity-based influences.  
2.3.3. Effect of Pore Sizes 
 Both natural and synthetic materials show varied biocompatibilities depending on their 
surface properties. One important factor is their pore size, which in the case of natural materials 
are not as rigidly controlled as it can be in synthetic materials. It is essential to observe the 
interaction of innate cell responses with these porous materials. This section of the review aims to 
distil the seminal papers, which demonstrate the variability of the FBR depending on the pore sizes 
of the underlying substrates and establish trends for macrophage and fibroblast phenotypic 
changes. 
An early proof of concept regarding the macrophage effect on the FBR mediated by porous 
substrates was conducted by Sussman et al.30 Their study showed a clear difference between the 
FBR towards porous and non-porous materials where the former showed a thinner fibrotic capsule, 
along with improved vascularization. They suggested a possible hypothesis for this difference 
could be attributed to a greater fraction of fibrous material in the pores, which affected the 
acceptance of the implant. In such systems, the acceptance of the implants was judged on the basis 
of greater vascularization, thinner fibrotic response, and an absence of both the inflammatory type 
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aspect of the M1 response as well as remodeling associated M2 macrophages. Down regulation of 
the M2 response could be attributed to cellular adhesion, which was markedly decreased in the 
case of the porous implant materials, with almost none for the 34 μm pores, and a negligible 
response for the 160 μm pores, as well. There was an interesting atypical non-inflammatory 
response observed for the adhered M1 macrophages, which has great potential in terms of sub-
classifications of phenotype changes in the host response. Specifically, due to the combination of 
surface area, pore size, etc., the 34 μm porous implants produced a combined M1 and M2 response 
which should be further studied. 
Decellularized organ models can be used to understand the mechanisms behind IPF, and 
showed how changes in pore size could provide treatments to alleviate the compromised lung 
capacity due to fibrosis.31 The role played by porous ECM substrates was analyzed where the L-
TGF-β activation is improbable after stripping of such proteins during decellularization, thereby 
placing emphasis on mechanical and adhesion cues in the microenvironment. Organized healthy 
ECM versus chaotic and disordered ECM in IPF samples was observed, along with increased 
myofibroblast differentiation showing high α-smooth muscle actin (α-SMA) levels, a protein 
characteristic of myofibroblasts, as compared to healthy tissues. The similarity of TGF-β levels 
could also be extrapolated towards assuming that there was lesser M1 macrophage presence. On 
the basis of the images published, this area of research could benefit from multimodal imaging to 
simultaneously evaluate biochemical and mechanical factors. Similar studies were also carried by 
Phipps et al.32 where they used large pore sized (on the order of 10 µm) based scaffolds for better 
biomineralization for bone tissue regeneration. 
Pore size effects on the progression of FBR, and vascularization of implants has been 
evaluated using different models. Studies on how pore size influences cellular responses were 
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conducted by Leight et al.23 Their experiments showed how pores formed due to 3D clusters made 
of polydimethylsiloxane (PDMS) on which MCF10A, a mammary epithelial cell line, was found 
to proliferate variably depending directly on the geometry and cluster sizes of the PDMS stamps. 
The island sizes (on the order of 100 µm) formed due to these micropatterns related well to research 
conducted by Liu and coworkers33,34 on the effects of surface topological cues, 
mechanotransduction, and the substrate porosity to the changes in macrophage phenotypes and 
their activation processes as a part of the FBR. Their results concurred with Booth et al.,17 in which 
healthy lung models showed significantly lesser myofibroblast presence as compared to their 
bleomycin treated IPF mimicking models.  
 
 
Table 2.1. Cell response to different pore size 
Pore Size Surface 
Type 
Shape of 
implants 
Fibroblast + Macrophage response Reference 
~5 nm Fibronectin 
based 
scaffolds 
Circular myofibroblast differentiation, 
macrophages based on cell implant 
location, and on compressive 
measures 
Tse et al 
(2012) 
Square 
Star-
shaped 
1-20 µm Alginate 
microcapsules 
with different 
coatings 
Circular Increased sizes of capsules showed 
lesser myofibroblasts+macrophages 
differentiation 
Vegas et al 
(2016) 
34 µm PMMA 
beads on 
PHEMA 
scaffolds 
Circular Increased 
myofibroblasts+macrophages 
Sussman et al 
(2013) 
160 µm Decreased 
myofibroblasts+macrophages 
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Table 2.1 Continued 
Pore 
Size 
Surface Type Shape of 
implants 
Fibroblast + Macrophage response Reference 
~50-100 
µm 
Cytokine 
coatings on  
PLLA/Gelatin 
Random IGF, bFGF coated substrates had 
higher 
myofibroblasts+macrophages 
presence 
Lee et al 
(2014) 
0.3-1.5 
mm 
Alginate, 
Steel, Glass, 
polystyrene 
Triagonal, 
circular, 
pentagonal 
Increased sizes, circular capsules 
showed lesser 
myofibroblasts+macrophages 
differentiation 
Veiseh et al 
(2015) 
 
2.3.4. Study of Mechanotransduction and Cell Signaling Pathways 
One of the most important characteristics, that differentiates the microenvironment within 
the many parts of the human body are ones related to the natural cell populations and the 
mechanical properties of the substrates within them. In recent years, research has been focused on 
understanding the role of the local mechanical properties that influence cell phenotypes and their 
responses. The role of this mechanotransduction response has been observed as the mechanical 
stress being converted to biochemical signals, and activation of certain cell signaling pathways.35,36 
Two of these important pathways are Yes-associated protein (YAP) and transcriptional coactivator 
with PDZ binding motif (TAZ). Regulation of these pathways affects the proliferation of human 
mesenchymal cells (MSCs) and fibroblasts on substrates of different rigidities ranging from 0.7 to 
40 kPa, where this higher rigidity environment was based on the stiffness of the fibronectin 
modified polyacrylamide hydrogel. Another often overlooked factor is focal adhesion kinase 
(FAK), which plays a crucial role in the wound healing response. The overexpression of FAK is 
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what results in the formation of hypertrophic scars or keloids in mammals.37 Similar to the studies 
conducted on YAP/TAZ, the responses of certain FAK-inhibited mice, and their wound healing 
response has been evaluated. Interesting results were obtained when valvular interstitial cells 
(VICs) were used to understand the fibroblast and macrophage activating pathways such as 
PI3K/AKT pathways, after being cultured or co-cultured on soft or stiff PEG scaffolds.21,38 Up 
regulation of the pathway was obtained as a response to the local rigidities and cytokines coatings. 
Sadtler et al.39 added to this theory through their observations of how biomaterial treated injuries 
responded differently, based on the treatment of the surface and rigidity of the scaffold in contact 
with the wound itself. The above factors affected the cell phenotype towards a quiescent or 
deactivated state for soft substrates, and towards a highly activated state on stiffer substrates. These 
cell-signaling and mechanotransduction studies thus motivated a detailed review of the host 
responses observed for different organs within the body, to understand what conditions could be 
modified in the implant or regeneration therapies to suit the purpose most efficiently.  
 
2.4. Location and Biocompatibility response 
Recent studies have shown the important role that macrophage and fibroblast phenotype 
play in the host response,40 by affecting the level of fibrosis observed. It is essential to understand 
the changes in their expression of phenotypes, depending on their location. There is no one favored 
phenotype for both macrophages and fibroblasts that positively affects bioimplants throughout the 
human body. Over the course of this section we aim to address this concern, by examining different 
organs and how their host response varies for both in vivo and in vitro studies. In this section, we 
will give a brief overview of important cell signaling pathways that influence the host response. 
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Then we will focus on biomaterial interaction studies for the different locations of implants within 
the body for lungs, bones, liver, skin, and heart.  
2.4.1. Lungs 
The effect of inhibiting different prostaglandins, for identification of critical points leading 
to a fibrotic response, has been the focus of theories formulated and experiments conducted by 
Hinz and co-workers41 over the past 20 years. Liu et al.16 and Dearth et al.42 hypothesized that 
inhibition of specific prostaglandin receptors such as PGE2 and the COX-1/2 (cyclooxygenase-
1/2) pathways causes stiffness driven activation of macrophages, which further leads to fibrosis. 
Bleomycin treated lungs are models for IPF affected lungs, and their stiffness was found to 
be significantly higher than healthy tissue, which showed a median stiffness range between 3 to 5 
kPa. Certain collagen rich regions in the IPF model showed high stiffness ranging from 25.6 to 40 
kPa. These locally pre-calcified regions were shown to increase CD68+ macrophage presence and 
resulted in high levels of α-SMA, indicating the alterations were connected to myofibroblast 
differentiation. Shifting lung fibroblasts from soft to stiff substrates and reversing this process was 
also studied for up to 5 weeks to analyze the reversibility of this myofibroblast conversion.43–45 
Even after returning the cells to soft substrates, the cells showed active markers for myofibroblasts 
indicating that the effect of the initial substrate could have long term effects on cell phenotype, as 
seen in Figure 2.2. 
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Figure 2.2: Effect of substrate stiffness on fibroblast differentiation to myofibroblasts. “Cell 
outgrowth on pathophysiologically stiff substrates. Lung parenchyma tissue explants (1 1 mm) 
were placed onto collagen-coated silicone substrates that were either 5, 25, 50, or 100 kPa in 
stiffness. After 6 days in culture, cells were paraformaldehyde fixed and examined by 
immunofluorescence for markers of cell proliferation (Ki67, red), myofibroblast presence (a-SMA, 
green) and distribution of cells (DAPI, blue). With increasing stiffness, myofibroblasts first appear 
on 25 kPa substrates and subsequently increase in number and distribution on 5–100 kPa models. 
Scale bar = 200 mm.” Reproduced with permission. Copyright 2012, The Royal Society of 
Chemistry 
 
On the basis of these studies, we can suggest several integral design principles for implants 
or regeneration strategies in lung tissue (see Lungs section of Figure 2.3). These design principles 
would include soft substrates with rigidity less than 3 kPa, having greater than 30 µm sized pores, 
and decellularized scaffolds, all of which would show reduced macrophage and myofibroblast 
presence. These results link back to previous observations on the influence of pore sizes on 
macrophage phenotypes, and how sequestering adhesion of macrophages within them affect their 
regular behavior. It was observed for pores larger than 35 µm that the natural pro-inflammatory 
behavior of M1 macrophages was significantly reduced, as was the fibrotic capsule formation 
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mediated by M2 macrophages. These large pore size effects show host responses where there is 
inhibited fibroblast to myofibroblast differentiation, also contributing to a thinner fibrotic capsule, 
due to lower collagen secreted by the fibroblast cells. This is a very important aspect of modulating 
these material properties, as lower myofibroblast differentiation results in inhibited fibrosis 
alleviates and, in some cases, improves compromised lung capacity symptoms faced by patients 
suffering from IPF or cystic fibrosis.  
2.4.2. Bone 
The process of bone tissue engineering involves fabrication of constructs for culturing cells, 
delivering growth factors, and exerting mechanical stimuli.46 There is limited information 
available regarding the effect different materials have on both macrophages and fibroblasts after 
implantation.47 Two common strategies are generally employed for bone tissue engineering and 
dental implants. These were based on reprogramming stem cell lines12,48 into bone tissue using 
growth factors or using mechanotransduction to induce differentiation towards osteoblasts.49 
Hydroxyapatite coatings on scaffolds made of collagen I have been shown to improve MSC 
adhesion and differentiation into osteoblasts.32,46 Such coated scaffolds have significant 
advantages over previous stem cell based bone tissue engineering approaches. A popular addition 
to these scaffolds is the inoculation with MSCs instead of previously used embryonic stem cells, 
as the latter can result in teratomas.50  
Chemically modified hydrogels have been fabricated with different surface groups exposed 
to the ECM for interrogating their influence on bone regeneration pathways. The use of RGD-
modified diacrylate hydrogels for improving biomineralization was studied by Eliseef et al.51 
These RGD modified substrates stimulated the production of bone-production proteins such as 
osteocalcin, and they had a 2.5-fold increase in osteocalcin compared to non-RGD modified 
substrates. This response was a marker for regenerating healthy bone tissue around areas that have 
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suffered from debilitating diseases such as volumetric muscle loss (VML). VML has been studied 
in mammals as the loss of function and resorption of bone in areas that have previously been treated 
for other tumors or due to shock damage.52 Hybrid substrates and therapies to regenerate functional 
bone tissue in such areas with the help of decellularized mouse ECM scaffolds seeded with 
perivascular stem cells have been proposed.53 These scaffolds have shown positive remodeling 
responses when transplanted into rat aortic valves by successfully recruiting M2 macrophages and 
myofibroblasts.  
Another common technique for bone tissue engineering is based on growth factor mediated 
reprogramming.54 For cases where there is severe muscle loss, there are several problems for 
treatment that include acceptance of new tissue and lack of available healthy tissue for implants. 
By pairing the ability of myofibroblasts to infiltrate gelatinous tissues and the acceptance of PLLA 
based scaffolds, a hybrid protocol was suggested to accelerate muscle regeneration at the site. 
Adding myogenic growth factors and observing their sustained presence within the implants 
activated STAT6 pathways, which resulted in both types of macrophages being differentiated at 
the site of the implants from freely circulating monocytes. The overall angiogenesis due to the 
activation of these pathways was a useful strategy showing the best empirical results for muscular 
regeneration, which was further modified using insulin-like growth factor treatment on gelatinous 
hydrogels. 
On the basis of these studies on musculoskeletal implants and the innate response, we 
propose the following design principles: implants must be relatively stiff (>40 kPa), have small 
pores (~50 nm) or non-porous substrates, increased surface roughness to promote osteoblast 
differentiation, and a higher M2 macrophage and myofibroblast presence. The higher rigidity 
would be promoting the myofibroblast differentiation for the remodeling and initiation of M2 
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macrophages. The small pores would keep the macrophages non-adhered to the surface and 
exhibiting their standard host response. 
2.4.3. Heart 
Cardiomyocytes are specialized cardiac cells, which are integral for the synchronous 
involuntary muscle function in the heart. Novel strategies for the treatment of congenital heart 
diseases where tissue engineered heart valves (TEHVs) are fabricated using biocompatible 
scaffolds (made of fibrin and thrombin coated tissue culture plastic plates) containing VICs have 
been proposed.55 Much like fibroblasts, VICs have a quiescent or dormant state where they freely 
circulate, and an activated state, which is initiated by certain cell signaling pathways (mostly 
GATA binding protein-4 and Tbox protein-5) that lead to ECM alterations. Neonatal human 
dermal fibroblasts can replace the VICs seeded in the scaffolds for TEHVs and the subsequent 
aortic remodeling. However, there are significant concerns that VICs in their activated state 
produce more ECM components and show high levels of α-SMA, which could result in fibrosis, 
leading to arterial blocking, rather than valve remodeling. To combat this concern, comparisons of 
pediatric VICs and dermal fibroblasts on different substrates were conducted to determine what 
components favor remodeling of the TEHVs, such that there are no adverse responses. Collagen 
type I was found to modulate the fibrosis to levels which would induce smooth angiogenesis 
around the fibrotic capsule. Wessels et al.56 explored similar solutions using epicardially derived 
fibroblast cells (EPDCs), which have been transformed from cardiac fibroblasts to MSCs and can 
play a very important role in the process of valve healing in vivo. The formation of atrioventricular 
(AV) valves by these VICs can be potentially useful for providing treatment strategies for 
congenital heart defects in infants. Though the studies were unable to conclusively use EPDCs in 
scaffolds for AV rebuilding because of inconclusive myocardial staining, the process may yet be 
useful for studies of other heart diseases. 
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The biocompatibility of synthetically derived hyaluronic acid based hydrogels57 has been 
well established. Chang et al.57 injected blood-growth factor based solutions in hyaluronic acid 
based hydrogels and surmised that there is need to optimize several parameters: gelation time to 
avoid pulmonary embolisms during injection, pore sizes to allow for transport of metabolites, and 
degradation kinetics to avoid unwanted host responses to erosion products. These formulations 
promoted angiogenesis, improved cell function, and reduced CD44+ macrophages. The second 
approach for cardiac implants, analogous to pulmonary and musculoskeletal implants, was the 
strategy of reprogramming of fibroblasts into functional cardiomyocytes using a mixture of 
transcription factors and cytokines. Qian et al.58 worked on treating quiescent fibroblasts with 
retroviral infection of Gata4, Mef2c, and Tbx4 doses that can potentially create techniques to heal 
organs in vivo by forming cardiomyocytes. These three genes are responsible for ECM alterations 
and activation of fibrocytes or quiescent fibroblasts to myofibroblasts, which concurs with their 
effectiveness in tracking VICs cell signaling responses. Lineage tracking was employed to monitor 
induced cardiomyocyte activity and their genetic signature was compared to native 
cardiomyocytes and non-infected heart cells. 
Based on the above review, optimal material properties for cardiac reprogramming of 
myofibroblasts and repair are very similar to those identified for lung implants. The important 
factors are that the material be soft (<3 kPa), and have large pores (>30 µm), and reduce M2 
macrophage and myofibroblast responses to avoid fibrosis and plaque to accumulate on the cardiac 
tissue. For heart implants it is essential to mediate a reduced fibrotic response to inhibit scarring 
of the cardiac tissue, which can disrupt its natural beatings. The adhesion of the macrophages 
within the pores of these surfaces would prevent an overall lower activated macrophage or 
myofibroblast response.    
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2.4.4. Liver  
The mortality rates for diseases brought on by liver fibrosis is very high, at about 20% one 
month after diagnosis,59 and can progress to non-treatable stages rapidly. It has been established 
that the hepatic stellate macrophages, known as Kupffer cells, play a key role in the progression 
of liver fibrosis.60 The change in the phenotype of monocytes to polarized M1, M2, or Kupffer 
macrophages is mediated by different cell activated signaling pathways and are also linked to the 
inducible nitric oxide synthase and arginine stimulated classical M1/M2 polarization signals. The 
range of interactions between these different factors influencing the fibrotic capsule formation 
necessitates the need for liver fibrosis studies in vitro and in vivo.61 
As fibrosis is a dynamic process, spanning multiple stages, it has been difficult to 
characterize based on the interactions of fibroblasts and macrophages. Macrophages play a critical 
role in the activation and differentiation of fibroblasts into myofibroblasts through the release of 
cytokines such as IL-13 and TGF-β.62 Modifying these cytokine release pathways in macrophages 
inhibited hepatic stellate cells, thereby reducing the fibrotic response. This key dynamic between 
macrophages and fibroblasts has perhaps been the best understood for liver fibrosis compared to 
other organs.62 
Different cell signaling pathways established for the progression of liver fibrosis and its 
inhibition have been widely studied. There are two major types of host responses that can be 
observed as a part of liver fibrosis progression, one for reducing liver scarring and the other for 
liver regeneration. 61 It was logically concluded that different polarized responses of macrophages 
would be essential for these diametrically opposed roles in the host response, and this is further 
detailed in Figure 2.3. Macrophages are critically involved in both the injury and repair of the 
tissue, and it is possible to alter their polarizations to prevent fibrosis from progressing. These 
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findings illustrate the great need for clinical studies to observe the multi-cell participation in liver 
fibrosis.  
Recruitment of GR1+ monocytes during liver injury is essential for the progression of liver 
fibrosis.60 This study corroborates research conducted by Duffield et al.61 on macrophage 
phenotypic changes in liver injury or repair states. The activation of GR1+ at different stages of 
fibrosis through TGF-β was studied to evaluate the threshold levels of cytokine that activate the 
monocytes. The role played by different macrophage polarizations that can inhibit fibrosis was 
studied and identified the effect of arginase-1 expressing macrophages on a rat model, which was 
exhibiting schistosomiasis, via thioacetamide induction. 63   
Key design principles for implants used for liver repair and fibrosis reduction have been 
identified based on the review above. For the purpose of reduction of liver scarring, there is a need 
for soft scaffolds or substrates (<2 kPa),64 with large pores (>30 µm), which can stimulate M1 
macrophage response themselves or through classic activation via cytokines like IL-4. For the 
explicit purpose of liver repair and regeneration, it is essential to have stiff scaffolds (>40 kPa)16 
which are non-porous or smooth, such that they can incite an increased M2 macrophage presence. 
2.4.5. Skin 
Skin undergoes a specific wound healing response. Macrophages are generally maintained 
at low levels in healthy skin, but can differentiate from monocytes in blood vessels shortly after 
implantation or injury and cause acute inflammation.65 Fibrotic encapsulation of dermal implants 
is highly related to the interaction between M2 macrophages and fibroblasts. Cytokines released 
by M2 macrophages, including TGF-β and MMPs, are known to enhance collagen production and 
endothelial cell migration, respectively. This further results in FGF-2 and PDGF production, which 
have been reported to cause myofibroblast differentiation.66   
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Several design principles have been found to reduce the FBR. From a mechanical aspect, 
dermal implants require larger pore sizes and lower stiffnesses to reduce the FBR. As previously 
mentioned, dermal implants with 34 μm pore sizes can significantly reduce the FBR by shifting 
macrophages to an M2 phenotype compared to the non-porous implant.30 Additionally, 
poly(hydroxyethyl methacrylate) implanted into mice with 20 μm pore sizes has lower epithelial 
migration compared to 40 and 60 μm pore sizes, whereas no statistical difference was found 
between the 40 and 60 μm sized scaffolds.67 Other research showed that titanium implants with 
larger pore sizes ranging from 40 to 160 μm did not have observable differences in cell ingrowth 
when implanted in rats,68 which suggests a critical pore size around 30 μm may be able to 
appropriately modulate the host response. On the other hand, collagen hydrogel implants with a 
lower stiffness (elastic modulus 0.7 kPa) was reported to increase dermal fibroblast ingrowth 
compared to an implant with an elastic modulus of 1.6 kPa.69       
From the chemokine and cytokine aspect, one of the most significant factors influencing 
dermal implant acceptance is NO release. It has been previously reported that a silicone elastomer 
coated xerogel polymer implant that released NO could significantly reduce collagen 
encapsulation and chronic inflammation in rats.70 The study suggested that NO release reduces 
both pro-inflammatory cytokine IL-6 and anti-inflammatory TGF-β release from macrophages. 
The former cytokine could lead to classical activation and the latter is known to enhance collagen 
production from dermal fibroblasts.70  
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More recently, the effect of NO release kinetics on subcutaneous implants has been studied 
in Yorkshire-type piglets. Polyurethane-coated wire implants with longer release duration and 
improved NO loading were found to have a greater decrease in inflammation and fibrotic 
encapsulation.71 Thus, dermal implants capable of loading larger amounts of NO and maintaining 
long term in vivo NO concentration will reduce the FBR.  
Other possible methods to modulate the FBR are through HA. HA naturally exists in skin 
at a high concentration.72 It plays an important role in skin regeneration and dermal fibroblasts 
cultured on an HA mesh has been shown to heal chronic wounds caused by skin loss clinically.73 
In skin wound healing, HA accumulation at the injury site is essential for macrophage 
recruitment.74 As described above, sulfated HA can shift macrophage phenotype to an M2 state75,76 
and enhance dermal fibroblast adhesion,77 which favors wound healing. Implants coated with 
sulfated HA may reduce the FBR.  
Based on the above review, the design principles for dermal implants would be using soft 
materials (~1 kPa) with large pores (>30 μm). Since skin contains high populations of resident 
fibroblasts, implants with long term NO release would further help reducing fibrotic encapsulation. 
M2 macrophage promoters or anti-inflammatory cytokines loaded into the scaffold can also 
decrease the host response.  
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Figure 2.3: Design principles for bioimplants based on their location. These examples 
cover a range of microenvironments with unique material property requirements for appropriate 
macrophage and fibroblast responses. These descriptions are not comprehensive but illustrate 
some key aspects for eliciting appropriate outcomes. 
 
 
2.4.6. Design Principles for Disparate Implant Locations  
Figure 2.3 summarizes the design principles identified above for biomaterials to be 
implanted into different locations within the body. With the help of such summarization, it should 
be possible to understand the key roles played by different materials properties on host responses, 
and the changes in behavior of the cells that are integral to such a response. It is very likely that 
these design principles may be combined with multimodal imaging techniques capable of probing 
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the host response in real time to further understand the dynamic responses of macrophage and 
fibroblast phenotype to biomaterials. 
2.5. Summary Table 
Table 2.2. Summary of macrophages and fibroblasts response on bioimplant 
Material Implant Site Macrophage effect Fibroblast effect References 
Bleomycin Lungs 
 
Increased myofibroblast 
differentiation for stiff 
substrates 
Liu104  (2010) 
Hemosiderin staining 
Higher myofibroblast 
differentiation + αSMA 
presence 
Carnesechhi 153(2012) 
Hyaluronan gel 
Heart 
Possibly both M1 and 
M2 
Positive FBR + decreased 
fibrosis over 7 days 
observation 
Chang144 (2012) 
 
Sulfation degree 
dependent 
Increased myofibroblast 
with increased dosage 
Franz (2013) 
 MW dependent 
Low MW-increased 
myofibroblast 
High MW-decreased   
myofibroblasts 
Rayahin (2015) 
Silk 
Bones 
Differentiation into 
FBGCs and infiltrating 
macrophages 
Osteogenic differentiation 
of hMSCs into osteoblasts 
Melke87  (2015) 
Skin 
Reduced macrophage 
number and 
inflammatory response 
Reduced fibroblast and 
myofibroblast diff 
Liu21 (2014) 
Dermal 
Macrophage 
differentiation inhibited 
Reduced myofibroblast 
diff and fibrotic response 
Zeplin20 (2014) 
Mesenchymal 
stromal cell  
Abdominal wall 
Enhanced M2 response 
compare to acellular 
hydrogel and MSC 
alone 
Increased myofibroblast 
diff and fibrotic response 
Stucky (2015) 
Hippocampal 
Reduced myofibroblast 
diff and fibrotic response 
Ayala (2015) 
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Table 2.2 Continued 
Material Implant Site Macrophage effect Fibroblast effect References 
Alginate 
hydrogel 
In Vitro 
G/M ratio dependent G/M ratio dependent Berven (2013) 
MW dependent 
Reduced myofibroblast 
with increased dosage 
Zhou (2015) 
Intraperitoneal M2 
Increased myofibroblast 
diff and fibrotic response 
Jain (2015) 
Chitosan 
In vitro 
DD dependent M1  Reduced myofibroblasts Fong (2015) 
MW dependent M1 Reduced fibrosis response Zhang (2014) 
Intraperitoneal Increased M1 
Reduced myofibroblast 
diff and fibrotic response 
Chakrabarti48 (2014) 
Knee trochlea 
Fast degradation on 
Low MW 
Reduced myofibroblast 
diff and fibrotic response 
Lafantaisie-Favreau43 (2013) 
Subcutaneous 
No significant 
difference 
No significant difference Li 49(2014) 
 
 
2.6. Conclusions 
In summary, bioimplant material, modification, and design should be selected based on 
implant location. For biodegradable materials, degradation rates need to match tissue regeneration 
rates in order to avoid implant deformation and fibrous encapsulation. Eliminating secondary 
inflammation caused by degradation products is also an essential issue. On the other hand, non-
degradable implants, especially for joint replacements, focus more on wear resistance and fibrotic 
encapsulation. In most situations, natural materials can reduce acute inflammation upon 
implantation, but are limited by mechanical properties and most natural materials’ degradation 
prod- ucts lead to secondary inflammation. In contrast, synthetic materials have high plasticity but 
are likely to cause acute or chronic inflammation after implantation. The host response 
mechanisms to most materials have not been fully elucidated at this point. 
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Several challenges remain for developing biomaterials with the appropriate host response 
for lungs, heart, liver, skin, and musculoskeletal implants. Depending on the natural mechanical 
properties of organ systems, the design principles differ greatly. For example, stiff substrates elicit 
an appropriate remodeling response for bone implants, while softer substrates incite an anti-
inflammatory response from macrophages and fibroblasts participating at the site of the implant. 
Furthermore, by understanding the effect of certain geometric cues affecting macrophages 
phagocytosis and stress sensing mechanisms in fibroblasts, more considerations were listed. On 
the basis of all these cues, the design principles can be applied to tailor the host response in these 
organs based also on the nature of the system they are exposed to, namely for regeneration 
strategies. 
On reviewing the research conducted on the role played by both these cell types, there is a 
need for concurrent studies in order to better understand the host response and evaluate the factors 
that polarize cells. With the focus in biomedical sciences shifting towards non-invasive techniques 
of observation, there is a strong case for popularizing non-linear optics and/or multi- modal 
imaging to elucidate the subtle changes in behavior of the cells that are present as a part of the 
FBR. Though there has been some research conducted on the timeline of such responses such as 
Langer and coworkers,40,89,139, 180-182 and Bratlie and coworkers,183 the common factor lacking 
across many such studies has been the application of techniques for efficient internal imaging. 
Non-linear optics have shown themselves as a useful tool to have in many such systems. Through 
the application of second harmonic generation microscopy combined with other bio- chemical 
imaging techniques such as two photon electron fluorescence microscopy,169 it has been shown 
that we can identify the progression of innate response in deep tissues. 184, 185 Over the course of 
the next decade, these methods may improve in terms of spatial and temporal resolution such that 
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real-time observations of macrophages, fibroblasts, and myofibroblasts become more 
commonplace. 
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CHAPTER 3 
MULTIMODAL IMAGING OF HARMONOPHORES AND APPLICATION 
OF HIGH CONTENT IMAGING FOR EARLY CANCER DETECTION 
 
Modified from a manuscript published in Materials Discovery, 1, 10-20 (2015) 
 
The importance of cancer detection has grown exponentially over the past few years, as 
medical costs and our demand for better quality of living rise. Multimodal imaging techniques aim 
to improve the efficiency of current diagnostic methods and provide greater insight into the 
mechanism of tumor metastasis. Second harmonic generation (SHG) microscopy is one such non-
destructive imaging technique available to researchers for detecting the changes in the morphology 
of chiral molecules such as collagen, which are selectively imaged by this technique. Researchers 
aim to understand the role played by changes in collagen morphology in tumor development, by 
combining SHG with other non-linear optics instruments. Different cancer diagnoses have been 
shown to be detected efficiently by these methods, with higher clarity than the standard protocols 
available. This is a significant improvement, especially in the case of aggressive, invasive tumor 
types such as basal cell carcinoma (BCC) and invasive ductal carcinoma (IDC). Analyzing the 
data produced by such multimodal imaging methods is currently a nascent field. The aim of this 
review is to provide an overview of the analysis techniques currently used in this field of high 
content imaging and establish concurrence of methods to further improve the understanding and 
efficiency of cancer detection. 
 
3.1 Introduction 
The latest reports from the National Cancer Initiative show that Cancer has grown to 
become the 2nd largest cause for death in the United States, behind only heart disease. Beyond the 
emotional trauma suffered by families across countries worldwide, cancer also has a very high 
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economic impact on countries all over the world. [1, 2] A recent study by the Agency for 
Healthcare Research and Quality estimated that $88.7 billion were spent just over 4 years back in 
2011. With the rising costs, and the fragile state of the economy, cancer has progressed in 
importance and there remains a need for immediate action, in spite of mortality trends suggesting 
that the situation has improved, as can be seen in Figure 3.1.  
 
Figure 3.1: Latest cancer trends report indicating the progress of cancer research in different types 
of cancer and their mortalities in men and women [1] 
 
Multimodal imaging has sought to provide early diagnosis and a better understanding for 
several of the fast-acting types of cancers that are becoming a common fixture of the health-care 
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sector. Techniques such as second harmonic generation (SHG) microscopy have provided 
researchers a hybrid imaging technique which can offer biochemical insights into clinical samples, 
and yield information on a multitude of tumor diagnoses. SHG imaging uses two incoming photons 
having the same wavelength, scatter after interacting with a chiral molecule, and produce one 
photon of exactly half the incoming wavelength. The nature, intensity of this scattering phenomena 
can provide information into the internal structure of the tissues. [3, 4] 
SHG imaging has been shown to have many advantages over traditional 
immunohistochemistry staining techniques or fluorescence microscopy. It is a non-linear optical 
approach toward imaging tissues both in-situ as well as being a part of endomicroscopy approaches 
[5, 6, 7] The SHG imaging approach is a non-staining, energy conservative technique. This is most 
suitable for non-destructive imaging of tissues, while simultaneously allowing for the internal 
visualization of the samples be clear.  The most important prerequisite condition for SHG-active 
sites within the tissues is for there to be a non-centrosymmetric salient component within, which 
are selectively detected by the incident beam. Common examples of SHG active molecules, known 
as harmonophores are collagen types I and III, myosin (when present within acto-myosin 
complexes), and cholesterol crystals (ChC) which are chiral in nature. [8, 9, 10] 
Studies conducted by Su et al. [11] have shown that extracellular matrix (ECM) alterations 
are a very important indicator for different kinds of tumor growth within corneal, colonic, cardiac, 
breast, and ovarian tissues. Intensity based SHG imaging can yield clear images of the 
modifications of the tissue structure, by elucidating collagen orientation changes in the ECM, as 
can be seen in Figure 3.2, which is an image taken of a sub-dermal tumor in a mouse, from the 
studies conducted by Brown. [12] 
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Figure 3.2: SHG image of a melanoma growth in sub-dermal tissue of a mouse. Image width was 
6.6 mm. [12] 
 
The most common challenge in methods such as SHG are that there is a complex amount 
of data generated for each tissue imaging, based on the fact that the harmonophores show varying 
intensity with polarization of the incident beams. These intensities, measurements of the forward, 
backward-scattering beams, and the variations of the angular pitch of the harmonophores 
necessitate a need for detailed analysis of the data generated. A significant concurrence needs to 
be achieved for the understanding of the results generated by this field of high content imaging. 
2.2 State of the Art 
It is interesting to note that the discovery of SHG as an imaging tool was by accident, and 
a consequence of experiments carried out to know more about piezoelectricity. Two young 
researchers Fukada and Yasuda, who were working on a piece of Achilles tendon observed that 
there observed to a macroscopic polarity to the sample. This polarity was hypothesized to be a 
consequence of charged repeating groups in crystal form, which was further confirmed by Lang a 
few years later to also show pyroelectric properties. [13] Together these created the breakthrough 
which allowed for biological molecules having chiral symmetry be visualized in a non-linear 
manner, without compromising on the structural or chemical integrity of the samples. One of the 
first examples shown to be easily differentiated on the basis of SHG imaging were rat tail tendons 
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and trachea cartilage, as they both contain collagen, but of different types [11]. These studies were 
gradually improved on to image differences in collagen morphology in mouse ovary, skin and 
bone samples [14]. 
It was observed that combining SHG with techniques such as two photon excitation 
fluorescence (TPEF) microscopy or coherent anti-Stokes Raman spectroscopy (CARS) can help 
provide biochemical specificity to the tissues being imaged. With the help of additional, non-
destructive non-linear optics, further information about cancers such as basal cell carcinoma 
(BCC) were readily available, as shown by Vogler’s group in 2010 [15]. The presence of fat 
reservoirs, collagen modifications, and fluorescing proteins was visualized by this multimodal 
imaging technique (as seen in Figure 2.3), providing new insight into BCC, which is an extremely 
fast acting cancer with a high mortality rate, as observed by Jamal’s study in 2008 [16]. These 
studies further made the case for high content imaging, to be popularized all over the world. [17, 
18, 19] 
 
Figure 3.3: (A) TPEF highlighting the fluorescing proteins in the tissue, (B) SHG indicating the 
collagen organization around the carcinoma, (C) CARS showing the fat reservoirs around the 
carcinoma, (D) Hybrid image of all three techniques, (E) Brightfield image of the carcinoma, (F) 
H&E staining of the tissue to provide perspective, with insets highlighted for imaging [15] 
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As demonstrated for BCC, dermal tissues were one of the first to get imaged using SHG 
due to the ease of access and availability of samples [20, 21]. Chen and his group showed SHG 
and TPEF as a viable hybrid imaging tool [22], by simultaneously imaging collagen and elastin 
respectively. There was a clear difference observed on how the scars and normal dermis showed 
different levels of elastin and collagen presence.  
Cicchi et al. demonstrated in 2010, how structurally different hypertrophic scarring in 
keloids is from healthy dermis at the micron scale [23, 9]. It was observed that normal dermis 
contained a randomly mixed presence of collagen and elastin, whereas keloids showed well 
aligned boundaries of collagen with very minimal presence of elastin.  As keloids are present only 
in humans [22, 24, 25], and the nature of keloids have been shown to be influenced by the melanin 
content, studies such as these hold great promise in the fields of tissue engineering. These studies 
were further substantiated by independently analyzing the orientation of the collagen fibers 
formed, through fast Fourier transform (FFT) analysis. It was clear the isotropic nature of collagen 
fibers in keloids matched well with the visual observations made previously by Su et al. in 2011. 
[21, 23, 25, 26, 27] 
The success of SHG imaging spurred interest in the early detection of breast cancer. In 
order to understand the significant difference between the clarity of tissue sections, Ambekar 
compared the hematoxylin & eosin stained (H&E) sections with the collagen mapped using SHG 
[28]. The sensitivity of SHG in detecting changes in collagen morphology has proved to be a game 
changer for this aspect of breast cancer detection at an early stage, as shown in Figure 2.4. Several 
groups such as Brown, Burke, Conklin, Ajeti have defined aspects of breast cancer types based on 
SHG [29, 20, 31, 32] 
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Figure 3.4: H&E and SHG imaging comparison for grades of breast cancer tissues [29] 
 
The process of ECM modifications in cartilage and mammary tissues was studied in depth 
by Burke and co-workers in 2015 [29, 30]. In their studies they aimed to provide visual 
confirmation of the hypothesis put forward by Conklin in 2011 [31] regarding how collagen fibers 
re-align themselves from a randomly ordered state to that of structured form, as evidenced by their 
imaging of mammary tumors which is shown in Figure 2.5. Conklin defined his theory on tumor 
associated collagen signatures (TACs) on this basis, which we shall delve into later during this 
review. Here too, SHG imaging agrees with the standard pathology of improve the early diagnosis, 
detection of breast cancer.  
 
Figure 3.5: (left, red) Collagen organization at the onset of breast cancer, (left, blue) collagen 
alignment three days after onset. Changes in the forward and backward scattering of SHG signal. 
[30] 
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Another salient example of the application of SHG in cancer detection was towards the 
diagnosis of liver fibrosis. By combining TPEF with SHG, clear SHG-fibrosis indices were 
established, which were confirmed by the Metavir scoring of fibrosis [33, 34]. This correlation of 
fibrosis indices, developed by Gailhouste in 2011[35] is further vindication of the multimodal 
imaging process, using SHG and TPEF as a hybrid imaging platform, which also elucidates the 
difference in the mechanisms between the two methods [36]. 
3.3. Analysis Techniques 
It is essential to understand that advanced imaging techniques such as SHG, two photon 
microscopy (TPM) and CARS are highly customizable. It is often up to the researcher to determine 
what data to extract from the imaging and how best to represent it in a coherent and effective way. 
These multimodal imaging techniques can produce vast amounts of data for a single image, and 
we will summarize the most common analysis techniques used by researchers all over the world. 
[37, 38, 39] 
The growing requirement for quantitative SHG imaging resulted in the development of 
techniques which are used primarily for cancer detection and classification studies. We have given 
below some of the salient analysis methods observed: 
3.3.1. Susceptibility Measurements (χ ratios) 
The SHG signal obtained for any collagen containing sample is characterized by the second order 
nonlinear susceptibility tensor χ(2). The relationship between the susceptibility, the Electrical field 
applied (E) and the polarization (P) is defined as: 
                                          𝑃𝑖𝑗𝑘 = 𝜒𝑖𝑗𝑘 𝐸𝑗  𝐸𝑘 (1) 
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For small molecules, it is understood that the main contributors to the susceptibility value are the 
C=O and the N-H groups present in the amide bonds. [40] Hence, this tensor is indicative of the 
collagen directionality within the imaged domains. For ease of analysis as well as approximation 
based on the point sized light source and the sample thickness not exceeding 5 μm, we consider 
the samples to observe cylindrical symmetry and follow the Kleinmann rules. The relation thus 
shall exhibit only two independent components: χXXX and χXYY= χXZZ = χYXY = χZXZ = χYYX= χZXX 
where X is the direction of the collagen fibrils [4, 27] 
An incident electric field E0 then induces the following second harmonic wave in the fibril frame 
XYZ:  
𝐸𝜒
2𝜔 ∝ [𝜒𝑋𝑋𝑋 𝑐𝑜𝑠
2(𝛼 −  𝜑) + 𝜒𝑋𝑋𝑋 𝑠𝑖𝑛
2(𝛼 −  𝜑)] 𝐸0
2 (2a) 
𝐸𝑌
2𝜔 ∝ [𝜒𝑋𝑌𝑌 sin 2 (𝛼 −  𝜑)] 𝐸0
2 (2b) 
In the above equations, α and φ stand for the laser excitation polarization angle and the 
fibril orientation angle, respectively, with respect to a fixed direction in the laboratory frame, 
usually taken as the X axis which is considered here to be the collagen fibril axis. This is valid 
because the lamellae within the collagen shall be parallel to the axis, and hence within plane of the 
electrical field E0. The total polarized collagen intensity is then given by: 
𝐼2𝜔 = 𝐾 (|𝜌 𝑐𝑜𝑠2(𝛼 −  𝜑) + 𝑠𝑖𝑛2 (𝛼 −  𝜑)|2  + |𝑠𝑖𝑛 2(𝛼 −  𝜑)|2 (3) 
In the above equation, K is a constant merging the squared incident intensity and setup 
geometrical parameters. Two quantitative parameters appear in this expression: (i) the angle 
difference of α and φ, of the laser excitation polarization to the collagen fibrils axis within lamellar 
domains; (ii) the ratio ρ, which reflects the anisotropy of the nonlinear response of these lamellar 
domains and is calculated as ρ = χXXX/χXYY. This approach to calculate the polarization anisotropy 
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(ρ) and susceptibility (P) is valid for both forward scattered SHG as well as backward scattered 
SHG signals. [22] 
In some cases, where the methylene contribution is considered separately, some of the 
above assumptions don’t hold true for all the tensor elements. Some cases studies and theoretical 
models show the polarizability of the sample denoted by β in such cases. Resulting in the system 
getting defined by three related elements: 
𝜒𝑋𝑋𝑋 = 𝑁
(𝑝)𝛽(𝑝) 𝑐𝑜𝑠3 𝜃(𝑝) +  𝑁(𝑚)𝛽(𝑚) cos 𝜃(𝑚)  (4a) 
𝜒𝑋𝑌𝑌 =
1
2
 𝑁(𝑝)𝛽(𝑝) cos 𝜃(𝑝) 𝑠𝑖𝑛2𝜃(𝑝) (4b) 
𝜒𝑌𝑌𝑋 =
1
2
 𝑁(𝑝)𝛽(𝑝) cos 𝜃(𝑝) 𝑠𝑖𝑛2𝜃(𝑝) + 𝑁(𝑚)𝛽(𝑚) cos 𝜃(𝑚) (4c) 
In these above equations, N(p) and N(m) refer to the number of peptide and methylene groups in the 
system respectively. And the θ(p) represents the pitch angle to which the collagen is oriented, and 
accordingly determined as per the following equations:    
a= χXXX/χXYY and b=χYYX/χXYY  
And,                             𝑡𝑎𝑛2 𝜃(𝑝) =  
2
𝑎 − 𝑏 + 1
          (5) 
 
Studies conducted by Jung Su [11], on cartilage imaging relied on using these equations and 
susceptibility ratios in order to characterize differences between collagen type I and type II in rats, 
as shown in Figure 2.6 [27, 35, 41]. 
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Figure 3.6: Normalized SHG intensity observed relative to the polarization angle [11] 
 
Jung Su et al., also demonstrated the clear change in intensity observed with respect to change in 
polarization. They highlighted one of the first examples of collagen morphologies being different 
in tendons and cartilage tissues, with the change in morphology from wavy, random signals to well 
aligned fibers. 
 
3.3.2. Polarization Resolved SHG imaging 
As the intensity of the SHG signal obtained for collagen presence is dependent on not just 
the concentration, but also the degree of ordering of the fibers, spacing, and the overall anisotropy 
of the collagen in the samples. This approach can be taken up in multiple applications, such as on 
the basis of the polarization anisotropy, or as separate measurements for each incident polarization 
angle. On the basis of polarization anisotropy, the images intensity was normalized over the 
following equation [42]:    
   𝑃𝐴 =  
𝐼||− 𝐼⊥
𝐼||+ 𝐼⊥
   (6) 
Here, the I|| values were for those with horizontal polarization and I⊥ values for the vertically 
polarized imaging. PA values of 0 signify a high order of stochasticity, and those tending towards 
1 or -1 are more uniaxial in orientation. 
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Polarization resolved imaging studies were conducted by the group of Ambekar et al., to observe 
the differences in the intensity [28] for different incident polarization angles (from 0 to 180º), in 
various stages of breast cancer tissues. [5, 8, 27] This differentiation based on polarization was 
further elucidated by mapping the anisotropy of each of the 4 samples. 
 
3.3.3. Fast Fourier Transform (FFT) Analysis 
The images obtained by SHG microscopy can be analyzed using a FFT based model where 
each image is divided into user-defined regions of interest (ROI), according to which each part of 
the image is fit through an elliptical model [43]. The major and minor axis of this ellipse define 
the orientation of the collagen fiber within the ROI. Optimized ROIs are used in order to define 
the best collagen resolution and obtain an orientation map. The shapes of the collagen fibers are 
first approximated to that of an ellipse, and the FFT analysis further estimates the centroid of the 
ROI and calculates the distance of each point in the fiber from the centroid in order to obtain an 
overall orientation angle using radial vectors which sweep over 360º from the x-axis. [44] Hsin-
Yuan Tan et al. [43] analyzed porcine cornea samples using FFT and obtained clearly demarcated 
orientation lines for different regions of the sample in Figure 3.7. 
 
Figure 3.7: (A) Large area of porcine cornea (scale: 40 µm); (B): Collagen orientation lines 
mapped for the yellow inset box based on FFT analysis (scale: 10 µm) [43] 
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Akilbekova et al. used the FFT analysis in order to obtain resolved orientations of the 
collagen in the samples [45]. They were able to obtain shape description values for each of the 
samples, showing the different overall distribution of the collagen, differentiating between systems 
where the collagen was well-aligned to those which showed a random distribution [8, 31] 
 
3.3.4. F/B Ratio Measurements 
Another analysis technique used the nature of SHG measurements having a forward and 
backward scattering component, hitherto referred as F-SHG and B-SHG respectively. It has been 
understood that the F-SHG imaging is extremely sensitive to the presence of large collagen bundles 
which are of the order of the magnitude of the incoming SHG signal, whereas the B-SHG is 
sensitive to the septa and interstices created by randomly distributed small deposits of collagen, 
where the forward signal gets collected, but the backward signal is propagated stronger. The ratio 
of these two area percentages or intensities observed in the samples is often denoted as the F/B 
ratio, and taken as measure of the evolution of collagen alterations in the sample [46] 
For each of the sample images, a stack is created, where a threshold is applied such that 
the signal to noise ratio is optimized for the individual F-SHG and B-SHG measurements. This 
threshold is used to create a mask, where all the non-collagen areas are automatically allotted a 
null value, with the collagen areas having value of 1. This sort of binary differentiation of the 
images brings the signal to the highest clarity. Depending on the types of cancer or tissue studied, 
the area percentage or the average intensity values are measured for each image in the F-SHG 
stack and divided by the corresponding images for the B-SHG one [47] 
Groups such as Latour et al., [41] took additional care to ensure the validity of such 
measurements by polarization resolving F/B ratio studies. As collagen is known to be anisotropic, 
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they were able to obtain even higher resolutions of the stromae observed in cornea samples, this 
analysis was combined with the direction maps created for the collagen alignment. 
Another method of representing F/B ratio data is through statistically calculating the 
difference in the ratios, observed for different types of healthy and cancer tissues [46]. Many 
different types of non-parametric testing such as the Newman-Keuls test, help calculate the 
standard deviation and variances without compromising the integrity of the data. Kottman et al., 
recently published their work on understanding the alteration in the ECM [48] as observed in 
different lung cancer tissues. Here, they studied an early detection strategy to differentiate between 
a highly invasive cryptogenic organizing pneumonia (COP) from usual interstitial pneumonia 
(UIP) and healthy tissue. UIP is characterized usually by decrease in lung volume and non-
productive cough and is a common yet highly serious medical condition amongst smokers. UIP or 
idiopathic pulmonary fibrosis (IFP) patients often need to undergo lung transplantation after 
diagnosis. On the other hand, COP can be characterized by the presence of granular buds in the 
alveoli and bronchioles. Most cases of COP are cured within three months of treatment with 
corticosteroids unlike for UIP, where such treatments are largely ineffective [49, 50]. In cases such 
as these, an early detection method such as SHG F/B ratio analysis can potentially avoid fatalities. 
3.3.5. Grey Local Correlation Matrix (GLCM) 
GLCM is a statistical method to analyze texture in greyscale images [51]. It analyzes each 
ROI, with relation to its neighboring areas. This method can be set to analyze the images even on 
a pixel by pixel basis, by changing the offset, accounting for different channels within the image. 
It can be classified largely on the basis of three applications: 
a. On the basis of weighted means which are multiplied to the GLCM values depending 
on distance from the main diagonal: 
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i. For analyzing dissimilarity (D) where the weights multiplied to the GLCM 
values increase as you move away from the diagonal 
        ∑ 𝑃𝑖.𝑗|𝑖 − 𝑗|
𝑁−1
𝑖,𝑗=0  (7) 
ii. For analyzing contrast (C) where the weights multiplied to the GLCM 
values decrease as you move away from the diagonal, also known as sum 
of squares variance. 
          ∑ 𝑃𝑖.𝑗(𝑖 − 𝑗)
2𝑁−1
𝑖,𝑗=0  (8) 
iii. For analyzing homogeneity (H) where the weights multiplied to the GLCM 
values decrease exponentially as you move away from the diagonal. This is 
most applicable to images having a high contrast range. 
 ∑
𝑃𝑖,𝑗
1+(𝑖−𝑗)2
𝑁−1
𝑖,𝑗=0         (9) 
b. On the basis of spatial matrix values, complete measurements based on orderliness. 
Similar to contrast wise measurements, Orderliness measures are calculated with 
GLCM weighted averages on the basis that: 
iv. Weights that increase with commonness shall increase with orderliness 
v. Weights that decrease with commonness shall increase with disorder 
The three orderliness measures defined under the GLCM theory are: 
• ASM or Energy mean which can be calculated by the following equation 
typically for cases where the matrix is highly orderly. 
∑ 𝑃𝑖,𝑗
2
𝑁−1
𝑖,𝑗=0
 
• Max Probability (MAX): Simply records the highest value of the matrix in 
the center 
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• Entropy measurement based completely on the disorderliness of the system, 
and calculated by: 
∑ 𝑃𝑖,𝑗 (−ln 
𝑁−1
𝑖,𝑗=0
𝑃𝑖,𝑗  ) 
c. On the basis of statistics, calculating the GLCM mean, median and variance 
The correlation (R) of each pixel to its neighboring ones are calculated as: 
In these equations, the expectation values are denoted by µ and the standard 
deviations are denoted by σ. 
𝑅 =  ∑
(𝑖 − 𝜇𝑖) (𝑗 − 𝜇𝑗) 𝑝𝑖.𝑗
𝜎𝑖𝜎𝑗
𝑖.𝑗  (10a) 
𝜇𝑖 =  ∑ 𝑖 . 𝑝𝑖,𝑗
𝑁
𝑖=1   ;   𝜇𝑗  =  ∑ 𝑖 . 𝑝𝑖,𝑗
𝑁
𝑖=1  (10b) 
𝜎𝑖 =  √
1
𝑁−1
 . ∑ 𝑖. 𝑝𝑖,𝑗   
𝑁
𝑖=1  ;  𝜎𝑗 =  √
1
𝑁−1
 . ∑ 𝑗. 𝑝𝑖,𝑗   
𝑁
𝑖=1     (10c) 
By modifying the offset values and studying the correlation, more information about the texture 
can be measured, as the offset directly influences the distance between each neighboring ROI taken 
into consideration. The group of Cicchi et al. [23] did important work on imaging and 
understanding the structural differences between keloids (K) and normal human dermis (HD) using 
the GLCM data analysis techniques. On the basis of calculating the homogeneity, correlation, and 
energy for different ROI values, they obtained a clear trend to tell apart normal dermis samples 
from excessively scarred keloid tissue. 
3.3.6. Second Harmonic to Autofluorescence Aging Index of Dermis (SAAID) 
In the field of dermatology, it became necessary to be able to image collagen for a variety 
of applications. Tissue engineering [9, 23, 42] also benefited from the studies conducted on 
quantifying the collagen density, especially when it could give more information on the 
proportions of elastin present alongside it. Such multimodal imaging studies were carried out by 
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researchers all over the world, where SHG was combined with any autofluorescence imaging 
technique which targeted the elastin present in the tissue samples. 
SAAID has been devised as a measure of the collagen fiber intensity based on the hybrid 
TPEF imaging done along with SHG. The combined intensity values are used to calculate SAAID 
as per the following formula: 
𝑆𝐴𝐴𝐼𝐷 =   
𝐼𝑆𝐻𝐺 − 𝐼𝑇𝑃𝐸𝐹
𝐼𝑆𝐻𝐺 + 𝐼𝑇𝑃𝐸𝐹
 (11) 
It can be used as a measure of the collagen to elastin ratio in the dermal samples, as the 
elastin can be tagged with TPEF-active fluorescent markers, and the SHG will specifically only 
show collagen density. The SAAID is a very useful tool hence to determine the difference between 
normal skin, keloids and normal scars. As humans are the only mammals who exhibit the presence 
of keloids in response to physical trauma or at times surgery [21, 52], this analysis technique helps 
evaluate the tendency of certain tissues to develop to the keloids stage, where the elastin is 
significantly higher than for normal skin or scars. 
Using these notations, the SAAID value hence approaches -1 when the collagen present in 
the sample is completely replaced by the elastin. In 2014, the group of Cicchi and Pavone [42], 
used the SAAID values to evaluate the effectiveness of laser ablative treatment in removing scarred 
tissue from normal dermis. In this study, they evaluated over three age groups of patients. Group 
I consisted of those less than 35 years of age, Group 2 had age between 35 and 60, whereas the 
last group had age above 60. Their images and results indicated clear differences in the amounts 
of collagen and elastin present, after multimodal imaging pre and post laser treatment [9, 23]  
The results showed clearly that the SAAID values for normal skin was close to -1 due to 
the high presence of elastin, whereas the scores for keloids and scar tissues were closed to 1 owing 
to the higher concentration of collagen in the samples. The SAAID value measurements are often 
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accompanied in every study by two-sample parametric test, to be sure of statistical differences 
observed for the different sample types and also evaluate the standard deviation and means. 
3.3.7. Depth Dependent Decay Measurements 
In order for techniques such as SHG and TPEF to be comparably applicable to imaging 
different kinds of tumors, research groups devised the depth dependent decay (DDD) studies 
analysis method, which helps quantify the SHG signal differing from the change in the focal plane. 
It was observed that the signal intensity would exponentially increase with the increase in depth, 
and such a system could be easily represented by a first order equation where ‘x’ represented the 
imaging depth, and ‘y’ represented the SHG collagen intensity. For such systems, A is the pre-
exponential scaling factor, C is the proportionality constant which ensures the non-collagen areas 
to have a null value.  [22, 53, 54]  
     𝑦 = 𝐴𝑒−𝑘𝑥 + 𝐶    (12) 
The k value obtained from the above equation is the DDD factor which is completely 
dependent on the sample absorption and composition.  It can be easily obtained the collagen 
intensities against the different focal plane depths and extrapolated as per the exponential equation 
to obtain the k values for different samples. 
Many groups such as Chen et al., [22] in Taiwan have studied the differences between 
cartilage, tendons, and normal skin using SHG. They applied the DDD model to identify the 
difference between hypertrophic scars and normal dermis in this study. 
These DDD studies can also be utilized for differentiating between collagen mixtures of 
different proportions due the sensitivity of the k values observed. Ajeti et al., [32] used the DDD 
study to identify how collagen type I and V showed very different absorption and scattering 
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properties, the results of which could go a long way in analyzing different artificial tissue samples 
and their preparation. 
 
3.4. Different Cancer Staging methods 
Imaging methods such as SHG, have been shown to have a significant number of advantages over 
traditional cancer scoring systems. The different data analysis approaches that can be applied to 
the SHG data provide greater details about the sample [56], and at the same time, they do not 
damage the sample or use stains of any kind. It is essential though to see how the standard scoring 
systems can be combined with SHG analysis to provide concurrence for cancer diagnoses. We 
shall discuss below, some commonly used oncological scoring systems: 
3.4.1. Metavir Scoring system 
In this system, the severity of the liver cancer diagnosis, observed through 
histopathological examination of a liver biopsy, is made on the basis of two levels [33, 34]. Firstly, 
on the basis of inflammation, where it is graded from A0 to A4-ranging from ‘no activity’ to 
‘severe activity’. And secondly, on the basis of the stage of fibrosis observed as: 
• F0—No fibrosis 
• F1—Portal fibrosis without septa 
• F2—Portal fibrosis with few septa 
• F3—Numerous septa without cirrhosis 
• F4—Cirrhosis 
3.4.2. TNM system 
The TNM system for classifying severity of cancer is one of the most commonly accepted 
and used to differentiate between different stages of cancer. Unlike the Metavir Scoring system, 
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the TNM scoring applies to a wide range of cancer diagnoses. 
In this system, each letter signifies a different key characteristic of the cancer diagnosis 
[55]. Starting with T, which denotes the size and hence reach of the primary tumor. For invasive 
cancer types, it is essential to know whether the cancer has spread to the nearby lymph nodes, and 
is denoted by N. And lastly, M denotes whether the cancer has spread to other parts of the body, 
forming secondary tumors in a process defined as metastasis-denoted by M. The values assigned 
to each of the letters can hence reveal a lot of information about the cancer diagnosis in a short, 
clear manner. 
For the primary tumor (T) classifications, TX represents that the tumor could not be 
evaluated. T0 indicates the absence of the primary tumor, whereas Tis shows that the tumor is non-
invasive at this stage. T1, T2, T3 and T4 all denote the size of the tumor. 
In the regional lymph nodes (N) scoring, similarly NX represents non-evaluable tumor 
presence lymph node, N0 shows absence of tumor in the nodes. And N1, N2 and N3 denote the 
severity of the lymph node involvement, indicating the number of lymph nodes affected. 
For the metastasis (M) scoring, MX shows that the metastasis could not be evaluated, M0 denotes 
absence of the invasiveness, and M1 shows its presence [56].  
3.4.3. Tumor Associated Collagen Signatures (TACS) 
For the purpose of understanding and defining key characteristics observed in collagen 
morphologies in cancer tissues, the group of Provenzano et al. [57] introduced the nomenclature 
of TACS. Studies had shown that in the cases of hyperplasia, adenocarcinoma and ductal 
carcinoma observed in mice, there were consistent epithelial clusters surrounded by an increased 
presence of collagen. These collagen morphologies were observed to always be one of three types, 
which helped classify the severity and invasiveness of the cancer diagnosis in the subjects [31].  
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• TACS 1-is recognized by highly dense and intense signal imaged for the small 
tumor detected 
• TACS 2-is recognized by a smooth tumor boundary, within which the collagen 
fibers are majorly aligned parallel to the tumor boundary 
• TACS 3-is recognized by collagen fibers being tangentially or perpendicularly 
aligned to the tumor boundary 
Figure 3.8 from the study conducted by Conklin, shows the visual differences between the three 
TACS classifications. 
 
Figure 3.8: Tumor Associated Collagen Signature types in A, B, C, along with associated bar 
graph profiles for intensity of collagen signatures for that TACS orientation [31] 
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3.5. Future Perspectives and Conclusions 
Positive trends have been observed for many of the cancer detection techniques, which 
have shown that these multimodal imaging techniques using SHG in combination with TPEF or 
CARS, have concurred with the standard pathology in place. This is a very important step in the 
establishment of protocol for early cancer detection, which shall improve the quality of living for 
the families affected by these deadly diseases, [57] which are often based on genetic traits  
We have discussed the varied applications of SHG and the different high content imaging 
approaches towards cancer research [57, 58, 59]. It is evident that these methods, produce highly 
complex data, and it thus requires the need for big data analysis. Over the course of our survey of 
the latest work using SHG analysis, we tried to observe certain trends and preferences for using 
set techniques for the treatment of data, but it was very difficult to do so.  Consensus established 
for optimized methods of testing which satisfy researchers across borders can help in global 
benefits. A possible step forward to this goal would be to encourage inter-disciplinary research 
projects to combat cancer types in laboratories and universities across the world. With the 
advancements, in the field of analytics, it would surely not be very long before non-parametric 
testing of data [59] as recommended in this review become the norm. Thereby reducing any bias 
of the data, based on the technique themselves, and establishing concurrence sooner with the 
existing clinical pathologies.  
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CHAPTER 4 
COLLAGEN ORGANIZATION OF FIBROBLASTS ENCAPSULATED IN 
PH RESPONSIVE METHACRYLATED ALGINATE HYDROGELS 
 
Modified from a manuscript published in Journal of Biomedical Materials Research Part A 
(2018) 
 
The pH of dermal wounds shifts from neutral during the inflammatory phase to slightly 
basic in the tissue remodeling phase. Stage specific wound treatment can be developed using 
environmentally responsive alginate hydrogels. The chemistry of these networks dictates swelling 
behavior. Here, we fabricated alginate hydrogels using chain growth, step growth, and combined 
mixed mode gelation methods to crosslink methacrylated alginate (ALGMA) and gain control over 
swelling responses. Methacrylation of the alginate network was confirmed through NMR 
spectroscopy. Strontium cations were introduced to fabricate stiffer, dually crosslinked hydrogels. 
Dual crosslinking significantly decreased the swelling response over the pH range of 3 to 9 for 
step growth and chain growth hydrogels, with no impact on mixed mode hydrogels. The extent of 
crosslinking altered the hydrogel degradation profiles under accelerated degradation conditions. 
Encapsulated NIH/3T3 fibroblasts in the different ALGMA hydrogels remained viable with 
greater cell proliferation in the stiffer gels. Collagen organization deposited by the NIH/3T3 
fibroblasts was monitored using second harmonic generation (SHG) microscopy and was 
influenced by the crosslinking mechanism. Ionic chain growth and ionic mixed mode crosslinked 
ALGMA hydrogels caused relatively isotropic collagen organization, particularly 10 days post- 
cell encapsulation. Principal component analysis (PCA) was employed to uncover correlations 
between the observed properties. The ability of these environmentally responsive gels to induce 
isotropic collagen and respond to pH changes means they hold promise as phase specific wound 
dressings.  
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4.1. Introduction 
 
 Wound healing responses are dynamic processes with both cell types and their 
populations changing throughout the process.1 The sequence of events following injury can be 
divided into four overlapping phases: hemostasis, inflammation, proliferation, and remodeling.2 
Depending on the physiological response from the inflammatory phase to proliferation, wounds 
can be classified as acute or chronic.3 Chronic wounds can result from a compromised immune 
response, as is common in diabetes.4 Diabetic foot ulcers occur in over 15 to 25% of diabetics, 
with an annual incidence rate of over 10%.5 A recent study showed that there has been an 
approximately three fold increase in the cost of skin disease related medical expenses from $29 to 
75 billion in the past 13 years.6,7 The economic burden and high incidence rate of chronic wounds 
demonstrates the need for rapid and effective treatments for these afflictions.  
Alginate has been widely used as a biomaterial for applications in wound healing and tissue 
engineering as it is naturally occurring, relatively inexpensive, can provide a moist environment 
suitable for encapsulated cells, and can be gelled under mild conditions. Divalent cations are 
typically used to ionically crosslink alginate in situ.8 However, these physical interactions are 
weak, meaning that divalent cations can be easily displaced by physiologically abundant 
monovalent sodium.9 Chain and step growth crosslinked hydrogels have been used to 
encapsulating cells for drug release and tissue engineering applications.10 Thiol-ene chemistry is a 
facile and selective reaction that can be used to crosslink a wide variety of naturally and synthetic 
polymers.11 This method is a viable modification strategy to chemically crosslink biological 
molecules using thiodendrimers, which is a significant improvement on previous copper based 
crosslinking reactions which caused cytotoxicity.12 Alginate hydrogels covalently crosslinked 
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through chain growth and click chemistry are cytocompatible, mechanically tunable hydrogels that 
are capable of providing a good approximation for studying in vivo biomaterial interactions.  
In situ photocrosslinkable polymers are a promising construct for fabricating hydrogel for 
varied applications such as drug release systems, as well as tunable sensors for biomedical 
applications.13 Ultraviolet (UV) light can be used to initiate free radical polymerization to 
covalently crosslink functional methacrylate groups on the polymer chain and induce liquid-solid 
transitions of cell-gel formulations. Previous studies showed successful crosslinking of alginate 
and hyaluronic acid based hydrogels using methacrylate functional groups to prepare tissue 
engineering constructs.14 These functional hydrogels were used to encapsulate chondrocytes in an 
osteochondral defect model.15 Increased collagen secretion, swelling responses, and 
biocompatibility of encapsulated cells were some of the key parameters identified in these studies 
that can be further studied for the development of environmentally responsive hydrogels 
synthesized from methacrylated polysaccharides.15,16  
An integral aspect of developing topical formulations to aid in the wound healing response 
is to synthesize environmentally responsive hydrogels.17 The chemical structure of the polymer 
network plays a major role in the response to different environmental cues. Many properties such 
as ionization equilibrium, counterion species, and ion concentration can control the pH response 
of ionically crosslinked hydrogels.16,18 However, less focus has been paid to pH responses of 
covalently crosslinked hydrogels. In this study, we present a method for functionalizing very low 
viscosity alginate using methacrylic anhydride to improve the mechanical properties and 
degradation kinetics of the hydrogel. This allows us to photo-crosslink ALGMA through step 
growth, chain growth, or a combination of the two, termed mixed mode to form soft yet 
biocompatible hydrogels. We investigated the mechanical properties, swelling responses under 
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diverse pH conditions, degradation kinetics, cytocompatibility, and collagen deposition by 
encapsulated NIH/3T3 fibroblasts in the hydrogels. With the use of statistical analytical techniques 
such as PCA, we aimed to identify key factors that can improve rational design for the synthesis 
of a hydrogel formulation that can be used for tissue engineering applications pertinent to the 
treatment of chronic wounds. 
 
4.2. Experimental 
4.2.1. Materials 
Very low viscosity alginic acid (CAS 9005-38-3) was obtained from Alfa Aesar 
(Tewksbury, MA). Other materials were purchased through Sigma Aldrich (St. Louis, MO) and 
were used as received, unless otherwise stated. Fresh deionized water (Milli-Q, Thermo Scientific 
Nanopure, Waltham, MA) was used throughout this study.  
4.2.2. Methacrylated Alginate (ALGMA) Synthesis  
ALGMA was prepared as previously described.19 Briefly, a 1% (w/v) solution of very low 
viscosity alginic acid in DI water was prepared. While the solution was mixing, 16 mL of 
methacrylic anhydride was slowly added. The pH was maintained between 8 to 9 using 5 M NaOH 
while reacting at 4 ℃ for 24 h. The solution was dialyzed for 48 h against water using a molecular 
weight cutoff membrane of 13,000 Da. The dialysate was changed twice daily. The solution was 
lyophilized (4.5L, Labconco, Kansas City, MO) and the ALGMA was collected as a white, soft 
solid. This reaction is illustrated in Figure 4.1. 
NMR was used to confirm methacrylation of the alginic acid. Solutions of alginate and 
ALGMA were prepared using standard protocols.20,21 Briefly, ALGMA was dissolved in D2O and 
lyophilized three times to replace all protons with deuterium before ~12.5 mg of polymer was 
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dissolved a final time in 600 µl of D2O. The 
1H spectra were recorded on a Bruker Avance III 
Spectrometer at 70ºC using a sweep width of 6602.1 Hz, a 90º pulse, and an acquisition time of 
2.48 s. A total of 128 repetitive scans with 64 k points were acquired and the data were processed 
in MNova with 128k points, zero filling, and exponential line broadening of 1.0 Hz. The extent of 
methacrylation was calculated by the relative integrations of the protons from the methacrylate 
groups (𝐼𝐶𝐻2at δ= 6.0 and 5.6 ppm, and the methyl peak (𝐼𝐶𝐻3), at δ= 1.8 ppm) to the carbohydrate 
proton peaks (𝐼𝐻)𝑝𝑜𝑙𝑦𝑚𝑒𝑟.  
𝑀𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛% =  
(
𝐼𝐶𝐻2
𝑛𝐶𝐻2
 + 
𝐼𝐶𝐻3
𝑛𝐶𝐻3
)
𝐼𝑝𝑜𝑙𝑦𝑚𝑒𝑟
𝑛𝐻𝑝𝑜𝑙𝑦𝑚𝑒𝑟
     (1) 
 
Figure 4.1. Synthesis and characterization of ALGMA. (A) Schematic representation of chemical 
modification of alginate. (B) 1H NMR spectra of alginate and methacrylated alginate. The 
guluronate (ii) and mannuronate (iii) peaks are located at δ = 3.7 and 4.7 ppm. Methacrylation of 
alginate polymer from unmodified to methacrylated with respective 1H NMR spectra confirming 
the presence of (ii) guluronate and (iii) mannuronate. The methylene was found at δ = 6.2 and δ = 
6.6 ppm (iv) and the methyl peaks at δ = 1.8 ppm (i). The degree of methacrylation was calculated 
as a percentage of hydroxy group substitution with the methacrylate groups per repeating unit. 
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4.2.3. Hydrogel Fabrication and Characterization 
To 10 ml of DI water, 300 mg of ALGMA was dissolved to obtain a 3% (w/v) solution. 
Irgacure 2959 (10 mg) was added to the stock solution. Three different gelation reactions, step 
growth, chain growth, and mixed mode polymerization were used to obtain different hydrogels. 
For chain growth gels, an aliquot of the stock solution was degassed under vacuum. For step 
growth polymerization, 250 µl of 4 mg/ml dithiothreitol (DTT) was added to the stock solution. 
For the mixed mode polymerization, 250 µl of 4 mg/ml DTT was added to the stock solution and 
it was degassed. All three pre-gels were exposed to UV light (365 nm, 2 W/cm2) for 10 minutes. 
For preparation of dually crosslinked ALGMA hydrogels, 100  l of 0.2 M SrCl2 was added after 
the gels were exposed to UV light. 
Hydrogel pegs (6 mm thick, 16 mm diameter, n = 4) were placed between two glass slides 
on top of which weights were added. Height changes and cross-section areas of the hydrogel pegs 
were measured through Image-J (NIH, Bethesda, MD). The compressive modulus was defined as 
the slope of the linear region in the stress-strain curve in the 5 – 15% strain range. 
To measure the swelling ratios, the hydrogels (n = 3) were dried at room temperature in a 
desiccator. The solid was then swelled in 1 mM acetate buffer solution at pH 3, 5, 7.4, or 9 for 2 
days. The wet and dry weights were recorded, and the swelling ratios were calculated using 
equation (1), where M𝑤 is the wet mas and M𝑑 is the dry mass. 
S =
M𝑤 − 𝑀𝑑
𝑀𝑑
                                                              (2) 
4.2.4. In Vitro Degradation 
For each gelation method, 1 ml of hydrogel was exposed to UV light and placed in 0.1 mM 
NaOH to determine how the crosslinking mechanisms affected gel stability and degradation 
90 
 
profiles. The hydrogels were first equilibrated for 24 h in water before measuring the initial mass 
to eliminate swelling effects. The mass of the hydrogel (n = 3) was measured every 24 h and 
compared with the initial mass.  
4.2.5. Cell Culture and Viability Assay 
NIH/3T3 fibroblasts (ATCC, Manassas, VA) were cultured at 37°C with 5% CO2 in 
complete medium (CM, Dulbecco’s modified Eagle’s medium (Thermo Scientific) supplemented 
with 10% bovine calf serum, 100 U/L penicillin, and 100 μg/ml streptomycin). To 48 well plates, 
200 μl of cell solution at 1  107 cells/ml was mixed with 300 μl hydrogel. Both live and dead 
controls were made in which the cells were plated directly on the tissue culture plastic in the 
absence of hydrogel. After 48 h, the dead control was aspirated and 300 μl of 70% ethanol was 
added for 10 minutes to kill the cells. The supernatant in each well was then aspirated and replaced 
with 150 μl phosphate buffered saline (PBS) with 0.3 μl of 1 mg/ml calcein-AM and 1.12 μl of 1 
mg/ml 7-aminoactinomycin D (7-AAD) and incubated for 40 mins. Images were taken with a 
EVOS Floid Cell Image Station (Thermo Scientific) using the red (excitation/emission 586/646 
nm) and the green channels (482/532 nm). 
4.2.6. SHG Microscopy Imaging of the gels 
NIH/3T3 fibroblasts were suspended at a concentration of 1  107 cells/ml and mixed with 
an equal volume of hydrogel precursor solution. This solution (100 μl) was pipetted between two 
glass coverslips, exposed to UV light for crosslinking, and placed in Petri dishes containing CM. 
The cells were fed every three days. Negative controls consisting of gels without cells were also 
prepared. After 5, 7, or 10 days, the samples were fixed in 10% formalin solution and imaged. 
All samples were imaged using a mode-locked Ti:Sapphire laser (100 fs pulse width, 1 
kHz repetition rate, Libra, Coherent, Santa Clara, CA) that produces an 800 nm fundamental. The 
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average power at the sample image plane was controlled using a combination of a half-wave plate 
and a Glan-Thompson polarizer (Thorlabs, Newton, NJ). Second harmonic signal was collected in 
the transmission mode. For this setup, an inverted microscope (AmScope, Irvine, CA) and Nikon 
Plan Fluorite objective (20 , 0.50 NA, 2.1 mm WD, Nikon, Melville, NY) was used to focus the 
beam and the SHG transmission was collected with a Nikon water immersion objective (40 , 0.8 
NA, 3.5 mm WD, Nikon). The transmitted SHG signal was reflected by a dichroic mirror 
(DMLP425T, Thorlabs) and separated from the fundamental beam with two short pass filters < 
450nm (FGB37M, Thorlabs) and 808 nm notch filter (NF-808.0-E-25.0M, Melles Griot, 
Rochester, NY), before detection by an intensified CCD (iCCD, iStar 334T, Andor, Belfast, UK). 
Polarized SHG imaging was conducted using a Glan-Thompson polarizer and a half-wave plate 
mounted on a motor driven rotational stage (Thorlabs) to achieve linear polarization. Images of 
the samples were collected every 10° from 0° to 350°. A minimum of three images for each 
experimental condition was taken. From this collection of images, regions of interest (ROI) were 
fit using the following equation: 
𝐼𝑆𝐻𝐺 = 𝑐 ∙  {[𝑠𝑖𝑛
2(𝜃𝑒 −  𝜃𝑜) + (
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
) 𝑐𝑜𝑠2(𝜃𝑒 − 𝜃𝑜) ]
2
+ (
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
)
2
sin2(2(𝜃𝑒 −  𝜃𝑜))}  (3) 
where 
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
 and 
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
 are second-order susceptibility tensor element ratios, 𝜃𝑒  and 𝜃𝑜 are incident 
polarization angle and collagen fiber angle, respectively, and c is a normalization constant. The 
orientation angle of collagen in each ROI was calculated and a histogram was generated. Collagen 
organization was measured by fitting the orientation angle histogram with a Gaussian fit over a 
180 profile and full-width at half maximum (FWHM) values were obtained. Collagen types were 
identified using a previously described method.22 Briefly, collagen gels with varying collagen type 
III concentrations were imaged using SHG microscopy and the data was fit using equation 2. 
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Histograms of 
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
 revealed the present of two peaks: one at ~0.8, which is assigned to collagen 
type III and the second at ~1.2, corresponding to collagen type I. The ratios of these integrated 
peaks were plotted against collagen type III concentration to yield a standard curve. This curve 
was used to estimate collagen type III concentrations in the imaged hydrogels. 
4.2.7. Statistical Analysis 
All data was subjected to statistical analysis and values are reported as mean ± standard 
deviation (SD). Statistical significance of the mean comparisons was determined by a two-way 
ANOVA. Pair-wise comparisons were analyzed with Tukey’s honest significant difference test. 
Differences were considered statistically significant for p < 0.05. Principal component analysis 
was conducted to uncover the correlations between the characterized properties of the gels and the 
collagen response from the encapsulated fibroblasts. 
 
4.3 Results 
4.3.1. Characterization of ALGMA Hydrogels 
ALGMA was characterized using 1H NMR spectroscopy (Figure 4.1), using a previously 
described protocol.23 The mannuronic acid content of the unmodified alginate was determined to 
be 45 ± 2%, with ii and iii labeling the guluronate and mannuronate residue peaks.24 Two peaks 
appear in the ALGMA spectrum at 6.0 and 6.4 ppm, which are assigned to the methylene and 
methacrylamide protons, labeled as iv (Figure 4.1). The extent of methacrylation was calculated 
through the relative integration of the methacrylate and methyl peak (at 1.8 ppm, labeled as i) to 
those from the protons of the modified alginate, as 25 ± 2%, using a previously described 
procedure.25  
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4.3.2. Compressive Moduli  
The compression modulus can serve as an approximation for the extent of crosslinking 
when comparing polymers with similar backbones (similar branching, molecular weight, etc.) 
fabricated using different crosslinking methods.26 The compressive moduli (Figure 2) increase 
from step growth to chain growth to mixed mode (0.71 ± 0.04, 1.29 ± 0.07, and 1.61 ± 0.03 kPa, 
respectively). Introducing ionic junctions through strontium ions further increased the moduli. 
Ionically crosslinked ALGMA has a modulus of 0.53 ± 0.03 kPa. The increase in the compressive 
moduli for dually crosslinked hydrogels are ~500 Pa higher than their counterparts that are not 
ionically crosslinked (1.21 ± 0.07, 1.99 ± 0.11, and 2.24 ± 0.12 kPa for step growth, chain growth, 
and mixed mode gels).  
 
Figure 4.2. Compressive moduli of alginate hydrogels. Compressive moduli of methacrylated 
alginate hydrogels crosslinked through the different mechanisms. Data represents the mean ± SD. 
n = 3. Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc test. * p < 0.05. 
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4.3.3. Swelling Response 
Significantly higher swelling responses were observed in basic conditions (pH 9) compared 
to the acidic conditions (pH 3, Figure 4.3). This trend was consistent for all crosslinked alginate 
hydrogels studied here. The swelling response (Figure 4.3) of the ionically crosslinked non-
methacrylated alginate hydrogels was higher than covalently crosslinked hydrogels. 
 
Figure 4.3. Swelling behavior of alginate hydrogels in different pH buffers. Hydrogels 
crosslinked through the different mechanisms were swelled in pH 3, 5, 7.4, and 9. Data represents 
the mean ± SD. n = 3. Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc 
test. * p < 0.05. 
 
4.3.4 Degradation Kinetics 
For efficient delivery of proteins, cells, or cytokines to wound sites,27 it is essential to have 
well characterized degradation kinetics. These hydrogels were incubated in accelerated 
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degradation conditions (0.1 mM NaOH, Figure 4.4). Statistically, there was no difference for step 
growth, chain growth, and mixed mode gels with all three gels degrading to 50% of their original 
mass within 5-6 days. The ionically crosslinked hydrogels degraded completely within 6 h and are 
not shown. Dually crosslinked hydrogels were more stable than their covalently crosslinked 
counterparts with 50% of their original mass remaining after 13-16 days.  
 
Figure 4.4. Alginate hydrogel degradation under accelerated conditions. Alginate hydrogels 
were immersed in 0.1 mM NaOH to mimic accelerated degradation conditions. Data represents 
the mean ± SD. n = 3. Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc 
test. * p < 0.05. 
 
4.3.5. Cytocompatibility of ALGMA Hydrogels 
Wound dressings must be cytocompatible. NIH/3T3 fibroblasts were encapsulated in the 
different ALGMA hydrogels and imaged using a live/dead assay. Cell proliferation after 48 h was 
normalized to the controls (cells cultured on tissue culture plastic) (Figure 4.5). Significant 
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differences were observed for the increase in cell proliferation with increasing compressive moduli 
of the ALGMA gels. The covalently crosslinked hydrogels showed proliferation of 24 ± 1, 32 ± 2, 
44 ± 1% for the step growth, chain growth and mixed mode respectively. The dually crosslinked 
hydrogels showed significantly higher cell proliferation of 54 ± 4, 62 ± 1, 65 ± 1% for the ionic 
step growth, ionic chain growth and ionic mixed mode gel types respectively.  The NIH/3T3 cells 
aggregated more for the dually crosslinked hydrogels compared to their covalently crosslinked 
counterparts. Overall, no dead cells were observed across all encapsulated conditions indicating 
minimal cytotoxicity of the alginate hydrogel solution. Cells were not encapsulated in non-
methacrylated alginate hydrogels, due to their rapid breakdown under accelerated degradation 
conditions. 
 
Figure 4.5. Proliferation of NIH/3T3 cells encapsulated in alginate hydrogels. NIH/3T3 
fibroblasts were mixed with ALGMA and crosslinked. Cells seeded on tissue culture plastic served 
as the controls. (A) Representative micrographs of live (green) and dead (red) cells cultured for 48 
h. (B) Quantification of live and dead cells. Data represents the mean ± SD. n = 6. Statistical 
analysis through two-way ANOVA and Tukey’s HSD post-hoc test. *p < 0.05. 
 
4.3.6. SHG Microscopy 
We used SHG microscopy to visualize the collagen deposition and remodeling in the cell-
gel environment. Molecules must be non-centrosymmetric to be SHG active, which means that 
cell culture medium and the hydrogel network will not contribute to the signal. There was a clear 
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trend for collagen organization in the chain and step growth hydrogels. Initially, collagen was 
highly ordered on day 5 and became significantly more disordered on days 7 and 10 (Figure 4.6). 
We observed the same trend for dually crosslinked hydrogels (Figure 4.6). Mixed mode hydrogels, 
both covalently and dually crosslinked, showed no significant changes in collagen organization 
from days 5 to 10. The % collagen III calculated from the susceptibility tensor ratios (Figures 4.7 
and 4.8) showed no trend for any of the hydrogel formulations, with their values varying from 1 
to 36%. 
Table 4.1. SHG analysis parameters for NIH 3T3 cells encapsulated in covalently crosslinked 
ALGMA hydrogels. 
 
Treatment FWHM Col III 
Chain Growth Day 5 12  2 25  5% 
Chain Growth Day 7 21  4 4  1% 
  Chain Growth Day 10 16  3 9  1% 
Step Growth Day 5 18  4 1  0% 
Step Growth Day 7 34  7 19  6% 
Step Growth Day 10 33  5 5  1% 
Mixed Mode Day 5 34  9 8  2% 
Mixed Mode Day 7 23  3 9  2% 
Mixed Mode Day 10 16  4 7  2% 
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Figure 4.6. Organization of collagen secreted by encapsulated fibroblasts in alginate 
hydrogels. NIH/3T3 fibroblasts were mixed with ALGMA and crosslinked. Samples were imaged 
using SHG microscopy to observe the changes in collagen organization.  
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Figure 4.7. Collagen III secretion in covalently crosslinked ALGMA: Histograms of 
χ_zzz/χ_zxx values obtained for NIH 3T3 fibroblasts encapsulated in covalently crosslinked 
ALGMA hydrogels 
 
Table 4.2. SHG analysis parameters for NIH 3T3 cells encapsulated in dually crosslinked 
ALGMA hydrogels. 
 
Treatment FWHM Col III 
Ionic Chain Growth Day 5 19  5 22  3% 
Ionic Chain Growth Day 7 35  7 36  6% 
Ionic Chain Growth Day 10 63  12 2  1% 
Ionic Step Growth Day 5 54  17 9  2% 
Ionic Step Growth Day 7 117  34 18  3% 
Ionic Step Growth Day 10 62  12 5  1% 
Ionic Mixed Mode Day 5 57  12 33  7% 
Ionic Mixed Mode Day 7 45  7 6  1% 
Ionic Mixed Mode Day 10 54  6 10  2% 
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Figure 4.8. Collagen III secretion in dually crosslinked ALGMA: Histograms of χ_zzz/χ_zxx 
values obtained for NIH 3T3 fibroblasts encapsulated in dually crosslinked ALGMA hydrogels 
 
4.3.7. PCA  
Relationships between the collected data were analyzed using informatics analysis. For 
PCA, similar distances and angles of the projections indicates the data are correlated. Here, a 
Euclidean geometric map was used to uncover trends between the materials properties of the 
alginate gels and the collagen organization and type present in those gels. These have been plotted 
as PC1 and PC2 which are a linear combination of the different variables mapped on two new 
axes. In our study, PC1 explains 57.6% data variance and PC2 explains 23.4% data variance, which 
represents >80% of the original data information. Swelling ratios and compressive moduli were 
negatively correlated. Cell proliferation was strongly correlated to the mechanical modulus 
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(Figure 4.9). The Pearson correlation was R = 0.86 (Table 4.3). As expected, the compressive 
modulus was strongly negatively correlated (R = -0.94, Table 4.3) to the swelling under basic 
conditions (pH 9). Strong positive correlations were observed for the collagen FWHM (d10) with 
the cell proliferation (R = 0.74, Table 4.3) and degradation half-life (R = 0.85, Table 4.3) under 
accelerated conditions.  
 
Figure 4.9. Loading plot of hydrogel parameters and their influence on cell proliferation and 
collagen secretion. PC1 explains 57.6% data variance and PC2 explains 23.4% data variance, 
which represents >80% of the original data information. 
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Table 4.3. Correlation matrix for the hydrogel properties and encapsulated cell responses. 
 
 
Compress
ive 
Modulus 
Swellin
g (pH 
3) 
Swelling 
(pH 5) 
Swel
ling 
(pH 
7.4) 
Swel
ling 
(pH 
9) 
Degra
dation 
(half-
life 
time) 
Cell 
proli
ferat
ion 
Colla
gen 
secret
ion 
(d10) 
Colla
gen 
FWH
M 
(d10) 
Col 
III 
% 
(d10
) 
Coll
agen 
secre
tion 
(d5) 
Collag
en 
FWH
M (d5) 
Col 
III% 
(d5) 
Compressive 
Modulus 
1.00 -0.92 -0.88 
-
0.90 
-
0.94 
0.86 0.86 0.31 0.37 0.19 
-
0.26 
0.40 0.79 
Swelling (pH 
3) 
-0.92 1.00 0.99 0.97 0.94 -0.81 
-
0.67 
-0.23 -0.04 
-
0.46 
-
0.12 
-0.44 
-
0.66 
Swelling (pH 
5) 
-0.88 0.99 1.00 0.94 0.91 -0.75 
-
0.57 
-0.13 0.10 
-
0.58 
-
0.23 
-0.46 
-
0.61 
Swelling (pH 
7.4) 
-0.90 0.97 0.94 1.00 0.95 -0.92 
-
0.86 
-0.17 -0.36 
-
0.34 
0.11 -0.58 
-
0.74 
Swelling (pH 
9) 
-0.94 0.94 0.91 0.95 1.00 -0.92 
-
0.92 
-0.36 -0.43 
-
0.11 
0.34 -0.62 
-
0.58 
Degradation 
(half-life 
time) 
0.86 -0.81 -0.75 
-
0.92 
-
0.92 
1.00 0.98 0.14 0.85 
-
0.10 
-
0.60 
0.66 0.58 
Cell 
proliferation 
0.86 -0.67 -0.57 
-
0.86 
-
0.92 
0.98 1.00 0.28 0.74 
-
0.08 
-
0.56 
0.65 0.58 
Collagen 
secretion 
(d10) 
0.31 -0.23 -0.13 
-
0.17 
-
0.36 
0.14 0.28 1.00 0.11 
-
0.66 
-
0.32 
-0.24 
-
0.20 
Collagen 
FWHM 
(d10) 
0.37 -0.04 0.10 
-
0.36 
-
0.43 
0.85 0.74 0.11 1.00 
-
0.46 
-
0.71 
0.50 0.22 
Col III % 
(d10) 
0.19 -0.46 -0.58 
-
0.34 
-
0.11 
-0.10 
-
0.08 
-0.66 -0.46 1.00 0.62 0.30 0.47 
Collagen 
secretion 
(d5) 
-0.26 -0.12 -0.23 0.11 0.34 -0.60 
-
0.56 
-0.32 -0.71 0.62 1.00 -0.08 
-
0.19 
Collagen 
FWHM (d5) 
0.40 -0.44 -0.46 
-
0.58 
-
0.62 
0.66 0.65 -0.24 0.50 0.30 
-
0.08 
1.00 0.18 
Col III% 
(d5) 
0.79 -0.66 -0.61 
-
0.74 
-
0.58 
0.58 0.58 -0.20 0.22 0.47 
-
0.19 
0.18 1.00 
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4.4. Discussion 
 
Here, ALGMA hydrogels were fabricated by methacrylating alginate using methacrylic 
anhydride.19 Characterization of the compressive moduli, degradation kinetics, and the swelling 
response to different pH conditions present ALGMA gels to be suitable for a variety of tissue 
engineering applications. The environmental response of the hydrogels to highly basic conditions, 
suggests that these gels could be used for controlled delivery applications of drugs to chronic 
wound environments.28 
ALGMA hydrogels were prepared through covalent crosslinking as well dual crosslinking 
using both ionic and covalent mechanisms. The mechanism of crosslinking has considerable 
influence on estimated compressive modulus.29 Purely ionic crosslinking of these very low 
viscosity alginate resulted in extremely soft hydrogels with a modulus less than 1 kPa. Covalent 
crosslinking of the methacrylated alginate structure (Figure 4.1) resulted in stiffer hydrogels. This 
result is in line with previous studies that showed that the compressive moduli increased from step 
growth to chain growth to mixed mode crosslinking of polymers.29,30 The additional strontium ions 
increased the number of crosslinks, which increased the compressive moduli of the gels.31 Overall, 
the ALGMA hydrogels were tunable over the range of 0.6 to 2.5 kPa (Figure 4.2). Previous studies 
for the developing soft tissue scaffolds to encapsulate fibroblasts and hepatocytes have used 
hydrogels with compressive moduli from 1 to 15 kPa. The matrix remodeling activity of these 
encapsulated cells was observed through the analysis of their degradation activity in different 
conditions of hydrogel composition.32,33 Another study compared ionic and photocrosslinked cell-
encapsulated hydrogels having similar mechanical moduli in vivo. The ionically crosslinked 
hydrogel did not retain structural integrity, whereas the stiffer covalently crosslinked hydrogels 
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remained intact with significant extracellular matrix (ECM) deposition on their surface, indicating 
successful biomaterial acceptance.34 
 The propensity of a hydrogel to swell is inversely related to its crosslinking density. 
Theoretical models based on the Flory interaction parameter can be used to predict swelling 
behavior. 35 Since crosslinking density and mechanical moduli are correlated,36 the softer gels were 
expected to degrade fastest, with stiffer gels degrading slower. Based on the compressive moduli, 
the step-growth gel was expected to have the largest swelling ratio, with the dually crosslinked 
mixed mode hydrogel swelling the least. This trend was observed for every pH condition (Figure 
4.3). The carboxyl group on mannuronic acid has a pKa ~3.5. At pHs above the pKa, the charged 
carboxylate groups will repel one another, leading to a conformational change and volume increase 
of the hydrogel.37 As such, significant increases were observed when the gels were exposed to 
increasingly alkali solutions. The swelling ratio was negatively correlated with compressive 
modulus (R = -0.94 with swelling ratios at pH 9) The purely ionic hydrogels with the lowest 
network density were observed to swell the most as expected at every pH condition, rising to 27 
times their original dry weight at pH 9. The dually crosslinked hydrogels swelled significantly less 
than their covalently crosslinked hydrogel counterparts, with the ionic mixed mode hydrogel 
swelling to 13 times their original weight at the same condition. Crosslinking density and 
mechanism are important material properties that are correlated. As per the theory of rubber 
elasticity, an increase in the crosslinking density results in increased stiffness of the hydrogel.36 
Alginate, being an anionic polymer with carboxyl groups along its structure, is expected to swell 
more under basic conditions, while simultaneously being influenced by the stiffness of the 
hydrogel itself due to its network structure.38 This propensity to swell more under basic conditions 
can be applied to delivery of cytokines to boost the immune response for chronic wound 
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treatments. Further transport phenomena characterization of optimal pore size and drug-matrix 
interactions can move this material towards use as a controlled release system.39,40 
 As focus has shifted towards naturally derived hydrogels for biomedical applications for 
their improved biocompatibility and control of mechanical properties and degradation rates are 
important parameters for improved regenerative medicine applications.41 The crosslinking 
mechanism influences the mechanical strength with step growth being lowest and mixed mode 
being highest. Ionic crosslinks had a uniform impact on the compressive modulus and did not alter 
this trend for degradation kinetics (Figure 4.4). Since mechanical strength is expected to be related 
to degradation, the covalently crosslinked gels were anticipated to degrade faster than their dually 
crosslinked counterparts. The dually crosslinked hydrogels had a half-life approximated twice as 
long as their covalently crosslinked counterparts. The changes in swelling ratios were similar to 
the degradation trends, with the stiffest hydrogels swelling the least. This is in line with previous 
studies on photocrosslinked alginate hydrogels that showed strong correlations between increased 
stiffness, decreased swelling, and degradation rate characteristics.8,42 
Hydrogels used for tissue engineering applications must be cytocompatible. Live/dead 
staining images showed no cytotoxicity for NIH/3T3 cells encapsulated in the ALGMA hydrogels 
(Figure 4.5). Cell proliferation showed a strong correlation (R = 0.86) with the mechanical moduli. 
Cells encapsulated in ionic chain growth and ionic mixed mode hydrogels had cell proliferation > 
60% (Figure 4.5). Typical monolayer cultures have reported cell viabilities of around 90% for 
surface-seeded chondrocytes and fibroblasts on stiffer methacrylated alginate substrates of 34 to 
175 kPa elastic moduli.8,33  
SHG imaging of fibroblasts encapsulated in the ALGMA hydrogels showed the changes 
in the organization of secreted collagen. Collagen organization progressed from anisotropic to 
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significantly more isotropic distribution for covalently crosslinked step and chain growth gels 
(Figure 4.6). This trend continued for the dually crosslinked ALGMA hydrogels. One possible 
explanation for this observation is that excessive network entanglements for the mixed mode gels 
inhibited reorganization of the secreted collagen by the fibroblasts. Based on the swelling ratio and 
compressive modulus data, step growth and chain growth gels have a lower crosslinking density 
compared with the mixed mode gels, meaning that encapsulated cells are not restricted by the 
network. In one of the few studies using SHG microscopy to measure collagen organization in 
hydrogels, the formation and degradation of collagen fibrils appeared to be influenced positively 
by higher cell seeding density, however it was difficult to obtain direct cause-effect relationships.43 
Most studies relied on fluorescent tagging protocols for qualitative or quantitative estimation of 
the types of collagen secreted.44,45 The use of multimodal imaging, specifically polarization 
resolved SHG imaging is a relatively rare technique, yet it holds great promise for characterizing 
cell-biomaterial interactions without requiring dyes.  
Factorial and Principal component analysis have been effective tools for evaluating 
correlations between material properties and biological responses. Studies previously conducted 
on modifying medium viscosity alginate with diverse functional groups sought to elucidate the 
macrophage-biomaterial interactions, particularly in identifying material and chemical properties 
that influence macrophage differentiation and reprogramming through PCA.20,46 Collagen 
secretion by fibroblasts is an integral aspect of the wound healing response, particularly with 
respect to the differentiation and activity of fibroblasts, which can be initiated by cytokines such 
as TGF-β.47 Initiation of specific pathways such as Rho-associated protein kinase (ROCK), Yes-
associated protein (YAP), TAZ (responsible for the coding of the Tafazzin gene) are often up-
regulated on stiffer substrates.48,49 The feed-forward loop associated with stiffer substrates 
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influencing fibroblasts to secrete more collagen and other ECM proteins is a biomarker for cancer 
associated fibroblasts, as well.50,51 Thus, rational design of tunable hydrogels for chronic wound 
treatment may be improved through PCA analytical methods that examine multiple facets of 
materials design. The positive correlation between the swelling responses at different pH 
conditions and compressive moduli indicated that there was strong connection for all those trends 
driven by their shared negative correlation to the latter (all between R = -0.88 and -0.94). The 
initial collagen secretion showed a strong negative correlation with the FWHM of collagen 
organization on the final day of the cell-gel SHG observations. This suggests that cellular activity 
was driving these changes. Though it was difficult to ascertain an overall trend for the collagen 
type III levels, the PCA showed that there was a strong negative correlation between collagen type 
III levels and the collagen secretion levels.  
 The modulation of collagen secretion by fibroblasts in hydrogels for understanding 
mechanical cues that can alter wound healing, using non-linear optics is a relatively new approach 
for tissue engineering. Collagen gels have been studied in the past for their efficacy in hastening 
the wound healing progress towards granular tissue formation.52 The structure and orientation of 
collagen fibers have been studied for their influence on cell-mediated migration, which could play 
an important role in the remodeling of the wound site.53 The relatively aligned collagen 
organization  in response to the softer covalently crosslinked hydrogels, was in contrast to the 
relatively more isotropic response on the dually crosslinked hydrogel. Coupled with the 
moderately strong correlation of the FWHM at d5 to the compressive modulus in Figure 4.7, there 
is some basis for the hypothesis that the initial collagen organization being influenced by the 
mechanical properties of the encapsulating hydrogel. Histological studies have shown that 
collagen is highly aligned in hypertrophic and keloid scar tissues as compared to being stochastic 
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in normal skin.54,55Highly aligned collagen fibers have been observed with increased collagen III 
% for inguinal hernia56 Greater interest has been generated towards replicating isotropic collagen 
organization for improved wound healing, particularly for treatment of chronic wounds.57 Dually 
crosslinked hydrogels show promise as hydrogels that promote isotropic collagen organization, 
and when combined with their moderately wide range of swelling responses, as viable drug 
delivery systems to promote chronic wound healing.  
 
4.5. Conclusions 
In this study, we successfully fabricated different methacrylated alginate hydrogels using 
covalent and ionic crosslinking strategies with tunable mechanical properties. Diverse 
polymerization mechanisms (such as step and chain growth) were used to fabricate alginate 
hydrogels ranging from very soft at 0.7 kPa to relatively stiffer gels prepared through dual ionic 
and covalent crosslinking. We demonstrated possible links between the increased swelling 
response and the crosslinking mechanisms for all hydrogel formulations under basic pH 
conditions, as expected from the anionic nature of the alginate polymer. Stiffer gels swelled to a 
lesser extent than softer gels across the same pH condition, possibly due to differences arising 
from the rubber elasticity theory. These ALGMA hydrogels were found to be cytocompatible when 
encapsulating NIH/3T3 fibroblasts. Stiffer gels were able to induce isotropic collagen 
organization, similar to that of healthy dermal tissues.  
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CHAPTER 5 
POLY-L-ARGININE MODIFICATIONS ALTER THE ORGANIZATION 
AND SECRETION OF COLLAGEN IN SKH1-E MICE 
 
Functionalized biomaterials interface with tissue upon implantation. There is a growing 
need to understand how materials properties influence this interaction so that efficient tissue 
engineering systems can be developed. In this study, we characterize collagen organization in 
response to functionalized glass beads implanted in SKH1-E mice. Poly-L-arginine (PLR) was 
modified with arginine derivatives to create a functionalized surface and was coated on glass 
beads. Tissue sections were removed 28 days post-implantation and were imaged using second 
harmonic generation (SHG) microscopy. These chemical modifications were able to alter the 
collagen distribution from highly aligned to disordered (~17 to 80° full width at half-maximum 
(FWHM)) and the collagen III/I ratio (0.02 to 0.42). Principal component analysis (PCA) 
comparing the physical properties of the modifiers (e.g. hydrophobicity, molar volume, freely 
rotating bonds, polarizability) with the SHG analytically derived parameters (e.g. collagen III/I 
ratio, collagen orientation) was performed. Chemical properties of the PLR-like modifications 
including lipophilicity, along with the number of freely rotating bonds and the polarizability had 
significant effects on collagen organization, both in terms of collagen orientation as well as the 
production of collagen III. These findings demonstrate the possibility of tuning the foreign body 
response in terms of collagen deposition and organization, to positively influence the acceptance 
of implanted biomaterials. 
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5.1. Introduction 
The foreign body response is a complex series of processes initiated upon implantation of 
a biomaterial. The affected tissue responds to the implant through the secretion of chemokines, 
cytokines, and matrix metalloproteinases (MMPs) in an attempt to restore normal function at the 
implant site.1 Different cell types participate in the foreign body response with specific roles as the 
tissue seeks to halt blood flow and repair the damaged extracellular matrix (ECM).2–4 The foreign 
body response interferes with the cascade of cell signaling pathways involved in normal wound 
closure by extending the inflammatory response phase.5 This hindered wound healing response to 
the implant consists of protein adsorption on the implant surface, recruitment of monocytes, 
monocyte differentiation from macrophages, macrophage fusion into foreign body giant cells, 
differentiation and activation of fibroblasts to myofibroblasts, and fibrotic encapsulation.6 Post 
inflammation fibroblasts and myofibroblasts secrete collagen, particularly types I and III, in the 
case of dermal tissues to synthesize a fibrotic layer in response to the implant. The organization of 
collagen in this fibrous collagen-rich layer can vary from well-aligned to a stochastic distribution 
of collagen fibrils.7 These deposited collagen fibrils become active components of the basement 
membrane reconstruction, by promoting the attachment of endothelial cells.8 During the 
remodeling phase of wound healing, collagen fibers are aligned stochastically similar to that of 
unwounded tissues.9 Healed tissues often do not recover their full mechanical strength, regaining 
only around 80% to the levels prior to the tissue damage.10 Scar tissue or incompletely healed 
tissue contain bundles of organized collagen fibers, compared to the isotropic organization in 
undamaged tissue.11 In scar tissue, collagen type III is replaced by fibrillar collagen type III, as 
observed in fibrotic capsules around implant sites.12 Isotropic collagen orientation with similar 
levels of collagen III as that in healthy dermal tissues, would be the ideal collagen response to 
implanted biomaterials.13  
115 
 
Multimodal imaging techniques such as second harmonic generation microscopy (SHG) 
enable sensitive, dye-free imaging of collagen in various clinical samples.14 In this non-linear 
microscopy process, two photons of the same wavelength are impinged spatially and temporally 
on a sample. When these photons interact with non-centrosymmetric moieties, they double in 
frequency.15 The non-centrosymmetric chemical structure of collagen arising from its triple helical 
structure, make it an SHG-active biomolecule. Changes in collagen density, organization, and type 
can be determined using SHG analysis. Other biomolecules that have been imaged using SHG are 
myosin in muscle tissue and cholesterol crystals in atherosclerotic plaques.16,17 SHG microscopy 
of triple helical collagen fibers can provide more information about the collagen response through 
susceptibility tensor analysis.14,15 These parameters are linked to the material properties, based on 
the molecular origins of the collagen signal arising from the ratio of their methylene to peptide 
bonds.18 Polarization resolved SHG microscopy is capable of differentiating between diverse types 
of collagen in dermal samples by generating a map of the susceptibility tensor components. 
Specifically, the ratio of collagen types I and III can be estimated by analyzing ratio of the 
nonlinear susceptibility tensor elements.14 Collagen type I is significantly more prevalent than type 
III in human skin, and the ratio of III/I is ~ 30% for unwounded adult dermis.19 As wound healing 
progresses, this ratio can rise to ~ 90% and gradually decreases during the re-epithelialization 
process.20 Elevated levels of collagen type III are linked to a prolonged wound healing process. In 
some cases, these elevated levels are associated with hypertrophic scarring or internal injuries such 
as inguinal hernia.21,20,22 However, there is no consensus on the role played by collagen type III on 
the wound healing process, or the biomaterials properties that can induce different levels of 
collagen type III. It has been observed that as wound healing progresses towards the granulation 
phase, collagen I is replaced by collagen III particularly for tissues that undergo significant 
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mechanical stress, which indicates a difference in mechanotransductive signaling roles in the two 
types of collagen in the ECM23,24. This change in significant tissue strength for higher collagen III 
is also observed for tissues prone to developing different types of hernias.20 During scar tissue 
formation, collagen type III is organized with collagen type I in aligned bundles, while they are 
stochastically arranged in healthy tissue.13  
Our study focuses on the analysis of the collagen response to functionalized glass beads 
implanted in SKH1-E mice. These mice are commonly used for studying dermal wound healing 
responses as they are hairless, making application and observation of topical treatments relatively 
easy.25,26 We used a library of chemical modifiers based off the amino acid arginine and its 
derivatives, which have been previously studied for their ability to influence the synthesis of 
collagen by fibroblasts in in vitro,27 to examine how materials properties alter collagen 
organization. In another study examining collagen responses to materials, functionalized 
polystyrene microparticles were studied and it was found that dimethylamino functionalized 
particles resulted in isotropic collagen organization and a thin fibrotic capsule.28 Poly-L-arginine 
(PLR) modified with arginine derivatives and coated on glass beads showed the influence of 
collagen directionality on the speed of fibroblast migration and secretion of angiogenetic cytokines 
such as vascular endothelial growth factor.29 Here, we have uncovered physicochemical properties 
of these materials that correlate with collagen organization and the ratio of collagen type III/I. 
Analyses such as this aim to improve rational design for biomaterials that can tune the fibrotic 
response towards better implant acceptance. 
 
 
 
117 
 
5.2. Materials and Methods 
Experiments were performed with a minimum of three replicates. Results were compared 
to controls of unmodified PLR and uncoated glass beads. All materials were purchased from Sigma 
(St. Louis, MO) and used as received, unless otherwise indicated. Fresh deionized (DI) water 
(Milli-Q Nanopure, Thermo Scientific, Waltham, MA) and sterile 1X phosphate buffered saline 
(PBS, diluted from 10X solution (Fisher, Pittsburgh, PA), to 0.1 M, pH 7.4) was used throughout 
this study.  
5.2.1. Materials  
Surface modifiers were coupled to 29,000 Da PLR (Alamanda Polymers, Huntsville, AL). 
These modifiers are shown in Figure 5.1 and include  -(1,2,4-triazol-3-yl)-alanine, 2-amino-3-
guanidinopropionic acid (Matrix Scientific, Elgin, SC), 3-guanidinopropionic acid, nitroarginine, 
creatine (Acros Organics, Pittsburgh, PA), carnitine, citrulline, 5-hydoxylysine, acetylglutamine, 
N-carbamyl-α-aminoisobutyric acid, acetyl-carnitine, 2,4-diaminobutyric acid, acetylornithine, 
albizziin, and arginine (Amresco, Solon, OH).  
 
Figure 5.1. Chemical structures of the molecules used in the modification of poly-L-arginine 
(PLR). The arginine derivatives shown here are numbered for easier identification in experiments 
and discussion throughout the paper. 
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5.2.2. PLR Modification  
The fifteen different modifiers (Figure 5.1) were coupled to PLR using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, Oakwood Chemical, West Colombia, SC). These 
materials were modified as previously described29 using 4 ml of a 2.5 mg/ml solution of PLR in 
PBS with 100 molar equivalents of arginine derivative. EDC (200 mg) was added to the 
scintillation vial and stirred for 4 h at room temperature. The modified polymers were dialyzed 
against H2O for 24 h and subsequently lyophilized (4.5 L, Labconco, Kansas City, MO). The 
modified PLR was re-suspended in PBS at 0.1% w/v and stored at -20C. 
5.2.3. Ethics Statement 
The research protocol was approved by the local animal ethics committees at Iowa State 
University (Institutional Animal Care and Use Committee) prior to initiation of the study. 
5.2.4. Animals  
6-week-old female SKH1-E mice were obtained from Charles River Laboratories 
(Wilmington, MA). The mice were maintained at the animal facilities in the College of Veterinary 
Medicine at Iowa State University, accredited by the American Association of Laboratory Animal 
care, and were housed under standard conditions with a 12-hour light/dark cycle. Both water and 
food were provided ad libitum.  
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5.2.5. Subcutaneous Injections 
 Animal tissue specimens previously obtained29 were used here. Briefly, injections were 
performed according to ISO 10993-6:2007. Glass beads (105 – 150 μm, Warrington, PA) were 
sterilized via autoclave and were coated with each of the fifteen modified PLRs, PLL (poly-L-
lysine), and unmodified PLR. Uncoated glass beads were also tested. Mice were anesthetized via 
isoflurane inhalation at a concentration of 1-4% isoflurane/balance O2 to minimize movement. The 
backs of the mice were scrubbed with 70% isopropyl alcohol and five modified glass beads (10% 
v/v, 100 μl) were injected in an array format with a sixth injection of unmodified PLR coated 
beads. All experiments were conducted in quintuplicate. After 28 days, the mice were euthanized 
via CO2 asphyxiation. The injected beads and surrounding tissue was excised. Sections were fixed 
in 10% formalin, embedded in paraffin, sectioned into 5 μm slides, and mounted on glass slides. 
5.2.6. Collagen Gel Preparation 
 Collagen type I (BD Biosciences, Franklin Lakes, NJ) was solubilized in acetic acid (20 
mM) at 10 mg/mL to prepare a stock solution. This solution was mixed on ice with 10  PBS, 1 
M NaOH and deionized water to prepare aliquots of 1, 2, 4 and 6 mg/mL of collagen type I 
solutions. This solution was then pipetted on to glass coverslips and gelled at 37°C for 1 h. 
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5.2.7. Second Harmonic Generation (SHG) 
The laser system is a mode-locked Ti:sapphire laser (100 fs pulse width, 1 kHz repetition rate, 
Libra, Coherent, Santa Clara, CA) that produces an 800 nm fundamental. The average power at 
the samples was kept at 1 – 10 mW to avoid tissue damage using a half-wave plate and a Glan-
Thompson polarizer (Thorlabs, Newton, NJ). SHG images were collected in transmission mode. 
An inverted microscope stage (AmScope, Irvine, CA) and a 20 Nikon Plan Fluorite objective 
(0.50 NA, 2.1 mm) were used to focus the 800 nm beam. The second harmonic signal was collected 
with a 40 Nikon water immersion objective (0.8 NA, 3.5 mm). The signal was reflected with a 
dichroic mirror (Thorlabs) and the fundamental beam was removed using a short pass filter < 450 
nm (Thorlabs) and an 808 nm notch filter (Melles Griot, Rochester, NY). The signal was detected 
using an intensified CCD camera (iCCD, iStar 334T, Andor, Belfast, UK) with 512  512 active 
pixels. The polarization of the incoming beam was changed using a Glan-Thompson polarizer and 
a half-wave plate mounted on a motor driven rotational stage (Thorlabs). These optics were 
inserted before the focusing objective. 
Images of tissue sections and collagen standard curve samples were collected every 10 
from 0 to 350. A minimum of three sets of polarization images for each experimental condition 
were taken. Birefringence was calculated to be within the resolution of the polarization angles for 
the thickness of tissues (5 μm) used in this study. 
5.2.8. Image Processing 
 The intensity of the second harmonic signal of collagen as a function of polarization 
angle of the incident laser beam can be written as: 
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 (1) 
where  and  are second-order susceptibility tensor element ratios; e and 0 are the 
incident polarization angle and collagen fiber angle, respectively; and c is a normalization constant. 
Tensor elements can be used as a contrast mechanism for distinguishing sources of SHG signal.12,30 
Images were filtered using a median noise filter (3  3) to attenuate the salt and pepper noise in 
the acquired images (ImageJ, NIH, Bethesda, MD). Images were binned to obtain regions of 
interest (ROIs) of 2  2 pixels. Collagen orientation angles and second-order susceptibility tensor 
element ratios were determined for every ROI by fitting to a Levenberg-Marquardt algorithm using 
Matlab (MathWorks, Natick, MA). Photon counts below 5 counts per pixel were excluded from 
the analysis as this was determined to be below the limit of detection for this setup. The limit of 
detection was determined by measuring ambient noise detected by the iCCD when the incoming 
light was blocked. The Matlab script generated images displaying the orientation angles of 
collagen determined for each ROI and heat maps for the second-order susceptibility tensor element 
ratios. Histograms for both were also obtained. 
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5.2.9. Statistics and Data Analysis 
Statistical analysis was performed using JMP® statistical software (Cary, NC). Statistical 
significance of the mean comparisons was determined by a two-way ANOVA. Pair-wise 
comparisons were analyzed with Tukey’s honest significant difference test. Differences were 
considered statistically significant for p < 0.05. Principal component analysis (PCA) was 
conducted to explain relationships between modifier properties and experimentally derived 
parameters. The principal components were calculated as linear combinations of the plotted 
parameters, to denote the directions of maximum variance. The correlations between different 
properties can be observed as projected values against the two principal components (PC1 and 
PC2).  
5.3. Results 
5.3.1. Collagen Signal  
Collagen signal was measured and compared against a standard curve of collagen 
concentration versus SHG signal intensity which was fit using the equation below (R2 = 0.99, 
Figure 5.2A). 
ISHG = (-7.75 × 10
5)x2 + (3.14 × 107)x  (2) 
where x is the collagen concentration in mg/mL 
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Figure 5.2. Quantification of collagen surrounding implanted glass beads coated with 
modified PLR. (A) Standard curve for collagen type I concentration. The SHG intensity is plotted 
against the known concentration of collagen concentration. (B) Quantification of collagen 
concentration surrounding implants. Data represents the mean ± standard deviation (SD). n = 15. 
Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc test. *p < 0.05. 
 There were no significant differences in the amount of collagen present in 16 of the 18 
modifications tested ex vivo (Table 5.1). The collagen signal in response to the creatine and 
albizziin modifications were ~2-fold higher than the control samples of naïve glass bead and 
untreated skin samples (Figure 5.2B).  
Table 5.1. Approximated collagen concentration and collagen type III ratio surrounding 
implanted glass beads coated with modified PLR. Data represents the mean ± standard error. n 
= 3 
Modification 
Collagen signal 
(in mg/ml) 
Collagen III ratio 
β-(1,2,4-triazol-3-yl)-alanine 2.17 ± 0.54 0.16 ± 0.04 
2-amino-3-guanidinopropionic acid 1.67 ± 0.51 0.18 ± 0.04 
3-guanidinopropionic acid 3.53 ± 0.65 0.19 ± 0.05 
Nitroarginine 3.27 ± 0.63 0.36 ± 0.08 
Creatine 4.56 ± 0.75 0.05 ± 0.02 
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Table 5.1 continued 
 
Modification Collagen signal  
(in mg/mL) 
Collagen III ratio 
Carnitine 3.68 ± 0.66 0.05 ± 0.01 
Citrulline 3.06 ± 0.61 0.02 ± 0.01 
5-hydroxylysine 2.80 ± 0.59 0.16 ± 0.03 
Acetyl glutamine 2.31 ± 0.55 0.08 ± 0.02 
N-carbamyl-α-aminoisobutyric acid 2.76 ± 0.59 0.07 ± 0.01 
Acetylcarnitine 2.92 ± 0.81 0.10 ± 0.03 
2,4-diaminobutyric acid 2.54 ± 0.70 0.09 ± 0.02 
Acetylornithine 2.14 ± 0.77 0.09 ± 0.01 
Albizziin 4.46 ± 0.74 0.42 ± 0.13 
Arginine 3.05 ± 0.61 0.18 ± 0.03 
Poly-L-arginine 2.64 ± 0.81 0.21 ± 0.03 
Poly-L-lysine 1.62 ± 0.51 0.07 ± 0.03 
Skin 1.94 ± 0.53 0.26 ± 0.07 
Glass Beads 2.04 ± 0.54 0.14 ± 0.04 
 
5.3.2. Collagen Organization  
The collagen organization was quantified by fitting the obtained histograms with Gaussian 
curves (Figure 5.3). Using the full-width at half-maximum (FWHM) values of the Gaussian fits, 
there were clear differences for some modifiers (Table 5.2). Collagen organization in response to 
modifications carnitine (Mod 6), 5-hydroxylysine (Mod 8), acetylcarnitine (Mod 11), albizziin 
(Mod 14), Poly-L-lysine (PLL) and arginine (Mod 15) was relatively isotropic. 
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The isotropy for these modifications was confirmed by an algorithm referred to as an 
isotropy check, given below as Equation 3. The half-width of the confidence interval (CIHeight) was 
subtracted from the peak of the Gaussian fit (Height) of the histograms and if this peak was greater 
than 125 points than the Average plus the half-width of the confidence interval of the average 
(CIAveraget), the peak was considered a false value. 
If [Height-CIHeight] > [ Average + CIAverage + 125]     (3) 
Then Collagen Organization = Isotropic 
This algorithm was applied to modifications where the peaks arose from only one or two 
bins, with the remaining bins being statistically similar. The FWHM for the nitroarginine 
modification (25 ± 4) showed highly aligned collagen organization whereas organization for the 
arginine modification was relatively isotropic and failed the isotropy check test. Comparisons of 
citrulline (55 ± 11) to albizziin (isotropic organization) and 2-amino-3-guanidinopropionic acid 
(55 ± 10) to arginine (isotropic organization) modifications showed clear differences in collagen 
response. These modifications have similar chemical structure with the exception that citrulline 
and arginine contain two additional CH2 groups, compared to their albizziin and 2-amino-3-
guanidinopropionic acid counterparts. The most aligned collagen response was observed for N-
carbamyl-α-aminoisobutyric acid (15 ± 3°) while the 3-guanidinopropionic acid modification 
elicited the widest, recognized (based on the isotropy check) collagen organization with a FWHM 
of 78 ± 1°. The area under the curve was tabulated from the orientation angle curve fits (Table 
5.2). The area under the curve was significantly higher for the citrulline modification (15099 ± 
3508), compared to the response of all other modifications.    
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Table 5.2. Collagen organization (measured as FWHM) and the area under the fit for tissue 
surrounding implanted glass beads coated with modified PLR. Data represents the mean ± 
standard error. n = 3 
 
 
 
 
 
 
 
Modification FWHM Angle Fit Area 
β-(1,2,4-triazol-3-yl)-alanine 17 ± 2 4530 ± 562 
2-amino-3-guanidinopropionic acid 55 ± 10 6229 ± 1306 
3-guanidinopropionic acid 78 ± 1 7127 ± 984 
Nitroarginine 25 ± 4 9298 ± 1382 
Creatine 16 ± 3 4646 ± 794 
Carnitine -- -- 
Citrulline 55 ± 11 15099 ± 3508 
5-hydroxylysine -- -- 
Acetyl glutamine 17 ± 6 2222 ± 728 
N-carbamyl-α-aminoisobutyric acid 15 ± 3 3608 ± 868 
Acetylcarnitine -- -- 
2,4-diaminobutyric acid 23 ± 5 3080 ± 634 
Acetylornithine 19 ± 4 4299 ± 880 
Albizziin -- -- 
Arginine -- -- 
Poly-L-arginine 29 ± 3 7773 ± 862 
Poly-L-lysine -- -- 
Skin 41 ± 5 9292 ± 1085 
Glass Beads 24 ± 2 7696 ± 723 
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Figure 5.3. Histograms of collagen organization surrounding implanted glass beads coated 
with modified PLR. The bars represent experimentally acquired data. The red line is the Gaussian 
fit to the data. 
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5.3.3. Collagen III Secretion  
The nonlinear susceptibility tensor ratios were calculated for each ROI and were plotted as 
histograms (Figure 5.4), which were then used to estimate the collagen III presence. A gradient 
curve previously obtained28 for collagen III concentration was used to estimate the collagen III/I 
ratio, thus enabling comparisons of the type of collagen deposited surrounding the different 
chemical modifications (Table 5.1). Nitroarginine (36 ± 8 %) resulted in almost twice the amount 
of collagen III surrounding the implant compared to arginine (18 ± 3 %). As noted above, collagen 
surrounding the nitroarginine modification was also more isotropic than collagen surrounding the 
arginine modification. In comparing the 2-amino-3-guanidinopropionic acid and arginine 
modifications, which differ by two CH2 groups, the fiber organization was significantly different, 
with the former being more oriented. In contrast, both modifications resulted in similar levels of 
collagen type III surrounding the implant (18%, p > 0.05). In the case of albizziin and citrulline 
modifications, citrulline was more isotropic than albizziin and resulted in twenty times less 
collagen type III than albizziin (2 ± 0 % for citrulline and 42 ± 13% for albizziin) surrounding the 
implant. Citrulline has two additional CH2 groups separating the urea and amine functional groups 
than albizziin. The PLL coating resulted in a third the amount of collagen type III (7 ± 2 %) 
surrounding the implant compared to the PLR coating (21 ± 3 %). Converting the urea functional 
group on albizziin to a guanidine (2-amino-3-guanidinopropionic acid) resulted in a two-fold 
decrease in the collagen type III levels in the neighboring tissue.  
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Figure 5.4. Histograms of 
χzzz
χzxx
 values obtained for implanted glass beads coated with modified 
PLR. The bars represent experimentally acquired data. The blue line is the bimodal Gaussian fit 
to the data. The individual modes are represented as green (collagen type III) and red (collagen 
type I) lines. 
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5.3.4. Statistical Analysis 
The correlation matrix (Table 5.3), and the PCA (Figure 5.5) were used to explain 
relationships between the experimentally observed second harmonic parameters and the chemical 
properties of the modifiers. Freely rotating bonds (r) of the modifiers was well correlated (R = 
0.47, Table 5.3) with the FWHM of the collagen orientation. There were also strong correlations 
for the collagen III ratio with surface tension and the hydrogen bond acceptors (HBA) of the 
modifiers (R = 0.72 and 0.62, respectively).  
Based on the PCA of the collagen organization with the properties of the modifiers (Figure 
5.5), the lipophilicity (LogD at pH 5.5), surface tension, and the number of HBA of the chemical 
modifier were correlated to the collagen III levels. These parameters were used to map an equation 
of for the explained collagen III ratio against the observed values, however the factorial equation 
obtained had insufficient goodness of fit (R2 = 0.56) and was not included with the analyzed data.  
Previously obtained cell responses to these PLR modifications28 were also analyzed using 
PCA to uncover additional correlations. The speed of the cell migration on PLR modified surfaces 
was negatively correlated with polarizability (R = -0.53) and molar volume (R = -0.50), while 
having a positive correlation to the log P (R = 0.48) of the modifiers (Figure 5.5). The persistence 
of the cells in response to the modifiers was found to correlate positively to log D at pH 5.5 (R = 
0.58). 
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Figure 5.5. Loading plot of physicochemical materials properties and their influence on cell 
mobility and collagen organization. PC1 explains 27.8% data variance and PC2 explains 21.6% 
data variance. HBD = hydrogen bond donors, HBA = hydrogen bond acceptors, r = freely rotating 
bonds. 
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Table 5.3. Pearson’s correlations for the chemical properties, SHG microscopy-based analysis 
and cell response parameters 
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5.4. Discussion 
Collagen organization and type are indicators of implant acceptance as well as the stage of 
the wound healing processes. Collagen is secreted and remodeled by stromal cells such as 
fibroblasts and myofibroblasts to promote wound contraction.31 SHG microscopy is a high 
information, dye-less, non-linear optical technique that can visualize collagen organization and 
type in diverse tissues.15,28,32 By examining how chemical modifications alter collagen 
organization, rational design of biomaterials can be improved. 
5.4.1. Collagen Signal Comparisons 
The collagen signal for the 18 different modifications was estimated to be in the range of 
2 to 5 mg/mL. Modification 5 (creatine) resulted in significantly higher collagen secretion at an 
estimated 4.56 ± 0.75 mg/mL, almost twice that of the control skin sample (1.94 ± 0.53 mg/mL). 
Creatine is a stimulant for promoting collagen secretion by fibroblasts in dermal tissues.33 In 
another study, creatine supplements were observed significantly increase skin firmness through 
stimulating procollagen secretion and collagen alignment in young and aged humans, which was 
measured in vivo using multiphoton laser scanning microscopy.34 The effect of the PLR-like 
modifications on the differentiation of fibroblasts associated with collagen synthesis and the 
wound healing response showed that it is possible to tune the modifier’s chemical properties to 
enhance angiogenesis related biomarkers such as VEGF.29 Statistical analysis on the chemical 
structure of the modifier and its influence on in vivo collagen organization indicated the modifier’s 
hydrophobicity was positively correlated to the collagen type III deposition.  
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Studies on collagen organization in response to chemical modifications are uncommon, 
and there is a growing need to elucidate the materials properties responsible for collagen deposition 
and organization during the foreign body response. It is important to note here that there are 
limitations in SHG based collagen sensing as well, deriving from the limited z-axis depth of 
imaging, as well as significant differences arising from imaging fibrillar and non-fibrillar sources 
of collagen.35 
5.4.2. Collagen Organization Response 
Collagen organization in response to in vivo implantation of PLR modified glass beads was 
quantified using Gaussian fit parameters of FWHM and area under the fit (Figure 5.3). For 
modifications that failed the isotropy check test, it was qualitatively observed that there was a 
relatively consistent amount of collagen imaged between 0 and 180, with the presence of a few 
bins that were causing over-fitting of the histogram. In Table 5.2, the FWHM and area under the 
curve for the histograms of isotropic collagen organization response have been removed. 
Comparisons between the different collagen organization responses can be mapped using a few 
key factors such as the effect of shorter versus longer chain lengths. There was an inconsistent 
trend for carbon chain length with collagen organization. Citrulline and albizziin have almost the 
same chemical structure, with the former having an -CH2 group making its chain length longer. 
Similarly, arginine has the longer chain with otherwise similar chemical structure as compared to 
amino-3-guanidinopropionic acid modification.  
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The comparison of the collagen organization response to albizziin and citrulline was 
interesting as the former is longer in chain length, and got a relatively aligned collagen response, 
with the shorter chain length containing albizziin resulting in an isotropic one. However, this trend 
was not continued for the case of comparing the shorter 2-amino-3-guanidinopropionic acid 
(aligned collagen response) to the longer modification of arginine (isotropic collagen response). 
There was also no consistent trend for the other modifications that elicited isotropic collagen 
organization responses. These observations support the hypothesis that the collagen organization 
response is a complicated process, which cannot be readily mapped on the basis of purely chemical 
structure comparisons of the modifications.  
Unwounded dermal tissue contains disordered collagen and is considered a marker for 
implant acceptance.2 Studies have shown the presence of the disordered collagen organization in 
dermal tissues, which is significantly different from the heavily aligned conformations shown for 
scarring and hypertrophic lesions.36 There are clear differences in the collagen organization even 
between different types of scarring, such as between keloids and hypertrophic scars which are 
analogous in some cases to fibrotic responses to rejected implants.37,38 These organizational 
Tuning collagen organization thus plays a key role in the foreign body response6 and wound 
healing.29  
5.4.3. Collagen III Response 
Secretion of collagen III is observed early in the wound healing process, with continued 
elevated levels of collagen III/collagen I ratios indicating prolonged healing as is seen in chronic 
wounds.21 Increased levels of collagen secretion is also observed in keloidal and hypertrophic scar 
samples, and are characterize by the formation of parallel collagen fibers.39  
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Patients suffering from direct and indirect hernias were found to have significantly higher 
collagen type III levels than those without hernias.22 This could be either a consequence or 
instigation from abnormal angiogenesis at the injury site.22 Surface modifications showing lower 
levels of collagen III are potential treatments that could assist progression to the remodeling stage. 
As the wound healing process progresses, collagen III is steadily replaced with collagen I.40 It is 
unclear to what extent surface modifications further facilitate the wound healing.41  
We compared the collagen III response for the arginine derivative modifications with key 
differences in their chain length and compared their effects on instigating similar collagen III levels 
as that of the skin control sample (Figure 5.4). Collagen III levels for the skin control (26.14 ± 
6.67 %), matched previously reported values.19 Overlapping levels of collagen III signal to that of 
the skin control, such as those measured for nitroarginine (36 ± 8%) and albizzin (42 ± 13%), could 
indicate possible progression of the wound healing process towards reepitheliazation.42,43 The 
collagen III levels had poor correlation with the FWHM of the collagen organization (R = 0.24).  
The estimated levels of collagen III varied greatly across the samples from 2 to 42%. Acute or 
chronic inflammatory responses to the implant can influence collagen III secretion.44 Additionally, 
the interaction of platelet derived growth factor with the material surface can influence the 
deposition of different collagen types.45,46  
Integrins are transmembrane receptors that facilitate ECM deposition, which is a key phase 
of the host response to naïve and functionalized surfaces.47 A specific integrin, α2β1, has been 
observed on platelets, fibroblasts, and epithelial cells for its affinity to bind with collagen, which 
contains the GFOGER sequence.48 It is possible that the arginine-like modifications studied here 
could be influencing the collagen deposition and organization47,48 through a similar mechanism.  
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Surface properties play a major role in how secreted types of collagen coalesce to form 
different network meshes on varied substrates.49 The hydrophobicity of functionalized polymer 
substrates has been studied for its influence on the adsorption of secreted collagen in the presence 
of different biological sera.50,51 This link between hydrophobicity and collagen was further 
explored by a study in which terminal-group modified self-assembled monolayers of alkanethiols 
on gold were implanted in air pouches. The most hydrophobic surface coating of -CH3 
functionalized monolayers triggered the densest collagen secretion and fibrotic layer formation.52 
Previous studies on functionalizing surfaces with PLR-like modifiers showed the significance of 
lipophilicity (logP) on the collagen secretion and organization.53   
 
5.4.4. PCA 
The physicochemical properties of different surface modifications can influence the 
cellular response of fibroblasts.29 Informatics analysis of this data using PCA (Figure 5.5) revealed 
correlations that can be used to explain relationships between chemical modifications and host 
responses to the implanted materials. Surface tension was well correlated with the collagen type 
III ratio surrounding the implant. It is important to note that the modifiers used here were relatively 
hydrophilic, with surface tensions ranging from 48 to 84 dyne/cm. Increased collagen III levels 
are essential in the earlier stages of wound healing. During later phases, collagen type III should 
be remodeled to collagen I.41,54 
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Larger FWHM values indicate isotropic collagen organization. Unwounded skin is 
isotropic.55 Kurtosis and skewness parameters are markers for the collagen organization. Skewness 
is considered a measure of symmetry for the statistical distribution and kurtosis is defined as a 
measure of whether the normal distribution is heavy or light-tailed. Together, these statistical 
parameters provide an analytical insight into the collagen organization beyond just the FWHM. In 
our study, we observed in the PCA (Figure 5.5) that unlike the FWHM, the skewness and kurtosis 
were positively correlated to the polarizability and molar volume of the modifiers. Polarizability 
has been studied as an intrinsic aspect to consider for the quantitative structure activity 
relationships (QSAR) analysis of diverse chemical structures influencing biological interactions 
such as nerve toxicity in frogs.56 This influence of polarizability and its correlation to the fit 
parameters indicates that it could play a possible role in the alignment of collagen fibers as a part 
of biomaterial interactions.  
Using PCA, we attempted to derive an empirical equation for the collagen III ratio in 
response to the implanted surfaces. However, this equation could not sufficiently explain the 
variability in the collagen III levels in response to the modification with a poor R2 and Q2 fit of 
0.56 and 0.4 respectively. The FWHM of the deposited collagen was not determined for all of the 
modifiers since some of these failed the isotropy check. Therefore, an empirical equation for the 
FWHM was not determined. It is possible though to discuss the strong correlations of some of the 
chemical parameters of the modifier to the collagen organization response with respect to 
biomaterial interactions.  
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The number of HBD, HBA, and surface tension of the modifiers are closely linked to the 
hydrophobicity and surface charge of the functionalized substrate. Previous research on the 
hydrophobicity of surfaces showed that rat hepatocytes and schwannoma cells preferred 
hydrophobic surfaces with functionalized ECM proteins.51 Considering the salient observations 
from the collagen organization and the collagen III levels together, it can be stated that albizziin 
modification elicited the best collagen response under the in vivo conditions. 
Altering the cell adhesion, migration, and proliferation on functionalized surfaces can 
improve wound healing and implant acceptance.57,58 Modifying the underlying substrates with 
different ligand chemistries influences cell attachment and the subsequent production of ECM 
proteins that are integral aspects of the foreign body response.59 Migration studies on these surfaces 
indicated that NIH/3T3 fibroblasts migrated faster on creatine coated substrates.29 In our SHG 
based analysis, we observed higher levels of collagen secretion and orientation in response to the 
creatine modified glass surface, which is in line with the aforementioned study. When the 
migration-based cell response parameters (i.e., speed and persistence) were combined with the ex 
vivo SHG analysis and chemical properties in a PCA plot, we uncovered correlations with the 
chemical properties of the modifier. The negative Pearson’s correlations for the speed with 
polarizability (R = -0.53) and molar volume (R = -0.50) were noted from the PCA, as possible 
influences on how the cell migration can be influenced by the electrochemical and physical 
properties of the modifier (Table 5.3).  The positive correlation of the cell persistence to the LogD 
(5.5) (R = 0.58) and negative correlation to the number of freely rotating bonds in the chemical 
modifier structure (R = -0.45), indicates the effect that the solubility of such chemical modifiers 
has on how cells migrate across functionalized surfaces. 
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5.5. Conclusions 
The collagen response to functionalized glass beads coated with modified PLRs was 
studied to better understand how chemical modifications can impact implant acceptance. Tissue 
sections were removed 28 days post-implantation and showed some significant differences in the 
measured collagen signal intensity, in particular for the creatine and albizziin modifications. 
Increased collagen type III had a positive correlation with hydrogen bond acceptors in the modifier 
structure and surface tension. PCA also uncovered correlations between the freely rotating bonds, 
and the enthalpy of vaporization of the modifier on the organization of collagen response to 
modified PLR coated glass beads. The insights obtained from correlating the chemical properties 
of the PLR modifications to the SHG imaging derived parameters can further the design principles 
for improving implant acceptance.    
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CHAPTER 6 
SECOND HARMONIC GENERATION IMAGING OF COLLAGEN FIBER 
ORIENTATION AS A MARKER FOR SCARRING 
 
More than US$25 billion was spent on costs related to chronic wound care treatment in the 
United States in 2008. In addition to the high cost, chronic wounds affect over 6.5 million people.1 
These slow-healing wounds are often seen in people suffering from diabetes and obesity. Wound 
care accounts for a significant economic expenditure in not just the US, but all over the world. The 
Corporate Research of Materials Lab at 3M collaborated with the Bratlie lab to understand the 
wound healing process from the perspective of changes in collagen that can be sensitively analyzed 
using Second Harmonic Generation (SHG) microscopy. By imaging tissues that have been 
subjected diverse treatment strategies, the Bratlie lab conducted a blind study on the effectiveness 
of the wound healing process. The ability of specific treatments to induce isotropic collagen 
organization, as well as similar collagen III % to unwounded tissue, were used to evaluate the 
efficacy of over 20 formulations spread across 272 tissue sections so far.   
 
6.1. Introduction 
 
A wound has been defined as a “a break in the epithelial integrity of the skin and may be 
accompanied by disruption of the structure and function of underlying normal tissue”.2 They are 
not limited to physical trauma, but can also be caused by diseases that cause internal or external 
damage to organs. The disruption of the local tissue environment causes the instigation of a cascade 
of biological responses including blood coagulation, inflammatory, and chronic wound healing.3  
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The natural wound healing process is timely and ordered, seeking to restore anatomic 
functionality of damaged tissues.4,5 The wound healing response varies greatly depending on the 
health status of the subject, particularly when treating for acute versus chronic wounds.5 Stochastic 
collagen order occurs in unwounded dermis, while scar tissue from hypertrophic scars is more 
aligned in parallel arrays.6 Collagen III typically rapidly decreases once wound healing progresses 
towards granulation tissue formation. Sustained, elevated levels of the collagen type III are 
associated with delayed healing response.7,8 Isotropic collagen orientation6 with similar levels of 
collagen III8 as unwounded tissue would be the ideal outcome for a wound dressing.  
Polarized SHG microscopy can sensitively visualize collagen organization in diverse 
clinical samples, without the use of dyes or complicated tagging protocols.9 SHG microscopy is a 
non-linear interaction between two incident laser beams with samples, resulting in the generation 
of photon that are frequency doubled.10 This technique can quantitatively characterize collagen 
organization in rat tail tendons and cartilage tissue.11 As this technique is a second-order optical 
process, non-centrosymmetric molecules are SHG active under the electric dipole approximation, 
while non-centrosymmetric molecules do not contribute to the signal.  
The susceptibility tensor elements measure using SHG are related to the material 
properties.9,12 Shifts in these susceptibility elements can be used to differentiate between different 
types of collagen signal based on differences in peptide or methylene binding.11 By extracting 
these susceptibility tensors, a map of  collagen type III to collagen type I can be obtained.9 The 
ratio of collagen III/I is approximately 30% for unwounded dermal tissues.13,14 Collagen III levels 
remain elevated in prolonged wound healing responses, as seen in hypertrophic scarring and 
inguinal hernias.7,15,16  
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There is no consensus, however, on the exact role played by collagen III in the wound 
healing process. During the granulation tissue formation phase, the replacement of collagen I by 
collagen III is higher in tissues that undergo greater mechanical stress.17 This indicates possible 
differences for the role played by the two types of collagen in terms of how they respond to 
mechanotransducive cues. The up-regulation of collagen III indicates decreases in mechanical 
remodeling of the wound site.15 In injuries from burns, it is common to see well aligned collagen 
in scar tissue, compared to disorganized unwounded dermis.14,18  
Our study evaluates five different wound treatments provided by 3M, as a blind study. 
Considerable information regarding the wound healing formulations were proprietary to 3M, and 
thus the treatments are defined with the limited titles assigned to each of them. 
   
6.2. Materials and Methods 
All the imaging studies were conducted in triplicate for each sample. Results were 
compared to controls as provided by 3M. Preserved tissue samples from porcine subjects were 
used throughout this study.  
6.2.1. Materials  
Treatments were prepared under confidential conditions by the researchers at the Corporate 
Research Materials Laboratory at 3M. 
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6.2.2. Second Harmonic Generation (SHG) 
 SHG imaging was conducted using a mode-locked Ti:sapphire laser (100 fs pulse width, 1 
kHz repetition rate, Libra, Coherent, Santa Clara, CA) that produces a fundamental of 800 nm 
fundamental. The samples were irradiated with a non-damaging power of 1 to 10 mW, which was 
tuned using a half-wave plate and a Glan-Thompson polarizer (Thorlabs, Newton, NJ). Images 
were collected in the transmission mode. The 800 nm beam was focused using an inverted 
microscope stage (AmScope, Irvine, CA) and a 20 Nikon Plan Fluorite objective (0.50 NA, 2.1 
mm). The SHG signal was collected with a 40 Nikon water immersion objective (0.8 NA, 3.5 
mm). The signal was reflected with a dichroic mirror (Thorlabs) and the noise from the 
fundamental beam was removed using a short pass filter < 450 nm (Thorlabs) and an 808 nm notch 
filter (Melles Griot, Rochester, NY). The signal was detected using an intensified CCD camera 
(iCCD, iStar 334T, Andor, Belfast, UK) with 512  512 active pixels. The polarization of the 
incident beam was tuned using a Glan-Thompson polarizer and a half-wave plate mounted on a 
motor driven rotational stage (Thorlabs). The focusing objective was placed after the optical 
elements. Images were acquired every 10 from 0 to 350. Images were collected in triplicate. 
6.2.3. Image Processing 
 The equation used for mapping the SHG signal of collagen in the imaged samples as a 
function of the polarization angle of the incident laser beam is as follows: 
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where  and  are second-order susceptibility tensor element ratios; e and 0 are the 
incident polarization angle and collagen fiber angle, respectively; and c is a normalization constant. 
The susceptibility tensor element ratios have been used to distinguish sources of SHG signal.19,20 
Images were compiled using ImageJ (NIH, Bethesda, MD) to prepare the image stacks for 
processing using MATLAB (MathWorks, Natick, MA). The SHG Images were binned to obtain 
regions of interest (ROIs) of 4  4 pixels. A Levenberg-Marquardt algorithm21 was used to estimate 
the orientation angle of the collagen and its associated susceptibility tensors for each ROI in the 
SHG image (MATLAB). A threshold signal of 5 photon counts per pixel was used for the analysis, 
based on the limit of detection for this setup. The analysis generated orientation maps 
superimposed on the SHG image stacks, which displayed the orientation angle determined for all 
ROI. Histograms of both the orientation angles and susceptibility tensor ratios were also obtained. 
 
6.2.4. Statistics and Data Analysis 
JMP® statistical software (Cary, NC) was used to perform the statistical analysis on all the 
obtained data. Statistical significance when comparing the means of the data sets was evaluated 
through a two-way ANOVA. Tukey’s honest significant difference test was used for and the 
differences were considered significant only for p < 0.05.   
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6.3. Results 
Collagen organization was analyzed by fitting the obtained histograms with Gaussian 
curves. Using the full-width at half-maximum (FWHM) values of the Gaussian fits, collagen 
organization was quantified. The collagen III % was estimated by measuring the area under the 
histogram curve. A gradient curve previously obtained by Akilbekova and Bratlie20 for collagen 
III concentration was used to estimate the collagen III/I ratio, thus enabling comparisons of the 
type of collagen deposited in response to diverse treatment strategies.  
 6.3.1. Fibrin Scaffold Treatment  
Thrice applied fibrin scaffolds were used as treatments for wounds for 14 days. The 
collagen response to this treatment and its corresponding controls were analyzed. For this 
treatment, both the sample and control (presumably wounded skin sample with no treatment) 
showed relatively low collagen order. There was no significant difference observed for the 
collagen organization in the control and treatment, with both samples having FWHM values above 
60 (Figure 6.1).   
 
Figure 6.1. Comparing collagen organization response to thrice applied fibrin scaffold 
treatments. Data represents the mean ± SD. n = 4. Statistical analysis through two-way ANOVA 
and Tukey’s HSD post-hoc test. * p < 0.05 
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The collagen III % in response to the fibrin scaffold was significantly different from the control 
(Figure 6.2). Both the sample and control showed relatively low collagen III % compared to 
typical levels in human dermal tissues of around 30%. 
 
Figure 6.2. Comparing collagen III secretion response to thrice applied fibrin scaffold 
treatments. Data represents the mean ± SD. n = 4. Statistical analysis through two-way ANOVA 
and Tukey’s HSD post-hoc test. * p < 0.05 
 
6.3.2. Partial Thickness Scaffold Treatments applied for 4 days  
Scaffold treatments on shallow wounds termed partial thickness (PT) wounds were 
analyzed for their effectiveness. The scaffolds were maintained on the wound site for 4 days before 
excision. For this treatment, four different treatments named Promogran, Foam, Biostep and 
“Collagen” were compared. There was no significant difference between the four treatments, all 
of which showed moderately isotropic collagen organization, with FWHMs above 40 for all four 
treatments (Figure 6.3).   
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Figure 6.3. Comparing collagen organization response to PT scaffold treatments applied for 
four days. Data represents the mean ± SD. n = 4. Statistical analysis through two-way ANOVA 
and Tukey’s HSD post-hoc test. * p < 0.05 
 
 In contrast, there were significant differences in the collagen III % response to the Foam 
treatment, compared to the other three PT scaffold treatments. All the treatments showed relatively 
moderate levels of collagen III % compared to the thrice applied fibrin scaffold treatments (Figure 
6.4). 
 
Figure 6.4. Comparing collagen III secretion response to PT scaffold treatments applied for 
four days. Data represents the mean ± SD. n = 4. Statistical analysis through two-way ANOVA 
and Tukey’s HSD post-hoc test. * p < 0.05 
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6.3.3. Full Thickness Scaffold Treatments compared over 14 and 21 days 
Scaffolds applied to full Thickness (FT) wounds were also studied. These treatments were 
maintained on the wound site for 14 and 21 days before excision. Treatments labelled as C, P, TG 
and TS were analyzed for their efficacy in restoring the wound site to its original state by 
comparing the collagen organization and secretion responses. There was no significant difference 
for any of the treatments which showed moderately isotropic collagen organization on d14, all of 
which had FWHM values above 40. (Figure 6.5). However, there were significant differences 
between the d21 and d14 sets for treatments C, TG and TS, which elicited a more disordered 
collagen response. Collagen organization was relatively unchanged over the treatment period only 
for treatment P, which remained around FWHM values of 60 across the three weeks of treatment. 
 
Figure 6.5. Comparing collagen organization response to FT scaffold treatments. Data 
represents the mean ± SD. n = 2. Statistical analysis through two-way ANOVA and Tukey’s HSD 
post-hoc test. * p < 0.05 
 
C 
d1
4
P 
d1
4
TG
 d
14
TS
 d
14
C 
d2
1
P 
d2
1
TG
 d
21
TS
 d
21
0
20
40
60
80
100
120
*
*
F
W
H
M
*
155 
 
The collagen III secretion followed the same trend as collagen organization with there 
being significant differences for the collagen III in response to the C, TG, and TS treatments when 
comparing their d14 and d21 levels. Furthermore, there were no significant differences across 
treatments when comparing treatments of the same application time. (Figure 6.6).  
 
Figure 6.6. Comparing collagen III secretion response to FT scaffold treatments. Data 
represents the mean ± SD. n = 2. Statistical analysis through two-way ANOVA and Tukey’s HSD 
post-hoc test. * p < 0.05 
6.3.4. Full Thickness Scaffold Treatments compared over 14 and 21 days — Set II 
 Scaffold formulations labeled as C, I, TG and TS were analyzed for their effectiveness in 
treating FT over 14 and 21 days before tissue excision. While TG and TS scaffolds initially resulted 
in more aligned collagen signal with FWHM of around 40, the variation in collagen response 
across the samples meant that there were no statistically significant differences across the d14 
sample set (Figure 6.7).  
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Two of the four treatments (C and I) showed significantly more aligned collagen after three 
weeks of treatment compared to the d14 samples. Treatment TG showed no significant difference 
for the collagen response after three weeks, remaining relatively isotropic. Only treatment TS 
showed significantly more isotropy in the collagen response after three weeks of application.   
 
Figure 6.7. Comparing collagen organization response to FT scaffold treatments—Set II. 
Data represents the mean ± SD. n = 2. Statistical analysis through two-way ANOVA and Tukey’s 
HSD post-hoc test. * p < 0.05 
 
There were significant differences for the collagen III levels in response to the I, TG, and 
TS treatments when comparing their d14 and d21 levels, with the latter eliciting significantly lower 
levels of collagen III secretion. There were no significant differences for any of the treatments 
when comparing samples across the same time point. Treatment C showed the least variation in 
collagen III% response across the two treatment times (Figure 6.8).  
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Figure 6.8. Comparing collagen III secretion response to FT scaffold treatments—Set II. Data 
represents the mean ± SD. n = 4. Statistical analysis through two-way ANOVA and Tukey’s HSD 
post-hoc test. * p < 0.05 
 
5.3.5. Full Thickness Scaffold Treatments compared over 21 and 42 days 
Longer treatment times of 21 and 42 days were also analyzed. For this treatment, two 
treatments (A and B) were provided with respective controls for both the time-points.  
The controls across d21 and d42 showed highly isotropic collagen organization which were 
significantly different from those in response to A and B treatments, which were moderately 
isotropic with FWHM around 50 (Figure 6.9). Only treatment B showed significantly more 
isotropic collagen on d42 compared to d21.  
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Figure 6.9. Comparing collagen organization response to FT scaffold treatments compared 
over d21 and d42. Data represents the mean ± SD. n = 4. Statistical analysis through two-way 
ANOVA and Tukey’s HSD post-hoc test. * p < 0.05 for comparison with control, # < 0.05 for 
comparison with d21 sample response 
 
Similar to the comparisons for collagen organization, there were significant differences 
observed for collagen III in response to treatment A on d21 and for treatment B on d42. All the 
control samples showed a wide variation in collagen III %, ranging from 9 to 17% (Figure 5.10).  
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Figure 6.10. Comparing collagen III secretion response to FT scaffold treatments compared 
over d21 and d42. Data represents the mean ± SD. n = 4. Statistical analysis through two-way 
ANOVA and Tukey’s HSD post-hoc test. * p < 0.05 
    
6.4. Discussion 
Collagen plays a key role in the wound healing process. Its secretion and organization by 
fibroblasts and myofibroblasts as a response to implants and injuries is similar.22 SHG imaging of 
this collagen response, with a view towards identifying key biomarkers for scarring and delayed 
healing are important insights that can improve our understanding of the dynamics of tissue 
remodeling.23–25 
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6.4.1. Fibrin Scaffold Treatment 
Collagen organization in response to the thrice applied fibrin scaffold treatment was 
analyzed (Figure 6.1). The treatment efficacy can be considered good, as there were no significant 
differences in the collagen alignment compared to the control. Both showed isotropic collagen 
signal, with high FWHM values. The collagen secretion responses to the treatments indicated that 
the fibrin treatment elicited significantly lower collagen III% (Figure 6.2). Fibrin scaffold 
treatments have been studied for their ability to promote clotting by aiding the natural platelet 
response to stem the blood flow at the wound site.26 Fibrin based scaffolds can controllably deliver 
cytokines such as basic fibroblast growth factor to promote wound healing for diabetic mice,27 as 
well as for treatment of dermal wounds.28 The efficacy of the 3M fibrin scaffold would 
undoubtedly have considered these successful design principles from previous studies for 
fabricating their product. 
6.4.2. Partial Thickness Scaffold Treatment applied for 4 days 
The effectiveness of the scaffolds for PT wounds was evaluated based on their ability to 
induce isotropic collagen organization within a short application period of 4 days. All four 
treatments showed relatively moderate levels of collagen disorder with similar FWHM values 
(Figure 6.3). Within these comparisons, it was only possible to acquire more information about 
the Promogran and Biostep wound dressings.  
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The Foam and Collagen named treatments appeared to be 3M test-products. As there were 
no control samples defined for these samples, it can only be speculated that the goal of this study 
was to compare the efficacy of the Foam and Collagen treatments as compared to commercially 
available treatments in Promogran and Biostep.29,30 The collagen III levels are difficult to compare 
for without controls, with the Foam showing significantly higher levels amongst the four sample 
sets (Figure 6.4). 
6.4.3. Full Thickness Scaffold Treatments compared over 14 and 21 days 
The effectiveness of the scaffolds for the FT wounds was evaluated for their ability to 
induce isotropic collagen organization over 2 and 3 weeks of application. All four treatments (C, 
P, TG and TS) showed relatively moderate levels of collagen disorder with comparable FWHM 
values when comparing their responses on d14 and d21 (Figure 6.5). The progression of 
moderately to highly isotropic collagen order by d21 was noted. This transition is in line with 
similar studies examining the timeline of wound healing across dermal wounds, which have shown 
that myofibroblast activity and its associated remodeling peaks by week 3, after which the extent 
of wound closure varies greatly over weeks to even months for the wound closure to be complete.2 
The P treatment showing no changes in collagen organization could be either a case of halted 
healing or a scarring response. The scarring response becomes more probable since the collagen 
III levels did not significantly change from d14 to d21 (Figure 6.6). Since these levels are lower 
than what has been reported for hypertrophic scarring, this would need to be confirmed through 
clinical observations.31 In the absence of controls, it was only possible to compare the relative 
efficacy of the different scaffold treatments as given.  
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6.4.4. Full Thickness Scaffold Treatments compared over 14 and 21 days—Set II 
The effectiveness of the scaffolds for the FT wounds was evaluated based on their ability 
to induce isotropic collagen organization over 2 and 3 weeks of application. All four treatments 
(C, I, TG and TS) showed moderate to relatively aligned collagen when comparing between their 
responses on d14 and d21 (Figure 6.7). Unlike Set I, there was no progression of moderately 
isotropic to highly isotropic states of collagen order by d21 for two of the four formulations 
analyzed. This lack of collagen isotropic levels by three weeks of application for treatments C and 
I, can be presumed a marker for either limited healing or scar formation.18 The treatment TG having 
no changes in collagen organization is likely a result of scarring. Unlike treatment P from Set I, 
the scarring response cannot be judged by comparing the collagen III % levels across d14 and d21, 
as the only treatment that shows no statistical change was treatment C (Figure 6.8). There are 
some studies that examine other markers for wound healing, such as presence of myofibroblasts 
and the expression of alpha-smooth muscle actin for scarring responses.32 This study stands in 
good contrast to the previous scaffold study of the same time period showing salient differences 
in wound healing response with what can be speculated as similar formulations of 3M treatment. 
6.4.5. Full Thickness Scaffold Treatments compared over 21 and 42 days 
Treatments A and B compared with their controls over 3 and 6 weeks of treatment showed 
interesting variations in collagen organization. Even with both the controls and samples showing 
relatively elevated levels of isotropic collagen, there were statistically significant differences in 
the higher disorder of the control samples for both d21 and d42 sets.  
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This was less significant for the d42 sets, where collagen organization is remodeled to that of 
unwounded tissues.22 In the case of treatment B there were significant differences from d21 to d42 
(Figure 6.9). The wide range of collagen III levels for the two treatments and their controls 
indicated that these treatments were not influencing the secretion of different collagen types as 
much as some of the above-mentioned treatments (Figure 6.10).  
6.5. Conclusions 
The analysis of wound healing samples from 3M provided valuable insight into the 
tunability of collagen organization and secretion in response to diverse treatments and 
formulations. Comparisons to the controls for some treatments were useful for understanding the 
extent of healing in the porcine subjects. Some treatments were statistically different compared to 
the other formulations within the same set. For most treatments studied over extended time periods, 
it was observed that collagen organization progressed to a more isotropic state and the collagen III 
% rose to similar levels as that of unwounded tissues. However, in the FT wound set II treated 
with scaffolds, the collagen response to treatments showed significantly higher alignment that 
could indicate scarring. Increased collagen type III was not commonly observed for most treatment 
sets as compared to their shorter time-point counterparts or controls.  
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CHAPTER 7 
SECOND HARMONIC GENERATION MICROSCOPY OF COLLAGEN 
ORGANIZATION IN TUNABLE, ENVIRONMENTALLY RESPONSIVE ALGINATE 
HYDROGELS 
 
We synthesized photocrosslinked, environmentally responsive alginate hydrogels for tissue 
engineering applications. Methacrylated alginate (ALGMA) hydrogels were prepared across a 
variety and combination of ionic, covalent (chain growth, step growth, and mixed mode) 
crosslinking strategies to obtain a range of compressive moduli from 9.3 ± 0.2 kPa for the softest 
ionically crosslinked hydrogels to 22.6 ± 0.3 kPa for the dually crosslinked ionic mixed mode gels. 
The swelling behavior of the alginate hydrogels was significantly higher at basic pH conditions. 
Stiffer gels consistently swell to a lesser degree compared to softer gels for all conditions. These 
hydrogels were stable – retaining >80% of their original mass for three weeks – when incubated 
in a basic solution of diluted sodium hydroxide, which mimicked accelerated degradation 
conditions. Encapsulated NIH/3T3 fibroblasts remained viable and proliferated significantly more 
in stiffer hydrogel substrates compared to softer gels. Additionally, the collagen secreted by 
encapsulated fibroblasts was quantifiably comparable using second harmonic generation (SHG) 
microscopy imaging. Fibroblasts encapsulated in the softer hydrogels secreted significantly less 
collagen than the stiffer gels. The collagen in these softer gels was also more aligned than the 
stiffer gels. The ability to tune collagen organization using hydrogels has potential applications 
ranging from corneal wound healing where organized collagen is desired to epithelial wound 
scaffolds where a random organization is preferable. 
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7.1. Introduction 
 The human body contains natural tissue environments with dynamic and diverse 
mechanical properties.1 Dynamic changes occur from regular maintenance of homeostasis, wound 
healing, or a response to implants.2 Cells reside within these tissues ensconced in a three-
dimensional scaffold known as the extracellular matrix (ECM), which responds to both 
macroscopic as well as microscopic perturbations.3 The ECM comprises of different combinations 
of proteins like collagen, glycosaminoglycans, and adhesive glycoproteins which vary from organ 
to organ.4 The macroscopic aspects derive from how the ECM provides structural integrity to the 
native tissue as well as a separation between different layers of tissue organization.5 On a smaller 
scale, there are biochemical cues provided by the proteins that comprise the ECM, such as collagen 
and fibronectin, that can instigate diverse cell signaling pathways,6,7 alter cell shape,8 as well as 
changes in cytoskeletal organization,1,9 and stress fiber formation,10 These aspects of the cell-
matrix interactions are influential for several critical processes including angiogenesis,11 
organogenesis,12 wound healing,13 as well as response to diseases14 and tumor metastasis.15 
 The goal of tissue engineering is to recapitulate the natural, dynamic in vivo environment 
in order to minimize unwanted host responses as well as replicate lost tissue.16 Tissue engineering 
covers not just the obvious motive of improving current healthcare solutions, but also to decrease 
costs associated with global healthcare, which is expected to rise to 8% of the US GDP by 2040.17 
An ideal material for tissue engineering scaffolds would be biocompatible, mechanically tunable, 
and have degradation rates that match tissue regeneration rates.18,19 Natural polymers, with their 
similarity to the ECM are easy to obtain, modify, and apply to diverse tissue engineering 
applications.20 
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Alginate is an anionic, polysaccharide which derives from seaweed or bacteria and has 
been effectively used as a supporting scaffold or tunable delivery system for tissue repair.21 It can 
be easily crosslinked using divalent cations, as well interact with a wide variety of proteoglycans 
and polyelectrolytes. The carboxylic acid moiety on alginate renders it pH-responsive and it can 
be used to deliver diverse payloads.22 Unlike conventional cationic crosslinking of hydrogels, we 
explored covalent crosslinking facilitated by methacrylation of the alginate backbone so that 
alginate could be chemically crosslinked through photoinitiated mechanisms.23 Covalently 
crosslinked hydrogels are more stable in vivo, unlike ionically crosslinked alginate which degrades 
rapidly due to preferential replacement of divalent cations by monovalent ones.24 UV-
crosslinkable methacrylated alginate (ALGMA) hydrogel formulations show structural stability, 
tunability of crosslinking mechanisms as well as significant cytocompatibility for use as cell-
encapsulation platforms to study secretion of ECM proteins in vitro 25,26 ECM proteins like 
collagen play a critical role in the structural integrity and cell-material interactions across a range 
of biological processes such as the host response.27,28 Both fibroblasts and myofibroblasts secrete 
collagen types I and III, as a critical part of their mechanotransduction processes.29 It has been 
observed that there is a great need to understand the mechanisms through which stromal cells sense 
diverse materials and the kinetics of ECM protein secretion particularly as to how dysregulation 
in collagen deposition has been linked to rejected implants as shown by over the top fibrotic 
response.27,30 These studies inspired preparation of tunable alginate hydrogel environments that 
can be used for studying collagen organization under very soft, responsive conditions.31 
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 Diverse crosslinking strategies can be employed to fabricate a range of materials properties 
of ALGMA hydrogels. Chain growth polymerization can be initiated using photoinitiators yja 
Irgacure 2959 in a degassed solution of the hydrogel to form dense chains of methacrylated 
alginate networks.32,33 Step growth polymerization occurs through thiol-ene photoclick chemistry 
wherein the free radical from cleavage of the photoinitiator abstracts a proton from the thiol 
crosslinker to create a thiyl radical. Subsequent propagation of the step growth mechanism takes 
place through the reaction of the thiyl radical and the vinyl group.34 . A combination of step and 
chain growth termed mixed mode has been previously studied to prepare hybrid covalent 
crosslinks in the ALGMA solutions.31,35,36 To further increase the range of mechanical properties, 
ionic crosslinking of the covalently crosslinked hydrogels has been done using naturally derived 
polymers like alginate37, carrageenan38 and hyaluronan.39 Collagen secretion levels from 
encapsulated fibroblasts has been largely evaluated using fluorescent tagging or SDS-PAGE.40,41 
Second harmonic generation (SHG) microscopy allows for sensitive, high-content-imaging of not 
just secreted collagen, but also collagen organization.42,43 In this study, we use SHG microscopy 
and subsequent data analysis to examine how hydrogel stiffness can tune collagen organization 
from tuned to stochastic when encapsulating NIH/3T3 fibroblasts. The ability to influence collagen 
organization is a relatively unexplored are with previous research focused on visualizing the 
collagen alignment in neocartilage secreted by primary mesenchymal stem cells showing no direct 
cause-effect relationships.44 We sought to decouple the effects of crosslinking density and 
compressive moduli, as well as crosslinking mechanism on how scaffolds influence remodeling 
by encapsulated fibroblasts. For specific applications such as skin grafts, cartilage repair, and 
corneal wound healing, being able to tune collagen organization to avoid compliance mismatch 
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from the local microenvironment will further improve scaffolds by better recapitulating the native 
environment. 
 
6.2. Experimental 
7.2.1. Materials 
Medium viscosity alginic acid (CAS 9005-38-3) was obtained from MP Biomedicals 
Fisher Scientific (Hampton, NH) and methacrylic anhydride (CAS 760-93-00) was supplied by 
Sigma Aldrich (St. Louis, MO). 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone 
(Irgacure 2959) was obtained from Sigma-Aldrich (St. Louis) and dithiothreitol (DTT) was 
obtained from VWR Chemicals (Batavia, IL). Other materials were purchased through Sigma 
Aldrich (St. Louis) and were used as received, unless otherwise stated. Fresh deionized water 
(Milli-Q, Thermo Scientific Nanopure, Waltham, MA) was used throughout this study.  
7.2.2. Methacrylated Alginate (ALGMA) Synthesis  
Methacrylated alginate solutions were prepared based on a previously described protocol.31 
A 1% (w/v) solution of medium viscosity alginic acid in DI water was prepared by mixing 2 g 
alginic acid powder in 200 mL of DI water. Methacrylic anhydride (16 mL) was slowly added to 
the solution. The pH of the solution was maintained between 8 and 9 using aliquots of 5 M NaOH 
at 4 ℃. After 24 h, the methacrylated alginate solution was dialyzed against water using a 
molecular weight cutoff membrane of 13,000 Da for two days with dialysate being refreshed twice 
daily. The final dialyzed product was lyophilized (4.5 L, Labconco, Kansas City, MO). NMR was 
used to confirm methacrylation of the alginic acid. Solutions of alginate and ALGMA were 
prepared using standard protocols.45 The % methacrylation was calculated by the relative 
integration of the protons from the methacrylate group (𝐼𝐶𝐻2  at δ = 6.0 and 5.6 ppm) and the 
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methyl group (𝐼𝐶𝐻3  at δ = 1.8 ppm) to the protons from the carbohydrate peak (𝐼𝑝𝑜𝑙𝑦𝑚𝑒𝑟) using 
equation 1 (Figure 7.1).  
% 𝑀𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 =  
(
𝐼𝐶𝐻2
𝑛𝐶𝐻2
 + 
𝐼𝐶𝐻3
𝑛𝐶𝐻3
)
𝐼𝑝𝑜𝑙𝑦𝑚𝑒𝑟
𝑛𝐻𝑝𝑜𝑙𝑦𝑚𝑒𝑟
      (1) 
7.2.3. Hydrogel Fabrication and Characterization 
The stock solution for methacrylated alginate hydrogels was prepared by dissolving 300 
mg of ALGMA and 10 mg of Irgacure 2959 in 10 mL of DI water. Step growth, chain growth and 
mixed mode polymerization was conducted to obtain a range of mechanically different hydrogels. 
The step growth polymerization was obtained by adding 250 µL of 4 mg/mL dithiothreitol (DTT) 
to the stock solution. Chain growth polymerization was conducted by degassing the stock solution 
under vacuum. Mixed mode polymerization was obtained by adding the 250 µL of 4 mg/mL DTT 
followed by degassing. All hydrogels were crosslinked by exposure to UV light (365 nm, 2 W/cm2) 
for 10 minutes. Dually crosslinked ALGMA hydrogels were fabricated by adding 100 L of 0.2 
M SrCl2 after exposure to UV light.  
To measure the compressive modulus of the ALGMA hydrogels, plugs (6 mm thick, 16 
mm diameter, n = 4) were prepared for testing. These hydrogel samples were placed between two 
glass slides, on which sequential series of weights were added. Image J (NIH, Bethesda, MD) was 
used to evaluate changes in height and cross-sectional area of the hydrogel samples in response to 
the weights. The slope of the linear region in the stress strain curve over a strain range of 5-15% 
was defined as the compressive modulus. 
Swelling ratios of the different crosslinked hydrogels (n = 3) were measured after drying 
at room temperature. These hydrogels were swollen in acetate buffers (1 mM) and maintained at 
pH 3, 5, 7.4 and 9 for two days. The swelling ratios were subsequently calculated after analyzing 
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the recorded dry and wet weights using equation 2 where Md is the dry mass and Mw is the wet 
mass. 
Swelling ratio =
M𝑤−𝑀𝑑
𝑀𝑑
 (2) 
7.2.4. In Vitro Degradation 
To test the degradation of the hydrogels, the gels were placed in accelerated degradation 
conditions (0.1 mM NaOH). After equilibrating these gels for one day in solution, masses were 
recorded for each consecutive day. The % mass remining was compared with the initial mass and 
recorded for each time-point.  
7.2.5. Cell Culture and Proliferation Assay 
NIH/3T3 fibroblasts (ATCC, Manassas, VA) were passaged at 37°C with 5% CO2 in 
Dulbecco’s modified Eagle’s medium (Cellgro, Thermo Scientific) supplemented with 10% 
bovine calf serum, penicillin (100 U/L) and streptomycin (100 μg/mL), referred to as complete 
medium (CM). Cell suspension aliquots of 200 μL (1  107 cells/mL) were mixed 300 μL of the 
different hydrogel solutions and were pipetted into 48 well plates. For each plate, live and dead 
controls were made by plating cells directly on tissue culture plastic. The plates were incubated 
for 48 h. The medium in the dead control wells was aspirated and replaced with 300 μL of 70% 
ethanol for 10 minutes. Subsequently, the supernatant in all wells was aspirated. To each well 150 
μL of working solution (2μM calcein AM (AnaSpec, Fremont, CA) and 7.5 μM of 7-
aminoacinomycin D (Tonbo Biosciences, San Diego, CA) in phosphate buffered saline (PBS)) 
was added and the plates were incubated for 30 – 40 min at 37°C in 5% CO2. Fluorescent images 
were taken using EVOS Floid Cell Image Station (Thermo Scientific) with the red 
(excitation/emission 586/646 nm) and green channels (482/532 nm) set to visualize the dead and 
live cells respectively. Live and dead cells were quantified at an excitation/emission of 485/528 
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nm and 645/490 nm, respectively, using a plate reader (BioTek Synergy HT Multidetection 
Microplate Reader, Biotek, Winooski, VT). The percentage of live cells was determined using the 
following equation: 
% 𝒍𝒊𝒗𝒆 𝒄𝒆𝒍𝒍𝒔 =  
𝑭(𝟓𝟐𝟖)𝒔𝒂𝒎𝒑𝒍𝒆− 𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍
𝑭(𝟓𝟐𝟖)𝑳𝒊𝒗𝒆 𝑪𝒐𝒏𝒕𝒓𝒐𝒍− 𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍
 × 𝟏𝟎𝟎% (3) 
where 𝑭(𝟓𝟐𝟖)𝒔𝒂𝒎𝒑𝒍𝒆 is the fluorescent signal at 528 nm from the cell laden samples, 
𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 is the fluorescent signal at 528 nm from the lysed control samples, and 
𝑭(𝟓𝟐𝟖)𝑳𝒊𝒗𝒆 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 is the fluorescent signal at 528 nm from the control samples. 
7.2.6. Second Harmonic Generation Microscopy of the gels 
Equal volumes of suspended NIH/3T3 fibroblasts (1  107 cells/mL) were mixed with 
hydrogel solutions. The cell-gel suspension (100 μL) was pipetted between two coverslips, which 
were exposed to UV light (365 nm, 2 W/cm2) for 10 min. These gelled samples were then placed 
in Petri dishes containing CM. Medium was replaced every three days. Negative controls were 
prepared by crosslinking the gels without cells. All samples were preserved in 10% formalin before 
imaging. 
A mode-locked Ti: Sapphire laser (100 fs pulse width, 1 kHz repetition rate obtained from 
Libra, Coherent, Santa Clara, California) that operates with an 800 nm fundamental, was used to 
image all samples. A half-wave plate and Glan-Thompson polarizer (Thorlabs, Newton, New 
Jersey) was used to control the power at the sample stage. The second harmonic signal from the 
interaction with the samples was collected in transmission mode.  
To image these samples, an inverted microscope (Amscope, Irvine, California) and a Nikon 
Plan Fluorite objective (20 , 0.50 NA, 2.1 mm WD, Nikon, Melville, New York) was used to 
focus the beam. The SHG transmission was collected using a Nikon water immersion objective 
(40 , 0.8 NA, 3.5 mm WD, Nikon, Melville, New York). This signal was reflected by a dichroic 
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mirror (DMLP425T, Thorlabs). Two short pass filters < 450 nm (FGB37M, Thorlabs) and an 808 
nm notch filter (NF-808.0-E-25.0M, Melles Griot, Rochester, New York) were used to separate 
the signal from the fundamental beam prior to detection by the intensified charge couple device 
(iCCD, iStar 334T, Andor, Belfast, United Kingdom). A Glan-Thompson polarizer and a half-
wave plate mounted on a motor-driven rotational stage (Thorlabs) was used to generate linear 
polarized light to conduct polarized SHG imaging. Images of the samples were acquired at every 
10° from 0° to 350°. For every experimental condition, images were collected in triplicate. The 
regions of interest (ROIs) were analyzed and fit using the following equation:  
𝐼𝑆𝐻𝐺 = 𝑐 ∙  {[𝑠𝑖𝑛
2(𝜃𝑒 −  𝜃𝑜) + (
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
) 𝑐𝑜𝑠2(𝜃𝑒 − 𝜃𝑜) ]
2
+ (
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
)
2
sin2(2(𝜃𝑒 −  𝜃𝑜))}  (4) 
where 
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
 and 
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
 are the second-order susceptibility tensor element ratios, 𝜃𝑒  and 𝜃𝑜 are 
the incident polarization angle and collagen fiber angle, respectively, and c is a normalization 
constant. Each ROI was individually analyzed for the orientation of collagen within it. A histogram 
was generated detailing the orientation of the collagen in the entire image. The organization of 
collagen was evaluated based on the full-width at half maximum (FWHM) of the Gaussian fit of 
the histogram. The types of collagen were identified using a previously described method.30 
Collagen gels of varying collagen III concentrations were fabricated and imaged using polarized 
SHG microscopy, and the resulting images were fit using equation 3. Histograms of 
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
 showed 
the presence of a peak at ~0.8 which was assigned to collagen III, and one at ~1.2 that was assigned 
to collagen I. The ratio of the integrated peaks was plotted against the actual collagen III 
concentration in the gels to yield a standard curve. This standard curve allowed for estimation of 
collagen III levels in the imaged samples.  
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7.2.7. Statistical Analysis 
Data generated was statistically analyzed and the values are reported as mean ± standard 
deviation (SD). Mean comparisons were determined to be statistically significant via a two-way 
ANOVA. Tukey’s honest significant difference test was used to evaluate the pair-wise 
comparisons. Statistically significant differences were identified for p < 0.05.  
7.3. Results 
7.3.1. Characterization of ALGMA Hydrogels 
 Characterization of the ALGMA was conducted using 1H NMR spectroscopy (Figure 6.1), 
based on a previously described protocol.46 Peaks appearing at 6.0 and 5.6 ppm were assigned to 
the methacrylamide protons confirming methacrylation of the alginic acid. The extent of 
methacrylation was calculated to be 27 ± 2% using equation 1. The mannuronic acid content was 
determined to be 50 ± 2%. 
 
Figure 7.1 Synthesis and characterization of ALGMA. (Left) Schematic representation of 
chemical modification of alginate. (Right)1H NMR spectra of alginate and methacrylated alginate. 
Methacrylation of alginate polymer from unmodified to methacrylated with respective 1H NMR 
spectra found at δ = 6.2 and δ = 6.6 ppm. The degree of methacrylation was calculated as a 
percentage of hydroxy group substitution with the methacrylate groups per repeating unit. 
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7.3.2. Compressive Moduli 
 The compressive modulus of medium viscosity ALGMA hydrogels was modulated via 
different crosslinking methods.31 Comparisons of the compressive moduli of the different hydrogel 
preparations are shown in Figure 7.2. Our previously published results using very low viscosity 
alginate are included.31 Stiffness significantly increased from 9.3 ± 0.2 kPa for step growth, 13.0 
± 0.3 kPa for chain growth, and 15.2 ± 0.2 kPa for the mixed mode conditions. Dually crosslinked 
hydrogels were formed by incubating the hydrogels in 0.2 M SrCl2 and had compressive moduli 
~7 kPa higher than the covalently crosslinked gels. These gels had compressive moduli of 16.7 ± 
0.3 kPa for ionic step growth, 20.2 ± 0.4 kPa for ionic chain growth, and 22.6 ± 0.3 kPa for the 
relatively stiffest formulation of the ionic mixed mode condition. The non-methacrylated ionic 
alginate hydrogels had a compression modulus of 8.3 ± 0.3 kPa. In comparison to the very low 
viscosity ALGMA hydrogels which showed a range of 0.7 ± 0.1 to 2.24 ± 0.1 kPa, these medium 
viscosity-based gels were significantly stiffer, thus depicting two completely different ranges of 
mechanical environment. These distinct ranges of mechanotransducive cues provide us with a 
good comparison of cell responses to stiff substrates (similar to what is observed for 
musculoskeletal environments47,48) and soft substrate (similar to fatty tissue in the liver49 or healthy 
lung tissues48,50). 
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Figure 7.2. Compressive moduli of alginate hydrogels. Compressive moduli of methacrylated 
alginate hydrogels crosslinked through the different mechanisms and alginic acid precursor 
viscosities. Data represents the mean ± SD. n = 3. Statistical analysis through two-way ANOVA 
and Tukey’s HSD post-hoc test. * p < 0.05. 
 
7.3.3. Swelling Response 
 The swelling response of these hydrogels was examined to evaluate their suitability as 
scaffolds for wound healing applications.45,51 By controlling the crosslinking density, swelling 
responses can be tuned and delivery kinetics of potential encapsulated drugs can be controlled.52,53 
Softer hydrogels were able to swell to a greater extent than the stiffer hydrogels. Under basic 
conditions, the swelling response was significantly higher for all hydrogels compared to swelling 
in acidic conditions (Figure 7.3). This swelling response plateaued at pH 9 for the mixed mode 
and all three dually crosslinked hydrogels, which were the stiffer gels (>15 kPa). Swelling was not 
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statistically significant for the dually crosslinked hydrogels at pH 3 and at pH 5. One interesting 
finding was that at pH 7.4 and 9, the swelling response increased from the mixed mode gels to the 
ionic step growth gels and then decreased again. This may result from the Sr2+ interaction with the 
free carboxylic acid groups, mitigating the otherwise downward trend. 
 
Figure 7.3. Swelling response of the medium viscosity alginate hydrogels in a range of pH 
buffers. Hydrogels crosslinked through different mechanisms were swelled in pH 3, 5, 7.4, and 9 
sodium acetate buffers. Data represents the mean ± SD. n = 3. Statistical analysis through two-way 
ANOVA and Tukey’s HSD post-hoc test. * p < 0.05. 
 
7.3.4. Degradation Kinetics 
 Hydrogels should have degradation kinetics that are similar to the tissue regeneration 
rate.54,55 All of the hydrogels in this study were incubated in 0.1 mM NaOH to mimic accelerated 
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degradation conditions (Figure 7.4). There were no statistical differences observed for the 
degradation kinetics of the covalently crosslinked hydrogels, with the three dually crosslinked 
hydrogels showing a relatively more stable response. The hydrogels degraded to 50% of their 
original mass over 31 ± 3 days for the former, while the half-life was extended to 25 ± 3 days for 
the latter. 
 
Figure 7.4. Degradation response of alginate hydrogels under accelerated conditions. 
Alginate hydrogels were immersed in 0.1 mM NaOH to mimic accelerated degradation conditions. 
Data represents the mean ± SD. n = 3. Statistical analysis through two-way ANOVA and Tukey’s 
HSD post-hoc test. * p < 0.05. 
 
7.3.5. Cytocompatibility of ALGMA Hydrogels 
 One of the major prerequisites for any viable hydrogel used in biomedical applications is 
cytocompatibility.18,56 Live/Dead assays were conducted to evaluate the cytocompatibility of the 
different ALGMA hydrogels encapsulating NIH/3T3 fibroblasts. The encapsulated fibroblasts 
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were imaged and compared after 48 hours of incubation, and the proliferation was normalized to 
the cells cultured on tissue culture plastic (Figure 7.5). We have included cell proliferation on very 
low viscosity ALGMA gels31 for comparison. The low viscosity ALGMA gels showed a 
monotonic increase in cell proliferation with increasing stiffness. This trend did not carry forward 
for fibroblasts encapsulated in medium viscosity ALGMA studied here. Here there was a steep 
increase in cell proliferation from step growth (27 ± 4 %) to chain growth (51 ± 1 %). Cell 
proliferation plateaued at ~ 60% for the dually crosslinked hydrogels, with values of 56 ± 2, 57 ± 
1 and 62 ± 1 % for the ionic step growth, ionic chain growth, and ionic mixed mode hydrogels, 
respectively. These results indicated that there is a threshold hydrogel stiffness for the medium 
viscosity ALGMA hydrogels beyond which increased stiffness does not improve cell proliferation. 
 
Figure 7.5. Proliferation of NIH/3T3 cells encapsulated in alginate hydrogels. NIH/3T3 
fibroblasts were mixed with ALGMA hydrogel solutions made from very low and medium 
viscosity alginic acid and crosslinked under different mechanisms. Cells cultured on tissue culture 
plastic served as controls. (A) Representative micrographs of live (green) and dead (red) cells 
cultured for 48 h. (B) Quantification of live and dead cells. Data represents the mean ± SD. n = 6. 
Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc test. *p < 0.05. 
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7.3.6. SHG Microscopy 
Encapsulated fibroblasts have been studied for their ability to synthesize collagen under 
diverse cell culture conditions.57 SHG microscopy allows sensitive visualization of collagen 
secreted by these encapsulated cells as collagen is a non-centrosymmetric protein that is known to 
be SHG active. Collagen secretion levels were normalized to the background obtained by imaging 
non-cell laden hydrogel controls that had been incubated under identical conditions. Across the 
different hydrogel conditions there was an increase in collagen levels on day 7 compared to day 5 
(Figure 7.6). For all but one of the cell-hydrogel samples (ionic chain growth), the collagen levels 
on day 10 were significantly lower than the day 5 values. Collagen levels were positively correlated 
(R = 0.98) to the modulus of the hydrogel for all materials studied here (Figure 7.7). Ionic chain 
growth and ionic mixed mode hydrogels caused the fibroblasts to produce more collagen after 5 
days of culture than the other hydrogels. There were significant differences observed for the 
increase in normalized collagen levels particularly for measurements taken on day 7 and day 10. 
 
Figure 7.6. Collagen secretion by NIH/3T3 cells encapsulated in alginate hydrogels was 
evaluated using SHG microscopy. Encapsulated NIH/3T3 fibroblasts were mixed with ALGMA 
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and crosslinked. Collagen signal was normalized to the signal from the respective non-cell seeded 
hydrogel samples. Data represents the mean ± SD. n = 3. Statistical analysis was conducted for 
each hydrogel type through two-way ANOVA and Tukey’s HSD post-hoc test. *p < 0.05 for 
samples compared to day 5 results. Red, green and blue colored bars represent the step growth, 
chain growth and mixed mode crosslinking mechanisms. Dually crosslinked hydrogels shown with 
additional cross-hatch pattern on top of the original covalent crosslinking color.  
 
 
Figure 7.7: Correlation of collagen levels to Young’s modulus. Normalized collagen levels 
plotted against the Young’s modulus of the different ALGMA hydrogels, as measured on day 7 
(A) and day 10 (B). Data represents the mean ± SD. n = 3. 
 
Collagen organization can influence on cell morphology and proliferation.58,59 It is also a 
biomarker for tumor progression.60,61 In comparing the organization of the collagen secreted, and 
possibly rearranged by the fibroblasts,61–64 there was an interesting trend in which softer gels 
resulted in more organized collagen, while stiffer gels resulted in less organized collagen (Figure 
7.8 and 7.9). This trend appears to reach a plateau or possible decrease for ionic chain growth and 
ionic mixed mode gels, which have compressive moduli > 20 kPa. The line is a guide for the eye. 
Mechanical properties have previously been shown to influence cell proliferation in which stiffer 
substrates corresponded to upregulation of protein secretion.65 Conversely, previous studies have 
shown that patterned protein presentation can be used to spatiotemporally tune stem cell 
differentiation, independent of the mechanics of the encapsulating hydrogel.66 This is the first 
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report to our knowledge on mechanical properties influencing collagen organization. The 
empirical evidence presented on the influence of the hydrogel crosslinking method on collagen 
organization secreted by encapsulated fibroblasts adds demonstrates how materials can influence 
host responses to tissue engineered scaffolds. 
 
Figure 7.8. Organization of collagen secreted by encapsulated fibroblasts in alginate 
hydrogels. Collagen secreted by NIH/3T3 fibroblasts encapsulated in the different alginate 
hydrogels were analyzed using SHG microscopy on day 10 and are reported as FWHMs. Data 
represents the mean ± SD. n = 3. The solid line is a guide for the eye indicating the trend for how 
collagen organization varies with changes in the modulus of crosslinked hydrogel. The legend to 
the organization of the collagen as seen in the heat-map is provided on the top right. 
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Figure 7.9. Effect of crosslinking mechanism on collagen organization. Collagen organization 
heat maps in response to the different ALGMA hydrogel environments showing clear changes 
with difference in crosslinked hydrogel environment. The legend for the heat map is on the right 
side of the figure. 
 
7.4. Discussion 
In this study, ALGMA hydrogels were synthesized through previously described protocols 
by reacting medium viscosity alginic acid precursor with methacrylic anhydride.31 Key properties 
of these tunable hydrogels were analyzed including the compressive moduli, degradation kinetics, 
and swelling responses to different pH environments. The resulting empirical observations 
indicated that the medium viscosity ALGMA hydrogels are suitable for fabrication of 
cytocompatible scaffolds for studying collagen secretion and organizational changes by 
encapsulated fibroblasts.  
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 Most cells are anchorage dependent and adhere to underlying substrates forming focal 
adhesions. This cell-substrate interaction senses substrate stiffness by the cell reaching out through 
the actin-myosin cytoskeleton and is critical to the subsequent expression of secreted proteins as 
well as differentiation to activated phenotypes.8,49 Ionic, covalent, and a combination of the two 
(dual crosslinking) crosslinking mechanisms were employed to prepare medium viscosity 
ALGMA hydrogels with compressive moduli in the range of 8.3 ± 0.3 to 22.6 ± 0.3 kPa (Figure 
7.2). From these measurements, it is evident that there is a considerable influence from both the 
alginic acid precursor as well the crosslinking mechanism on the compressive moduli with our 
previously studied very low viscosity based ALGMA hydrogels restricted within a range of 0.5 ± 
0.1 to 2.2 ± 0.1 kPa,31 compared to the significantly stiffer ones synthesized here from medium 
viscosity precursors. The overall trend of the increase in compressive moduli conforms to the 
theory of rubber elasticity.31,67 We are primarily concerned with how hydrogel properties can 
influence collagen organization. As such, this range of mechanical environments will allow us to 
disentangle trends between hydrogel stiffness and collagen alignment as this range of moduli 
traverses previously observed thresholds for fibroblasts to express actin stress fibers and 
differentiate to myofibroblasts.68,69 Some studies have indicated the presence of an intermediate 
stage of proto-myofibroblasts that not express α-smooth muscle actin, while still showing 
significantly higher overall actin expression.70,71 Another study used chemically modified, soft 
alginate hydrogels with compressive moduli over the range of ~10 to 12 kPa, that showed low 
immune cell activation, and significantly reduced fibrotic response.72 
 Acute wound sites show rapid transition in pH from slightly acidic immediately after injury 
to basic conditions during granulation tissue formation, to more neutral levels upon 
reepitheliazation.73,74 Chronic wounds remain slightly alkali, which makes the wound site more 
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susceptible to opportunistic pathogens.74,75 Hence, an important aspect of designing biocompatible 
scaffolds from naturally derived, anionic polymers is utilizing their natural tendency to swell under 
basic pH conditions.76,77 Responsive scaffolds that swell in alkaline pH can be used to deliver 
payloads of cytokines and chemokines to boost the natural wound healing process, and 
dynamically mitigate the chronicity of the wound site.78,79 As the crosslinking density is inversely 
related to the swelling response,67 it was expected that the softer purely ionically or covalently 
crosslinked hydrogels would swell more than the dually crosslinked gels. This trend held for 
previously studied very low viscosity ALGMA gels,31 as well as the gels prepared here from 
medium viscosity alginic acid (Figure 7.3). All the ALGMA hydrogels swelled the most at pH 9 
condition, which makes these viable materials for preparing scaffolds for chronic wound 
treatments. Further studies can be conducted to evaluate the kinetics of using such responsive 
hydrogels for drug delivery to chronic wounds, by studying the transport of clinically relevant 
biomolecules from swollen hydrogels.22 To this end, there have been studies carried out using 
additional stages of wound treatment using acidified solutions,80 allo-grafts derived from neonatal 
foreskin to instigate accelerated wound healing81 as well as synthetically derived scaffolds such as 
Apligraf®, which closely resembles the structure of natural skin.82 An environmentally responsive 
scaffold that can be tuned to deliver payloads of wound-healing relevant growth factors or patient-
derived stromal cells could personalize wound care management with minimal immune 
rejection.83,84  
 The degradation of hydrogels results in decreased crosslink density over time.85 Alginate 
hydrogels are very stable in PBS. Thus, to measure hydrolytic degradation, the ALGMA gels were 
incubated in a basic solution of 0.1 mM sodium hydroxide.86,87 Covalently crosslinked ALGMA 
hydrogels derived from very low viscosity degraded to 50% of their original mass within 6 ± 1 
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days with dually crosslinking increasing the half-life to 13 ± 2 days. The gels fabricated here were 
almost 5 times as stable, with half-lives of 31 ± 3 days (Figure 7.4). However, dually crosslinking 
the medium viscosity gels did not increase the half-life (25 ± 3 days). Ideally, degradation kinetics 
of the scaffold should match tissue regeneration rates. Potential inflammatory or fibrotic responses 
can result if these rates are not equivalent.88  
 Scaffolds must be cytocompatible..89 NIH/3T3 cells showed no cell death when 
encapsulated in the different crosslinked ALGMA hydrogels (Figure 7.5B). Additionally, the 
encapsulated cells had cell proliferation above 50% compared to the controls of tissue culture 
plastic (TCP), with the exception of step-growth gels. When looking at the compressive moduli 
and cell proliferation (Figure 7.5A), it appears that there was a threshold compressive modulus 
beyond which the cell proliferation showed few significant changes with increased crosslinking 
density. 3D encapsulation of cells allows for relatively better approximations of the natural in vivo 
conditions, as compared to surface seeding studies.18 Comparing the cell morphology in the 
live/dead assay, there were no differences for the different hydrogel environments which agrees 
with Huebsch et al.65 In an effort to decouple the mechanical effects of 3D modified alginate 
matrices on the morphology of human mesenchymal stem cells (hMSCs, which are similar in many 
ways to fibroblasts), the cells were encapsulated in alginate hydrogels of varying Young’s modulus 
and fixed concentration of the RGD motif that was used to increase cell adhesion. There were no 
significant changes in morphology observed when cultured for 2h, 24h and even one week under 
encapsulated conditions. Such studies indicate the complexity in using nanoporous cell 
encapsulation hydrogels such as alginate for studying the changes in cell morphology responses. 
The plateaued trend of the cell proliferation to the dually crosslinked hydrogels introduces the 
possibility that once the ALGMA hydrogels are uniformly crosslinked above 20 kPa, would it be 
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possible to disentangle the effect of gelation mechanism and the rigidity to determine which factor 
holds greater significance on cellular responses.90,91 
 Fibroblasts have mechanical memory regarding the stiffness of the substrates they are 
cultured on, particularly with respect to how they differentiate to myofibroblasts that has been 
positively correlated to over-secretion of collagen I.48,57,92 Qualitative as well as quantitative 
analysis of the secreted collagen using SHG microscopy has allowed for an informed rational 
design of biocompatible materials.30,93 Here, we see a significant increase of the collagen levels on 
day 7 for all hydrogel conditions compared to day 5 (Figure 7.6). This was expected as protein 
deposition typically increases with culture time. The overall timeline can vary based on several 
factors such size, shape and topography of the environment.94 As such, the ionic chain growth gel 
may have a different timeline related to its crosslinking mechanism compared with the other gels. 
The positive correlation of the collagen levels to the modulus of the underlying substrate 
conformed to previous studies in which stiffer substrates cause stromal cells to secrete more ECM 
proteins particular around day 7 to day 10.56,95 The decrease in collagen levels beyond day 7 may 
result from an increase in MMP-13 (collagenase).95 These results could also indicate an 
upregulation in overall cell activity which may be a precursor for fibroblast-to-myofibroblast 
differentiation, particularly in the stiffer microenvironments.96 Similarly, Huebsch et al. found that 
alginate hydrogels encapsulating hMSCs instigated osteogenic differentiation when the gels were 
stiffer. Encapsulated, with a biphasic influence of the modulus on ECM secretion.65 Beyond just 
the quantification of the collagen levels, it is of great importance to understand the influence of 
collagen organization.58 There is a dearth of studies conducted on the tunability of local collagen 
organization using sensitive visualization techniques. As has been previously stated, the timeline 
of collagen secretion and its organization can determine the fate of implanted materials and 
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understanding how materials alter these responses will allow us to improve implant compatibility 
and prevent a fibrotic response.30  
 The organization of collagen in the ECM influences the remodeling of wounds,97 as well 
as acceptance of implants.30 Aligned collagen is found in specific natural environments such as 
mammalian tendons as well as cornea.98,99 Stochastic collagen is present in natural dermis.100 
Keeping collagen alignment in mind, we can determine how materials properties will change 
cellular responses and this understanding can improve scaffold design for tissue repair in different 
organs.22 Collagen angles were measured using SHG and were plotted using a heat map to better 
visualize regions of organization. Softer step growth gels (~10 kPa) can be seen as having a lower 
FWHM, which the hydrogel resulted in more aligned collagen (Figure 7.10). This can be 
visualized in the heat map in which there are large regions of collagen having the same orientation 
angle. The FWHM of collagen decreases with increasing compressive modulus, which means the 
collagen is more isotropic. The heat map shows that there is a large variation in collagen angles 
for the ionic step growth condition (~15 kPa) (Figures 7.8 and 7.9). This suggests that not only 
mechanical stiffness of the underlying substrate influences collagen response, necessitating further 
research on disentangling the influence of crosslinking mechanism on cell interactions. As this 
study is limited to collagen based analysis, future studies on the expression of FAK and MAPK 
expression along with quantified immunocytochemical staining of cells cultured in or on such 
scaffolds could further elucidate the mechanism that is causing collagen organization.101,102 This 
study provides further development of SHG microscopy as a platform for visualizing the influence 
of materials properties in tunable hydrogels to how cells sense their local microenvironment. 
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Figure 7.10: Comparing collagen alignment over 10 days. Histograms of collagen organization 
obtained for collagen secreted by NIH 3T3 fibroblasts encapsulated in the ALGMA hydrogels. 
The bars represent experimentally acquired data. The red line is the Gaussian fit to the data. 
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7.5. Conclusions 
 We successfully fabricated methacrylated alginate hydrogels from medium viscosity 
alginic acid through ionic, covalent, and a combination of ionic and covalent crosslinking 
mechanisms. These mechanisms yielded a range of hydrogels that were stiffer, pH responsive as 
well as significantly more robust under accelerated degradation conditions of incubation compared 
to hydrogels fabricated from very low viscosity alginate. NIH/3T3 fibroblasts encapsulated in 
these hydrogels showed no cell death and a preferred threshold stiffness above which cell 
proliferation was > 60 % compared to TCP controls. Collagen secretion in response to the 
encapsulation conditions was positively correlated with the modulus for all environments. 
Collagen was more isotropic for the mixed mode and ionic step growth conditions, whereas the 
softer gels resulted in more anisotropic organization. The detailed characterization of the influence 
of crosslinking mechanisms for these responsive ALGMA hydrogels indicates the need for 
including it as an important factor for the fabrication of tissue engineering scaffolds. 
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CHAPTER 8 
PHOTOMASK-TUNED AND FIBRONECTIN-MODIFIED ALGINATE HYDROGELS 
FOR STUDYING FIBROBLAST MORPHOLOGY AND COLLAGEN ORGANIZATION 
 
Methacrylated alginate hydrogels were synthesized across a range of stiffness (6.9 ± 0.4 to 20.2 ± 
kPa) using photomasks to tune the amount of UV exposure. NIH/3T3 fibroblasts were viable for 
ten days of culture when surface seeded on these hydrogels. The proliferation of fibroblasts was 
significantly higher on the stiffer hydrogels, and further surface functionalization of the gel with 
fibronectin increased cell confluence on these substrates. The cells had a rounded morphology 
after two days, with stellate morphology observed after four days. After ten days the stiffer 
substrates were almost completely covered with  NIH/3T3 cells that were expressing -smooth 
muscle actin. Collagen secretion and organization from the surface-seeded fibroblasts was 
visualized using second harmonic generation (SHG) microscopy. For both the fibronectin 
modified and naïve substrates collagen was significantly less organized on the softer substrates 
and more aligned on stiffer substrates. Cell spreading normalized to secreted collagen on the 
different hydrogels indicated a clear influence of the stiffness on the cell morphology as well as 
collagen levels for both four and ten days of culture. This study showed the substantial influence 
of cell adhesion motifs as well as substrate stiffness on cell morphology and organization of 
collagen. 
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8.1. Introduction 
 The primary aim of tissue engineering is to recapitulate the intricate complexities of natural 
tissues so they can be used for treating diseased, damaged, or missing tissue.1–3 To develop more 
effective scaffolds, the role of biomaterials properties on  cell-matrix interactions must be 
understood to develop enhanced design criteria.4,5 In the United States alone, it has been reported 
that over 77 people receive transplants daily which is still does not cover the demand for the same 
resulting in wait-listing over 98,000 patients for an average of three years or more.6,7 Regenerative 
medicine seeks to cover these shortages by fabricating tunable, biocompatible materials.  
 Hydrogels fulfil many of the material requirements for tissue scaffolds with their tunable 
mechanical properties, ease of functionalization, and, in the case of naturally derived materials, 
their  compositional similarity to natural extracellular matrix (ECM).8 It is possible to tailor 
hydrogels with finely tuned scaffold properties to alter cell adhesion and proliferation, as well as 
degradation kinetics such that they are similar to that of natural tissue growth.9,10 The interaction 
between cells and the ECM is an integral aspect of how tissues maintain homeostasis.11 Through 
diverse scales of interaction with the ECM, from the molecular to the macroscopic, cells are able 
to sense dynamic changes in their microenvironment.12 With such a significant influence of the 
ECM over cell adhesion, differentiation, and proliferation, there is a need to engineer interactions 
that can increase the compliance of scaffolds.13,14 
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 Naturally derived hydrogel materials such as alginic acid derived from algae or seaweed 
can be used as a scaffold for tissue engineering applications.15–17 Alginate can be crosslinked 
through ionic binding or through covalent bonds after chemically modifying alginate.18,19 
Although ionic crosslinking is relatively facile and rapid, ion exchange with monovalent ions in 
physiological media can result in a loss of mechanical stability.20,21 Through methacrylation of 
these alginate networks, hydrogels can be formed through chain growth polymerization using 
photocrosslinking.22 By tuning the opacity of photomasks, it is possible to further tune the UV 
exposure and result in a gradient of hydrogel stiffnesses.23 To increase the cytocompatibility of 
such hydrogel gradients, fibronectin (FN), laminin, and collagen have been used to mimic natural 
tissue environments by providing cell adhesion motifs for better cell attachment.24–26 Patterns of 
such photocrosslinked platforms have been previously used to study the differentiation and 
mechanotransducive sensitivity of mesenchymal stem cells.27,28 These studies showed that both 
the magnitude and the spatial organization of the stiff regions influenced the differentiation of stem 
cells to more elongated morphologies. Collagen is a key component of mammalian connective 
tissue systems.29 Collagen has both organizational and compositional differences in different 
tissues that dictates the function of the tissue.30–32 Previous studies characterizing collagen secreted 
by cells using molecular biology techniques or expensive dyes have been unable to completely 
capture the intricacies of the cell-matrix interactions.33,34 Second harmonic generation (SHG) 
microscopy is a powerful tool that can provide detailed mapping of collagen organization in a wide 
range of tissue samples.35–37 
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 In this study, we characterize cell viability, phenotype, and collagen secretion in response 
to FN-modified as well as naïve alginate scaffolds prepared across a gradient of stiffnesses through 
photocrosslinking. Fluorescent immunocytochemical staining and live/dead assays provided 
insight into the biocompatibility and cell morphology of surface-seeded NIH/3T3 fibroblasts. 
Using the sensitive, dye-less visualization of collagen through SHG imaging, we examined how 
substrate stiffness influenced collagen secretion and alignment. Through our analysis, we propose 
design criteria for achieving different collagen organization based on hydrogel stiffness. 
  
8.2. Experimental 
8.2.1. Materials 
Medium viscosity alginic acid (CAS 9005-38-3) was procured from MP Biomedicals 
Fisher Scientific (Hampton, NH). Dithiothreitol (DTT) was supplied by VWR Chemicals (Batavia, 
IL). All other materials used for the experiments were procured from Sigma Aldrich (St. Louis, 
MO) and used as received, unless otherwise specified. Deionized (DI) water (Milli-Q, Thermo 
Scientific Nanopure, Waltham, MA) was used throughout these experiments.  
8.2.2. Methacrylated Alginate (ALGMA) Synthesis  
The medium viscosity alginic acid precursor was used to prepare alginate solutions and 
methacrylated as described previously.38 Briefly, 2 g of alginic acid powder was dissolved in 200 
mL of DI water to prepare a 1 % (w/v) solution. The modification of this solution was initiated by 
slowly adding 16 mL of methacrylic anhydride. The pH was maintained between 8 and 9 using 
aliquots of 5 M NaOH at 4 ℃. This reaction was stopped after 24h, and the methacrylated alginate 
(ALGMA) was transferred to molecular weight cutoff membranes of 13,000 Da. The ALGMA 
was dialyzed against DI water for two days, with the dialysate refreshed twice a day. The final 
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ALGMA product was lyophilized (4.5 L, Labconco, Kansas City, MO) to obtain a white, foamy 
powder. NMR spectroscopy was conducted on solutions of the unmodified alginate and ALGMA 
to characterize the methacrylation extent of the synthesized ALGMA. The 1H spectra were 
acquired on a Bruker Avance III Spectrometer at 70°C, a sweep width of 6602.1 Hz, a 90° pulse, 
and an acquisition time of 2.48 s; 128 repetitive scans with 64 k points were acquired and the data 
were processed in MNova with 128k points, zero filling, and exponential line broadening of 1.0 
Hz.22 Methacrylation % was evaluated through the relative integration of the protons from the 
methacrylate group (𝐼𝐶𝐻2  at δ = 6.0 and 5.6 ppm) and the methyl group (𝐼𝐶𝐻3  at δ = 1.8 ppm)  to 
the protons from the carbohydrate (𝐼𝑝𝑜𝑙𝑦𝑚𝑒𝑟) using equation 1. 
% 𝑀𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 =  
(
𝐼𝐶𝐻2
𝑛𝐶𝐻2
 + 
𝐼𝐶𝐻3
𝑛𝐶𝐻3
)
𝐼𝑝𝑜𝑙𝑦𝑚𝑒𝑟
𝑛𝐻𝑝𝑜𝑙𝑦𝑚𝑒𝑟
      (1) 
8.2.3. Hydrogel Fabrication and Characterization 
Ionic chain growth crosslinking of the stock solutions was initiated based on protocols 
previously described.39The stock hydrogel solution was prepared by dissolving 300 mg ALGMA 
and 10 mg Irgacure 2959 in 10 mL DI water. This solution was degassed under vacuum. A 
photomask of varying opacities was applied to the gel and the gel was exposed to UV light (365 
nm, 2 W/cm2) for 10 min. The hydrogels were further exposed to 100L of 0.2 M SrCl2 to 
incorporate ionic crosslinks. 
The compressive moduli of the different hydrogels across the gradient were measured by 
testing plugs (n = 4) that were 6 mm thick and 16 mm wide. The samples were placed between 
two glass slides and sequential series of weights were placed on top. Images of measuring the 
compressive moduli were analyzed using ImageJ (NIH, Bethesda, MD) by evaluating changes in 
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height and cross-sectional area of the hydrogels. The compressive modulus of each gel was defined 
as the slope of the linear region over 5-15 % strain, from the stress-strain curve. 
8.2.4. Cell Culture and Proliferation Assay 
Cell adhesion and proliferation are essential aspects of testing in vitro cytocompatibility of 
different scaffolds.9,40 Proliferation of NIH/3T3 fibroblasts (ATCC, Manassas, VA) was tested on 
both fibronectin (FN) modified and naïve replicates of all hydrogel surfaces. NIH/3T3 fibroblasts 
were passaged in Dulbecco’s modified Eagle’s medium (Cellgro, Thermo Scientific) 
supplemented with 10% bovine calf serum, penicillin (100 U/L) and streptomycin (100 μg/mL) at 
37°C under 5% CO2. In a 48 well plate, 300 μL of the different hydrogel solutions and were 
pipetted. For the FN modified surfaces, a solution of 50 μL of 200 μg/mL solution of FN (human 
FN 95%, AnaSpec, Thermo Fisher) was added to the well and the plates were incubated for 30 
min. Glass control surfaces were also incubated at rt for 1 h after addition of the FN. The hydrogels 
were then exposed to the UV light (365 nm, 2 W/cm2) using the photomask for 10 min to crosslink 
the gels. To all controls, FN modified hydrogels, and naïve hydrogels, 200 μL cells (1.25  105 
cells/cm2) was added. Live and dead controls for each plate were prepared by seeding the cells 
directly on the tissue culture plastic. After 48 h of incubation, the medium in the dead controls was 
aspirated and 300 μL of 70% ethanol was added for 10 min to lyse the cells. The supernatant in all 
remaining controls and samples was subsequently aspirated and to each well 150 μL of a 
Live/Dead working solution (2 μM calcein AM (AnaSpec, Fremont, CA) and 7.5 μM of 7-
aminoactinomycin D (Tonbo Biosciences, San Diego, CA) in phosphate buffered saline (PBS)) 
was added. The plates were incubated for 40 min at 37°C in 5% CO2. Fluorescence images were 
obtained using the EVOS Floid Cell Image Station (Thermo Scientific) with the red 
(excitation/emission 586/646 nm) and green channels (482/532 nm) to observe the dead and live 
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cells, respectively. Live cells were quantified using a plate reader (BioTek Synergy HT 
Multidetection Microplate Reader, Biotek, Winooski, VT) using an excitation/emission of 485/528 
nm. The % of live cells was determined using the following equation: 
𝐿𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 % =  
𝑭(𝟓𝟐𝟖)𝒔𝒂𝒎𝒑𝒍𝒆− 𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍
𝑭(𝟓𝟐𝟖)𝑳𝒊𝒗𝒆 𝑪𝒐𝒏𝒕𝒓𝒐𝒍− 𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍
 × 100% (3) 
where 𝑭(𝟓𝟐𝟖)𝒔𝒂𝒎𝒑𝒍𝒆 is the fluorescent signal at 528 nm from the cell laden samples, 
𝑭(𝟓𝟐𝟖)𝑫𝒆𝒂𝒅 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 is the fluorescent signal at 528 nm from the lysed control samples and 
𝑭(𝟓𝟐𝟖)𝑳𝒊𝒗𝒆 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 is the fluorescent signal at 528 nm from the control samples. 
8.2.5. Second Harmonic Generation Microscopy of the gels 
Cells seeded on hydrogels were prepared as described above. The medium was changed 
every three days. Cells were preserved using formalin (10% v/v) by aspirating the medium and 
incubating for 20 min at rt.  
A mode-locked Ti: Sapphire laser (100 fs pulse width, 1 kHz repetition rate, Libra, 
Coherent, Santa Clara, California) with an 800 nm fundamental was used for imaging all samples 
and controls. The power at the stage was controlled using a half-wave plate and a Glan-Thompson 
polarizer (Thorlabs, Newton, NJ). The second harmonic signal from the samples was collected in 
transmission mode. A Nikon Plan Fluorite objective (20 , 0.50 NA, 2.1 mm WD, Nikon, Melville, 
NY) was used to focus the beam to image the samples on an inverted microscope (Amscope, Irvine, 
CA). The SHG transmission through the sample was collected using a Nikon water immersion 
objective (40 , 0.8 NA, 3.5 mm WD, Nikon, Melville, NY). A dichroic mirror reflected the signal 
on to the optical path containing two short pass filters <450 nm (FGB37M, Thorlabs) and an 808 
nm notch filter (NF-808.0-E-25.0M, Melles Griot, Rochester, NY). This filter combination was 
used to separate the signal from the fundamental beam prior to detection using an intensified 
charge-coupled device (iCCD, iStar 334T, Andor, Belfast, United Kingdom). Polarized SHG 
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imaging was conducted by generating polarized light through a Glan-Thompson polarizer and a 
half-wave plate mounted on a motor-driven rotational stage (Thorlabs). Samples were imaged at 
every 10° from 0° to 350°. Images were collected in triplicate for all experimental conditions. 
Regions of interest (ROIs) were analyzed and fit using MATLAB using the following equation:  
 𝐼𝑆𝐻𝐺 = 𝑐 ∙  {[𝑠𝑖𝑛
2(𝜃𝑒 −  𝜃𝑜) + (
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
) 𝑐𝑜𝑠2(𝜃𝑒 − 𝜃𝑜) ]
2
+ (
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
)
2
sin2(2(𝜃𝑒 −  𝜃𝑜))}             (4) 
where 
𝜒𝑧𝑧𝑧
𝜒𝑧𝑥𝑥
 and 
𝜒𝑥𝑧𝑥
𝜒𝑧𝑥𝑥
 are the second-order susceptibility tensor element ratios., 𝜃𝑒  and 𝜃𝑜 are 
the incident polarization angle and collagen fiber angle, respectively, and c is a normalization 
constant. The orientation of collagen was analyzed in each ROI individually. These orientation 
angles were then compiled in a histogram. The collagen organization was assessed by measuring 
the full-width at half-maximum (FWHM) of the Gaussian fit of the histogram. Analysis of the 
types of collagen was done using previously optimized protocols.41  
8.2.6. Immunocytochemical Staining 
Samples preserved for SHG microscopy imaging were processed for immunocytochemical 
staining. All the samples were blocked (5% dry milk and 0.03% TWEEN-20 in PBS) at rt for 1 h. 
Cells were stained for α-SMA (1:400, ab5694, Abcam, Cambridge, MA) and actin (phalloidin-
iFluorTM 488 conjugate, Cayman Chemicals, Ann Arbor, MI). A secondary antibody was used to 
visualize α-SMA (1:600, ab150080, Abcam). Nuclei were stained using DAPI (4′,6-diamidino-2-
phenylindole, 0.1µg/mL) for 2 min. Cells were imaged using the Floid EVOS Floid Cell Image 
Station with the blue (excitation/emission 390/446 nm), red (excitation/emission 586/646 nm) and 
green channels (482/532 nm) tuned to visualize the nuclei, actin cytoskeleton, and α-SMA, 
respectively. 
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8.2.7. Statistical Analysis 
The data generated was statistically analyzed and reported as mean ± standard deviation 
(SD). Statistical significance was determined through mean comparisons via a two-way ANOVA. 
Pair-wise comparisons were evaluated using Tukey’s honest significant different test. Statistically 
significant differences were identified for p < 0.05.  
 
8.3. Results 
8.3.1 Compressive Moduli 
The ALGMA hydrogel solution crosslinked using chain growth polymerization through a 
photomask allowing for the opacity to control the level of UV exposure. These gels were further 
crosslinked using SrCl2. The opacity of the photomask was adjusted to generate hydrogels of 
different Young’s moduli ranging from 20.2 ± 0.4 kPa at 0% opacity to 6.9 ± 0.4 kPa at 90% 
opacity (Figure 8.1). 
 
Figure 8.1. Compressive moduli of alginate hydrogels. Compressive moduli of methacrylated 
alginate hydrogels crosslinked through chain growth after which they were crosslinked by UV 
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radiation through a photomask across different opacity levels and reinforced by Strontium ions to 
get discrete hydrogel samples of varying stiffnesses. Data represents the mean ± SD. n = 3. 
Statistical analysis through two-way ANOVA and Tukey’s HSD post-hoc test. * p < 0.05. 
 
NIH/3T3 fibroblast transitions to protomyofibroblasts and subsequently myofibroblasts 
have been observed over the range of 16 kPa, which matches well with these gels.42,43 All future 
discussions on classifying the gradient hydrogels within this manuscript will refer to by the % 
opacity  of the photomask through which they were crosslinked. 
 
8.3.2 Cell Viability 
The cytocompatibility of these hydrogels across the gradient of mechanical stiffnesses is a 
key aspect in their suitability as tissue engineering scaffolds.44,45 To enhance cell attachment on 
these hydrogels, fibronectin (FN) was covalently linked to the surface.46,47 Viability of surface 
seeded NIH/3T3 fibroblasts was assessed through a live/dead assay. Fibroblasts on both naïve and 
FN-modified surfaces showed no cell death after 48h incubation on the gels (Figure 8.2).  
 
Figure 8.2. Proliferation of NIH/3T3 cells surface-seeded on gradient of alginate hydrogels 
across FN-modified and naïve conditions. NIH/3T3 fibroblasts were seeded on the both naïve 
and fibronectin modified, dually crosslinked ALGMA hydrogels across the stiffness gradient. 
Cells cultured on tissue culture plastic served as controls. (A) Representative micrographs of live 
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(green) and dead (red) cells cultured for 48 h. (B) Quantification of live and dead cells. Data 
represents the mean ± SD. n = 6. Statistical analysis through two-way ANOVA and Tukey’s HSD 
post-hoc test. *p < 0.05. Scale bar represents 100 µm. 
 
Cell proliferation increased from just 29.0 ± 0.2% on the softest gel (90%) to 52.0 ± 1.0% 
for the stiffest gels (0%). These values were normalized to controls on tissue culture plastic (TCP). 
As expected, FN-modified substrates significantly increased proliferation with cells on the softer 
gels (90% FN) at 60.0 ± 0.5% and cells on the stiffer gels at 84 ± 1.8%, an increase of 1.6 times 
over the naïve substrates for the same rigidity.  
 
8.3.3 Immunocytochemistry 
Immunocytochemistry (ICC) fluorescent staining enabled us to visualize cell morphology 
and differentiation in response to being seeded on the different hydrogels. Actin filaments were 
stained with phalloidin and the nuclei was visualized with DAPI. α-smooth muscle actin (α-SMA) 
was used to show myofibroblast presence. Representative images of the cells show the presence 
of α-SMA and dense surface coverage of the NIH/3T3 fibroblasts on the stiffer substrates (Figure 
8.3).  
Figure 8.3. Immunocytochemical fluorescent staining of fibroblasts cultured on the ALGMA 
hydrogels. The representative fluorescent staining images showing fibroblasts proliferating on 
substrates with varying stiffnesses across the gradient. Fibronectin modified versions of the same 
hydrogel samples are placed below non-modified, naïve substrates.  Here, α-SMA expression is 
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stained red, the cytoskeletal structure is stained green, and nuclei are blue colored. Scale bar 
represents 100 µm. 
 
Unlike the live/dead assay, which were carried out after two days, these samples were 
incubated for ten days. This longer time period allowed for greater cell proliferation a on the stiffer, 
naive substrates as well as all FN-modified gel surfaces.32 On the softer substrates, the fibroblasts 
exhibited stellate morphology, indicating their potential ECM remodeling activity which will be 
discussed further.48  
 
8.3.4 Secreted Collagen Levels 
 We are interested in the  influence mechanical stiffness has on collagen secreted by 
fibroblasts to better understand how materials properties influence the host response49 to improve 
rational design of scaffolds. Collagen is a non-centrosymmetric protein and is SHG active. Here, 
we quantified collagen secreted by NIH/3T3 fibroblasts in response to these hydrogel substrates. 
Combining the analysis from ICC staining of the cell-hydrogel samples with the SHG microscopy, 
the collagen signal was normalized to the number of nuclei stained by DAPI (Figure 8.5). This 
normalization allowed us to gauge the influence of the underlying substrates while controlling for 
differences in cell numbers on each substrate. For 30% and softer hydrogel samples, more collagen 
was measured on FN-modified substrates compared with the naïve substrates. There were no 
differences observed for the stiffer FN and naïve surfaces. Glass controls had significantly more 
collagen than the softer gels. 
212 
 
 
 
Figure 8.4. Collagen secretion by NIH/3T3 cells seeded on alginate hydrogels was evaluated 
using SHG microscopy. Surface seeded NIH/3T3 fibroblasts on naïve and FN-modified ALGMA 
hydrogels were imaged using SHG microscopy after being cultured for 10 days. Collagen signal 
was normalized to the signal from the respective non-cell seeded hydrogels as well as to the 
number of nuclei observed from the ICC staining of these samples. Data represents the mean ± 
SD. n = 3.  
 
8.3.5 Collagen Organization 
 Remodeling ECM proteins is an important aspect of fibroblast activity at different tissue 
interfaces.50,51 There is a dearth of information on how materials properties influence collagen 
organization. Here, we studied how alginate-based hydrogels with Young’s moduli in the range of 
~7 to 20 kPa influences collagen organization by NIH/3T3 fibroblast. Orientation maps are 
presented in Figure 8.5 in which the lines illustrate the angle calculated for each individual ROI. 
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These lines are color coded to better visualize regions of organization. Images with a range of 
colors indicate that the collagen is disorganized, whereas images with regions of one color are 
more aligned. 
 Stiffer substrates resulted in more aligned collagen organization as evidenced by lower FWHM 
values (< 60 °). The FWHM increased, indicating collagen was more disordered, on the softest 
substrates (Figure 8.6). Modifying the surface with FN caused collagen to be less aligned (higher 
FWHM). The ability of FN-modification to increase stochasticity of collagen organization could 
be pertinent for dermal tissue engineering platforms, in which native tissue is isotropic.41 
Figure 8.5. Visualizing organization of collagen secreted by fibroblasts on alginate hydrogels. 
Collagen secreted by NIH/3T3 fibroblasts seeded on the different alginate hydrogels were 
analyzed using SHG microscopy on day 10. The arrows are placed on areas where collagen signal 
was detected, and the colors represent collagen organization angle. The legend for the heat map is 
provided on the right 
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Figure 8.6. Correlating Young’s modulus to changes in collage organization. Collagen 
organization mapped in terms of the FWHM against the Young’s modulus of the gradient 
hydrogels for both the naïve and FN-modified samples. 
 
Myofibroblast activity indicates remodeling the ECM and is often associated with a fibrotic 
or scarring response post-wound healing.52,53 We analyzed the α-SMA expressing cells to quantify 
the cell population % that shows possible transition to myofibroblasts. This analysis yielded an 
interesting observation in which there appears to be a possible threshold stiffness beyond which 
there is less fibroblast differentiation at the 30% hydrogel (15 kPa) for the FN-modified hydrogels 
(Figure 8.8). The naïve substrates on the other hand showed no significant α-SMA positive cells 
beyond the glass control and the stiffest 0% hydrogel substrate.  
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Figure 8.7. Evaluation of α-SMA expression by NIH/3T3 cells seeded on alginate hydrogels. 
Surface seeded NIH/3T3 fibroblasts on naïve and FN-modified ALGMA hydrogels were imaged 
using SHG microscopy after being cultured for 10 days. Collagen signal was normalized to the 
signal from the respective non-cell seeded hydrogels as well as to the number of nuclei observed 
from the ICC staining of these samples. Data represents the mean ± SD. n = 3.  
8.4. Discussion 
The organization of collagen during diverse biological processes such as response to 
foreign implants,54 wound healing,29,55 and aging56 has a significant impact on tissue properties. 
Studies have shown strong correlations between the stiffness of a material and the collagen 
response to it under both in vivo and in vitro conditions.57 In this study, we examine the role played 
by stiffness of photocrosslinked ALGMA hydrogels across a range of 7 to 20 kPa. Through 
quantitative as well as qualitative analysis of the cell response to the different mechanical 
environments, the mechanotransduction of NIH/3T3 fibroblasts was examined to improve design 
of criteria compliant scaffolds.  
 The adhesion of cells to solid interfaces is a fascinating process that occurs across a wide 
variety of conditions both in vitro and in vivo.12,58 We have previously observed how cells sense 
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the mechanical stiffness of their encapsulating environment of soft38 and relatively stiffer ALGMA 
hydrogels.39 Here we used a photomask to tune the stiffness of ionic chain growth ALGMA 
hydrogels from 6.9 ± 0.4 kPa to 20.2 ± 0.4 kPa (Figure 8.1). This range allows us to observe the 
impact of stiffness on the mechanotransduction of cells, particularly their ECM deposition, 
differentiation, and morphology over a physiologically relevant range.59–62 Previous studies have 
shown the sensitivity of fibroblasts to the stiffness of substrates that they are cultured on, 
particularly for establishing necessary conditions to avoid senescence.63 We are interested in 
determining the effect stiffness has not only on fibroblast-to-myofibroblast transitions, but also on 
collagen organization. Tissues have different collagen organization depending on their function, 
ranging from disordered structures within healthy dermis55 to highly aligned collagen fibers in 
tendons64 and parts of the cornea.65 The influence of the collagen organization at the micro-scale 
has the potential to instigate differentiation of stromal and mesenchymal stem cells, and their 
subsequent activity at the cell-matrix interface.66,67 Fibroblast differentiation to myofibroblasts in 
particular is clinically relevant in that it is linked to scar tissue.68 
 FN is a well-known surface adhesion protein and was incorporated on the surface of the 
ALGMA hydrogels to examine the effect of cell adhesion motifs on cell behavior. As expected, 
there was an increased cell proliferation normalized to TCP on the FN-modified hydrogels 
compared to naïve substrates (Figure 8.2). As the opacity of the photomask increased (stiffness 
decreased), cell proliferation decreased. Similar studies have used laminin-derived cell adhesion 
motifs to examine how cell-binding domains influence how cells sense surfaces for attachment.25 
Additionally, cell encapsulation within these gradient hydrogel environments will provide closer 
approximations for the cell response to native tissue which is anticipated as the ideal next step in 
preparing effective tissue engineering scaffolds.69 
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 Visualization of the cell response to diverse underlying substrates allows us to observe 
changes in morphology.70 The sensitivity of fibroblasts to the underlying substrates can be 
observed by how the cells spread, show actin stress fibers, and exhibit stellate morphology.32,71 
Even on the softest, naive 90% hydrogel substrates (~7 kPa), the cultured fibroblasts showed 
stellate morphology with clear actin stress fibers (Figure 8.3). Although cell proliferation itself 
was significantly lower on the naïve substrates, there were no morphological differences in cell 
organization. This correlated well with the live/dead images obtained in this study as well as our 
previous research which showed that the sensitivity of cells on such substrates influences 
proliferation but not morphology.39 Similar studies on functionalizing alginate hydrogels with FN 
showed no significant differences in the morphology of encapsulated mesenchymal stem cells 
regardless of adhesion motifs over a range of mechanical stiffnesses (5 to 110 kPa).72 A seminal 
study on the mechanical memory of lung myofibroblasts showed the cells’ preference for stiffer 
substrates across a similar range of 5 to 100 kPa to TCP with no differences in cell morphology 
after decoupling proliferation effects.63 
ICC staining aided in identifying fibroblast response to the different hydrogel gradient 
surfaces through the expression of α-SMA. As expected, myofibroblast presence was observed on 
the FN-modified glass, 0%, and 10% substrates. The amount of α-SMA+ cells decreased 
exponentially with decreasing stiffness. Very little α-SMA is expressed in the naïve surfaces 
outside of the glass controls. The presence of actin stress fibers with no α-SMA expression can be 
interpreted as evidence of protomyofibroblast transitions of the seeded fibroblasts.73,74 Previous 
studies suggested that the protomyofibroblast transition is at 5 to 9 kPa, which is in line with these 
results. Similarly, these studies have also seen that myofibroblasts differentiate at 16 kPa.75 
Previous studies have indicated that FN can alter the mechanotransducive signaling of surface-
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seeded fibroblasts.76 Extra domain-A(ED-A) FN domain was found to be critical for the 
differentiation of cultured subcutaneous, lung, and dermal fibroblasts when exposed to 
transforming growth factor-beta1 (TGF-β1). The ED-A domain FN expression showed a positive 
correlation with α-SMA levels, with a 5-fold increase over the first 24 h and a 6.5-fold over the 
next 48-72 h.77 This indicated that the expression and binding to FN is an important intermediary 
step for effectively differentiating fibroblasts which in turn influences ECM remodeling and 
collagen I expression.78 
 Designing scaffolds for minimal foreign body response necessitates better understanding 
of how cells secrete ECM proteins in response to different environments.79 Our previous studies 
mapping the differences of secreted collagen levels inside diverse crosslinked hydrogel 
environments and showed that this aspect can be tuned through different materials properties.38 In 
this study, we focused on the effect of the compressive modulus of underlying hydrogel substrates 
for modulating collagen secretion response. The FN-modified surfaces mimicked natural 
conditions in which cell binding motifs would be readily available.80 Collagen secretion was 
measured using SHG microscopy. Molecules are SHG active if they are non-centrosymmetric. 
Collagen, by having a triple helix, is non-centrosymmetric and SHG active. The collagen signal 
was normalized to the number of cells using the DAPI channel in the ICC images. In general, there 
appeared to be a downward trend for the FN-modified and naïve substrates (Figure 7.4), as was 
expected from comparison to similar studies.24 When comparing the FN-modified and naïve 
substrates, there were no significant differences for glass, 0%, and 10% substrates. Once the 
stiffness increases to ~16 kPa (30% opacity), the amount of collagen secreted normalized to cell 
number is higher on the FN-modified substrates than the naïve surfaces. Differences in the stiffness 
of surrounding ECM critically influence protein expression. Studies on both epithelial as well as 
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3T3 cells showed significantly up-regulated integrin on stiffer gels (22 kPa) as compared to very 
soft gels (< 1 kPa), which concur with our observations.81,82 With the integrin expression 
influencing the effectiveness of TGF-β based differentiation of fibroblasts to myofibroblasts, how 
fibroblasts sense different substrates is important to understand.12,83 These results suggest that there 
is a continuum transition from fibroblasts to protomyofibroblasts to myofibroblasts based on 
collagen secretion and α-SMA expression. Depending on the site of activity, different stiffnesses 
instigate differentiation, which is subsequently followed by increased expression of collagen I.78,84 
The threshold stiffness for myofibroblast differentiation has confounded researchers, as it is 
variable based both on location but also the characterization technique applied.75,85,86 Substrates as 
soft as 16 kPa have been sufficient for instigating differentiation.75,87 Fibrotic tissues on the other 
hand have been shown to exhibit stiffnesses of 25 to 50 kPa for differentiation to myofibroblasts 
with consistent α-SMA expression.42,88,89 
 Achieving similar collagen organization in tissue engineering scaffolds compared to native 
tissue would increase compliance of implanted materials.90,91 SHG images of the hydrogels were 
obtained and the angle of collagen in each ROI was calculated using equation 4. These angles were 
the mapped and color coded using a heat map to better illustrate regions of alignment – areas of 
similar color indicate aligned collagen, whereas areas with many different colors are isotropic 
(Figure 8.5). In general, organization on both FN-modified and naïve substrates decreased with 
decreasing stiffness. This effect was quantified by generating histograms of orientations maps and 
fitting them to a Gaussian curve. The FWHM obtained from the fit is plotted in Figure 8.6 against 
Young’s modulus and shows a negative correlation for both substrates (R = -0.94 and R = -0.93). 
By extending the plotted fits for both conditions, it was estimated that they would intersect at a 
stiffness of 30.7 kPa, where it would be interesting to see if cell binding motifs, in this case FN, 
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would lose their ability to influence collagen organization at this higher stiffness. In examining 
glass, which is approximately 3 GPa, the amount of collagen secreted per cell does not appear to 
be influenced by FN, however, FN does influence the presence of myofibroblasts. Using these 
experimental observations, we can formulate some basic design principles for achieving the 
desired collagen organization for a particular application. First, relatively soft hydrogels can be 
used as dermal wound dressings, which would require isotropic collagen alignment.92 Patients 
suffering from burn wounds in particular show significantly ordered conformation at the surface, 
which can be treated with scaffolds that instigate stochastic neo-collagen secretion to boost the 
healing process.93,94 On the other hand, one of the critical differences in diseased versus healthy 
lung tissue has been observed as the increased stiffness of the former.78,95 Cartilage tissue is more 
aligned and would require hydrogels ~ 15 kPa based on collagen alignment, which are significantly 
softer than the stiffness of cartilage (>0.5 MPa) observed in human subjects. 96–98 Collagen 
organization within tissues such as the cornea is complex as it varies greatly with highly aligned 
fibers observed in bundles, which on a bigger scale are a part of a dense network of connective 
tissue.67,99,100 Aligned collagen has been observed in mechanically stiffer environments like bones 
and tendons where relatively rigid scaffolds can be applied to obtain greater compliance of the 
secreted collagen response to guide tuning of disordered collagen which get deposited upon 
injury.101  The influence of such tuned hydrogel systems to elicit diverse organization of secreted 
collagen (Figure 8.8) can help inform innovative tissue engineering platforms for diverse 
biomedical applications.  
221 
 
 
 
Figure 8.8: Influence of FN on collagen FWHM. Histograms of collagen organization obtained 
for collagen secreted by NIH 3T3 fibroblasts surface seeded on the ALGMA hydrogel across the 
naïve and FN-modified substrates. The bars represent experimentally acquired data. The red line 
is the Gaussian fit to the data. 
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8.5. Conclusions 
 In this study, we fabricated ALGMA hydrogels across a range of mechanical stiffnesses (7 
– 22 kPa) using photomasks to control the crosslinking density for examining the influence of 
mechanical cues on cell morphology and collagen secretion. NIH/3T3 fibroblasts showed no 
cytotoxic response to being seeded on these substrates. FN surface modifications increased cell 
proliferation across all conditions. A clear influence of the stiffness of the hydrogel gradient 
substrates on the NIH/3T3 fibroblasts was seen with a positive correlation for secreted collagen 
levels, as well as cell proliferation. Modifying the surface with FN also increased myofibroblast 
differentiation as well as the disorder of collagen deposited by these cells. In-depth 
characterization through the ICC staining and SHG imaging provides design guidelines for 
effective tissue scaffolds that can be tuned for specific natural implant environments. 
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CHAPTER 9 
GENERAL CONCLUSION 
 
Over the course of this research, detailed insight into the complex nature of cell-matrix interaction 
was obtained. Particularly from the perspective of tuning soft, biocompatible materials into 
physiologically relevant approximations of natural tissue environments, it was possible to evaluate 
cell proliferation and ECM secretion that is critical to wound healing, foreign body response and 
synthesis of bioactive scaffolds. Methacrylated alginate hydrogels were observed to swell 
significantly more under basic pH conditions, and demonstrate a range of viable crosslinking 
mechanisms, and thereby considered appropriate for responsive tissue engineering scaffolds. The 
collaborative studies with 3M provided a wide variety of wound healing tests that contributed to 
understanding the complexity of wound healing processes, particularly those relevant to reduction 
of scarring responses. Decoupling the influence of covalent crosslinking chemistry from the cell-
matrix interactions, provided insight into fibroblast differentiation and collagen fiber organization 
that will inform future studies on making extracellular matrices more compliant to the natural 
microenvironments. The overall goal of these studies on cell-laden hydrogels, animal tissue 
samples was achieved on the basis of the insight that has been obtained on the significant role 
played by collagen organization that needs to be considered for diverse biomaterial scaffolds.    
 
